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Elucidating Mechanisms of Neurobehavioral Dysfunction in a 
Rodent Model of Traumatic Brain Injury 
 
Aric F. Logsdon 
 
 
Neuropsychiatric symptoms and cognitive deficits are common among victims of a traumatic 
brain injury (TBI), and currently, there are no effective treatments to improve outcome. We first 
developed a clinically-relevant blast TBI model based on lung scaling parameters to elucidate 
mechanisms of neuronal cell death. In order to discover effective treatments to improve outcome, 
we had to validate our novel preclinical model of TBI. TBI is an external force that can cause 
damage to the neurovascular unit (NVU), which can lead to secondary effects, cell death and 
behavioral dysfunction. In our first study we observed that our model damaged the NVU, 
increased neuronal cell death, and produced cognitive deficits in young adult Sprague-dawley 
rats. The link between damage to the NVU and neurobehavioral dysfunction following TBI is 
poorly understood. Recently secondary injury cascades, such as endoplasmic reticulum (ER) 
stress and neuroinflammation, have been hypothesized to be early indicators for the development 
of neurobehavioral dysfunction. Therefore, we examined the regional and temporal profile of 
these secondary injury cascades using our validated rodent TBI model. We also measured 
neurobehavioral dysfunction using a variety of functional assays at various time points post-TBI. 
Tissues from brain regions associated with the behavioral sequelae of TBI were evaluated for 
biochemical changes. Furthermore, we investigated the neurophysiological response in brain 
slice recordings at various time points after TBI. We discovered that TBI produced spatial 
memory deficits in the rats and altered synaptic firing rates in the hippocampus. In our next 
study, we revealed a robust increase in markers of ER stress and neuroinflammation within the 
frontal cortex after TBI. Interestingly, we observed impulsive-like behavior in rats after TBI, 
which is indicative of damage to the frontal cortex. After characterization of the injury response, 
we investigated the role of ER stress modulation in mediating secondary injury cascades and 
neurobehavioral dysfunction following TBI. Salubrinal, an ER stress modulator, attenuated 
markers of neuroinflammation and neuronal cell death. Most importantly, ER stress modulation 
ameliorated impulsive-like behavior in rats after TBI. The final portion of this study was to 
elucidate a link between ER stress and the development of Chronic Traumatic Encephalopathy 
(CTE). We revealed a potential link between repetitive blast injury and neuropsychiatric 
symptoms associated with CTE. Tau phosphorylation and aggregation are considered hallmarks 
of CTE development. We observed an increase in marker of tau phosphorylation and 
conformational change in rats exposed to repetitive blast. We also observed spatial memory 
deficits and impulsive-like behavior after repetitive TBI. Together, these results suggest that 
repetitive blast exposure may lead to tauopathy and the behavioral sequelae associated with CTE. 
Future studies should aim to causally link secondary injury cascades to tauopathy in order to 
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Traumatic brain injury is acquired from an external force, which can inflict devastating 
effects to the brain vasculature and neighboring neuronal cells. Disruption of vasculature is a 
primary effect that can lead to a host of secondary injury cascades. The primary effects of neural 
injury are rapidly occurring while secondary effects can be activated at later time points and may 
be more amenable to targeting. Primary effects of brain injury include diffuse axonal shearing, 
changes in blood brain barrier permeability, and brain contusions. These mechanical events, 
especially changes to the BBB, can induce calcium perturbations within brain cells producing 
secondary effects, which include cellular stress, inflammation, and apoptosis. These secondary 
effects can be potentially targeted to preserve the tissue surviving the initial impact of TBI. In the 
past, TBI research had focused on neurons without any regard for glial cells and the 
cerebrovasculature. Now a greater emphasis is being placed on the vasculature and the 
neurovascular unit following TBI. A paradigm shift in the importance of the vascular response to 
injury has opened new avenues of drug treatment strategies for TBI. However, a connection 
between the vascular response to TBI and the development of chronic disease has yet to be 
elucidated. Long-term cognitive deficits are common amongst those sustaining severe or 
multiple mild TBIs. Understanding the mechanisms of cellular responses following TBI is 
important to prevent the development of neuropsychiatric symptoms. With appropriate 
intervention following TBI, the vascular network can perhaps be maintained and the cellular 








Traumatic brain injury (TBI) represents an enormous societal burden both with regard to 
prevalence/incidence and economic cost (initial treatment and long-term care due to high 
morbidity), largely irrespective of initial injury mechanism.  In fact, TBI is the leading cause of 
trauma-related morbidity and mortality in developed countries, with over 55 million people 
affected internationally (Bruns and Hauser, 2003).  Interestingly, the mechanism of TBI 
sustained is often related to the patient’s age with younger patients more likely suffering TBI as 
the result of motor vehicle accidents, sports, or battlefield exposure to blast waves whereas the 
elderly population is generally afflicted by falls (neurogenic or cardiogenic in origin).  TBI is 
also distributed bimodally with peak incidences between 15-24 years, and after 75 years of age.  
Notably, after age 65, patients have increased mortality and worse functional outcome following 
TBI (Susman et al., 2002). The most prominent cause of TBIs is motor vehicle collisions 
(Dagher et al., 2010). Concussive injuries are also high amongst professional athletes and the 
active military due to the high-risk for a neurotraumatic event to occur on the job (Guskiewicz et 
al., 2003; Rigg and Mooney, 2011). These sub-populations should therefore be the focus for 
future translational studies. 
TBI is unique in that it is always acquired from an external force. One difficulty when 
treating TBI patients is that we never know when, or how, a TBI will occur. Therefore, the 
contribution of genetic predisposition and comorbidities to overall post-injury outcomes are hard 
to ascertain. A valuable scale, called the Glasgow Coma Scale (GCS), is used to assess verbal, 
motor, and eye-opening responses in order to classify TBI severity (Kay and Teasdale, 2001). 
The score is based on a 15-point scale.  Mild injury correlates with a score of 13+, moderate with 
a score 9-12, and severe with a score of <8.  Its clinical utility is mostly to help determine patient 
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status in relation to intracerebral pressure (Balestreri et al., 2004).  As such, the clinician can use 
the score to determine the need for appropriate treatment or management. The values obtained 
from the GCS help define the severity of TBI and allows clinicians to address the injury more 
appropriately (Foreman et al., 2007). In addition, patients can display cognitive, emotional, and 
sensory impairments following mild TBIs and even exhibit physical impairments following more 
severe forms of TBI. Research now suggests that visible signs, or symptoms, of neurological 
dysfunction from sports-related TBI may not develop for an extended period of time (Bailes et 
al., 2013). 
Imaging modalities have recently been used to detect some of the subtle injury changes 
associated with TBI. Microdialysis in combination with nuclear magnetic resonance imaging was 
used to determine that TBI patients have increased anaerobic metabolism dependent on the 
pentose phosphate pathway (Jalloh et al., 2014). Diffusion tensor imaging has been used with 
mixed success in detecting white track lesions following concussion (Shin et al., 2014). 
Functional magnetic resonance imaging (fMRI) has been used to tease out differences in 
Salience Network functioning following TBI indicative of failed cognitive control (Jilka et al., 
2014). In the clinic, Czosynka’s pressure reactivity index can be used to establish a dynamic 
target for cerebral perfusion pressure (Depreitere et al., 2014). Another important consideration 
is monitoring of cerebral blood flow to prevent the occurrence of ischemia following TBI.  
Positron emission tomography, perfusion-weighted MRI, and the perfusion computed 
tomography scan may be used for this endeavor (Rostami et al., 2014). 
Two general forms of TBI exist: closed head injury and penetrating head injury (Peek-
Asa et al., 2001). TBI is grouped into three levels of severity: mild, moderate and severe 
(Peskind et al., 2013). Further subclassification of injury is based on symptoms. Subconcussive 
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injury can have no initial symptoms, concussive injury (acute) presents with cognitive, 
emotional, and sleep symptoms, while juvenile head trauma syndrome presents with a lucid 
interval and unconsciousness. Post-concussive syndrome involves concussive symptoms lasting 
greater than 3 months, and chronic traumatic encephalopathy involves a several year symptom 
free stage followed by onset of neuropsychiatric symptoms (McKee et al., 2014). Mild TBIs are 
common and can go undetected with conventional screening tools, although balance tests and 
cognitive measurements have been used with varied success rates (Harmon et al., 2013; Ruhe et 
al., 2014). Typically, mild TBI leaves the subject conscious with mild symptoms; however, 
rodent students have shown that secondary effects often lead to chronic deficits in cognition, 
memory, and behavior (Hamm et al., 1992; Milman et al., 2005). Molecular mechanisms of the 
secondary effects of mild and moderate TBI are being investigated due to the increased 
awareness of how these effects contribute to chronic neuropsychiatric symptoms (Koponen et al., 
2002). Severe TBI is often life-threatening and requires immediate care. Fewer basic scientists 
study severe TBI because its effects are more likely irreversible in both the short-term and the 
long-term.    
We have limited knowledge of what brain regions are most affected after a TBI, due to 
the fact the injury can either be focal or diffuse depending on the type and severity. As such, 
clinicians struggle with identifying which brain regions have been affected after injury. The 
brain’s response to TBI is more often globally distributed with a vast number of dilated 
perivascular spaces (Inglese et al., 2005). Pathologic changes are scattered throughout the brain 
as well and are highly dependent on neuroinflammation as evident from gliosis (Streit et al., 
2004). With the many different forms of TBI, the diagnosis and treatment plans must be 
adaptable and situational specific. 
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To date, the primary focus of TBI research has been on neurons with little emphasis on 
glial cells or the cerebrovasculature. Indeed, for this review, we identified 1030 published reports 
that assess neurons, and only 326 reports that assessed other brain cell types, including 46 reports 
on brain microvessels. The current skewing of research in TBI literature toward neurons is 
understandable, given the underlying goal of protecting neurons and preserving brain function. A 
neurocentric approach however has not resulted in successful translation of therapeutics in TBI 
(Maas, 2001; Kabadi and Faden, 2014), or other models of neural injury (Korczyn, 2012). It is 
clear other approaches are needed to be successful. Microvessel disruption plays a substantial 
role in primary, secondary and chronic effects of TBI, and understanding the response of the 
vascular system on brain trauma is critical to our ability to effectively treat brain trauma. As 
such, it is clear other approaches are needed and this review deals with the response of all brain 
cell types to trauma and focuses on the potential role of microvessel damage to neuronal loss and 
dysfunction. 
Forms of Traumatic Brain Injury 
In human subjects, there are a number of causes of TBI and include motor vehicle 
collisions, falls, sport-associated injuries, blast exposure, and shaken baby syndrome in infants 
(Table 2)(Zhang et al., 2014b). Besides characterizing the injury based on a specific inciting 
event, the injury can be described as open or closed head injury, focal or global injury, and 
impact or blast in origin.  Blast injury can be subdivided further into primary, secondary, tertiary, 
or quaternary injury, a level of detail beyond the scope of this review but discussed in detail 
elsewhere in the literature (Covey and Born, 2010; Yeh and Schecter, 2012). The different forms 
of neurotrauma can further be classified based on clinical features through the GCS assessment, 
pathological features through advanced imaging assessment, or a combination of the two.   
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While numerous causes of neurotrauma exist, TBI is uniformly associated with both 
primary and secondary injury mechanisms. The primary injury is induced instantaneously by the 
application of external forces to the skull and associated brain tissue, depending on the form of 
TBI. Impact TBI induces focal brain contusions (Sutton et al., 1993), while blast TBI globally 
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shears axons (Raghupathi and Margulies, 2002) and damages brain microvessels (Abdul-Muneer 
et al., 2013) (see Fig 1, Adapted from (Turner et al., 2013a)). The secondary injury follows the 
primary injury temporally and rodent studies have shown it is associated with induction of 
signaling cascades that alter metabolic, cellular and molecular events, ultimately leading to 
alteration in cellular function and/or death (Rink et al., 1995). This period of secondary injury 
can last from minutes to years and is mediated by biochemical processes that may be targeted by 
and amenable to therapeutic development (Ramlackhansingh et al., 2011); whereas primary 
injury can only be prevented (through safety devices, preventative measures, reduced exposure, 
etc). 
To improve understanding of TBI pathophysiology, as well as develop potential 
therapeutic agents, an array of TBI models have been created and utilized. Some of the most 
commonly utilized models include the fluid percussion models; variations of the impact 
acceleration or weight drop models, the controlled cortical impact models, and variations of the 
shock tube blast models. These models and others such as penetrating injury models are 
reviewed in depth elsewhere (Albert-Weissenberger and Siren, 2010; Xiong et al., 2013; Angoa-
Perez et al., 2014; Zhang et al., 2014b). Importantly, TBI represents a highly heterogeneous 
condition due to the various mechanisms involved and range in forces that are applied/sustained.  
As such, it is unlikely that one model is adequate for all TBI research and consequently a multi-
faceted approach is likely required. This is reflected in the approach taken by oversight and 
advisory groups in which consortiums have been formed to evaluate proposed therapeutics 
across a range of models in search of identifying not only promising therapeutic candidates but 
also the most appropriate scenarios in which to clinically test agents (Kochanek et al., 2011). 
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Importantly, the diversity of pathophysiological processes involved in neurotrauma has 
been increasingly recognized with recent studies investigating the role of non-neuronal cell 
types, such as astrocytes and microglia in neurotrauma, as well as the role of the neurovascular 
unit and associated blood-brain barrier (BBB). Emerging evidence with in vivo models has 
implicated these cell types and the BBB in outcomes following neurotrauma, with a particular 
emphasis on both microvascular and macroscopic components of vascular disruption (Jiang et 
al., 1992; Pop and Badaut, 2011; McKee et al., 2013; Miyauchi et al., 2013; Yeoh et al., 2013; 
Liao et al., 2014). This is particularly relevant clinically as macroscopic bleeds, such as epidural 
and subdural hematomas, may be managed neurosurgically, and microvascular/microscopic 
bleeds have been implicated in neurodegeneration associated with neurotrauma (Wilberger et al., 
1991; McKee et al., 2013).  
Traumatic Brain Injury Effects on Neurons 
Following TBI there are immediate primary effects and sub-acute secondary effects. 
Primary effects to the brain from TBI cause damage to neurons, glia, and the vasculature (Table 
3). Secondary effects to the brain from TBI include: inflammatory responses (Begum et al., 
2013), cellular stress (Farook et al., 2013), and apoptotic cascades (Clark et al., 1997). The 
physical forces of TBI can shear axons (Raghupathi and Margulies, 2002), break down 
plasmalemma (Cullen et al., 2011), and rupture brain microvessels (Arun et al., 2013). When an 
axon is torn, or a cell membrane is broken from the external forces of TBI, the neurons can 
rapidly depolarize and activate voltage gated Ca2+ channels; thereby, increasing intracellular 
Ca2+ (Gurkoff et al., 2013). Appropriate modeling of the primary effects of TBI will enable 
researchers to effectively study therapeutic options for the secondary effects.  
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Axonal injury has emerged as one of the most important pathological features of TBI. 
The rotational and acceleration/deceleration components of blast-induced TBI, commonly tears 
axons apart leading to a robust gliosis response and axonal degeneration (Creed et al., 2011; 
Goldstein et al., 2012; Li et al., 2013b). Axonal swelling and bulb formation are common 
morphological hallmarks observed following TBI and contribute to decreased action potential 
firing (DiLeonardi et al., 2009, 2012). Axonal injury is a result of TBI and is evident in the white 
matter areas of the brain (Li et al., 2013c), and is the initial pathology in neurodegenerative 
diseases (Adalbert et al., 2009). Injury to axons is present in all severities of TBI and may 
represent a key hallmark of TBI for modeling purposes (Johnson et al., 2013b). Therefore, 
defining the neurodegenerative mechanisms induced by axonal injury would allow us to better 
model the injury and identify specific targets for neuroprotection.  
The mechanical forces of brain trauma can also rupture microvessels (Abdul-Muneer et 
al., 2013). Specifically, the traumatic force causes an intracranial pressure spike which causes 
cerebral microvessels to burst (Arun et al., 2013). When an external force damages brain 
microvessels they can release cytotoxic levels of iron into the brain parenchyma (Liu et al., 2013; 
Nisenbaum et al., 2014). Iron promotes Ca2+-dependent mechanisms, which can stimulate cell 
survival, or trigger cell death depending on severity and duration of iron exposure (Munoz et al., 
2006; Munoz et al., 2011). Ca2+-dependent mechanisms observed following TBI include the 
unfolded protein response (Ron and Walter, 2007; Farook et al., 2013), proteasomal degradation 
(Sano and Reed, 2013), autophagy (Bernales et al., 2006), apoptosis (Clark et al., 2000; 
Nakagawa and Yuan, 2000), and neurodegeneration (Salminen et al., 2009). TBI-induced 
intracellular Ca2+ increase also prompts reactive oxygen species (ROS) accumulation (Cho et al., 
2013), triggers neuroinflammatory cascades (Szmydynger-Chodobska et al., 2010), and can 
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influence excitatory amino acids release (Shohami and Biegon, 2014). These secondary effects 
could potentially be targeted for therapy and warrant further investigation. 
Vascular Effects of Traumatic Brain Injury 
The external forces of a TBI induce vascular damage with both the initial insult and the 
ensuing secondary effects (Roth et al., 2014). It has been proposed that secondary effects can be 
therapeutically treated because they are driven by pathogenic alterations to signal transduction 
mechanisms. The vascular effects of TBI include vasospasms, hemorrhage, hypoxia 
inflammation and BBB disruption. Determining how TBI leads to cell death will provide a better 
understanding of the secondary effects and provide better therapeutic options. Targets could 
include BBB restoration after injury, or even using the injury to advantageously deliver drugs 
during a time window where the BBB is more permeable. This approach will allow 
pharmacological investigation of mechanisms using drugs that do not easily cross the BBB. 
Vasospasms, Subarachnoid Hemorrhage, Edema and Ischemic Hypoxia 
Cerebral vasospasm can be a serious outcome of TBI due to the resulting cerebral hypoperfusion 
(Izzy and Muehlschlegel, 2014). TBI can trigger molecular mechanisms that rapidly mediate 
vascular tone (See Fig. 2) (Chen et al., 2013a). One such mechanism is the release of a potent 
vasoconstrictor, endothelin-1, from damaged pericytes (Dore-Duffy et al., 2011; Paradis and 
Zhang, 2013). Parenchymal contusions and fever increase the risk for vasospasm (Shahlaie et al., 
2011). Up to 68% of individuals with TBI experience short duration vasospasms (Kramer et al., 
2013), which are especially common in soldiers exposed to blast TBI (Alford et al., 2011). 
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Vasospasms resulting from TBI can lead to ischemic episodes, energy depletion and cell 
necrosis; in other words, an inability for brain cells to compensate for increased metabolic 
functional overload (Ling et al., 2009). Vasospasms are frequently associated with recurrent 
intracranial hypertension and subarachnoid hemorrhage (Razumovsky et al., 2013; Wilson and 
Shankar, 2014). Blast TBI, in particular, can cause cerebral vasospasms that last for more than 
30 days and are associated with altered mental status (Magnuson et al., 2012). Severe vasospasm 
must be adequately treated to avoid permanent neurologic deficits or ischemic stroke (Bauer and 
Rasmussen, 2014). CT angiography is the diagnostic gold standard for vasospasm (Sanelli et al., 
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2014). Endovascular treatment and vasodilator therapy have both proven to be successful 
treatment approaches (Asakuno and Ishida, 2014; Kelman and Reavey-Cantwell, 2014). 
Mild TBIs typically exhibit subdural hemorrhaging, while more severe TBIs can display 
traumatic subarachnoid hemorrhage—increasing the likelihood of diffuse axonal injury, edema, 
and skull fracture (Mata-Mbemba et al., 2014b). CT imaging is the gold standard for diagnosis of 
subarachnoid hemorrhage severity (Mata-Mbemba et al., 2014a). The recent establishment of the 
clinical course score has allowed for the improved monitoring of subarachnoid hemorrhage over 
time (Brandner et al., 2014), and follow-up CT scans are only needed if new bleeding is a 
concern (Rubino et al., 2014). TBI has the highest average years of potential life lost for all 
neurological disorders partly due to traumatic subarachnoid hemorrhage (Rosenbaum et al., 
2014). Subarachnoid hemorrhage can lead to increased mortality, extended hospital stays, and 
central diabetes insipidus (Hochstadter et al., 2014). Most importantly a likely complication of 
subarachnoid hemorrhage is cerebral vasospasm (Faust et al., 2014). A common treatment option 
for hemorrhagic change that infiltrates the ventricles is a ventriculostomy followed by 
ventriculoperitoneal shunt placement (Chalouhi et al., 2014). In severe cases of TBI with 
subarachnoid hemorrhage where herniation is anticipated, decompressive craniectomy can be 
performed (Lazaridis and Czosnyka, 2012). Fortunately, most intracerebral hemorrhages are 
minor and will resolve on their own with time (Levy et al., 2013). 
Brain edema following TBI can cause serious complications by limiting brain oxygen 
delivery and increasing intracranial pressure (Nirula et al., 2014).  The pressure increase is more 
common in children experiencing TBI than adults (Ewing-Cobbs et al., 2000) Hounsfield unit 
values from brain CT mapped across an intracranial area can be used to accurately predict brain 
edema following TBI in children (Kim et al., 2014). A new imaging modality, shear wave 
14 
 
elastography, has also been tested in rodents and gives an accurate representation of edema (Xu 
et al., 2014b).Ulinastatin, a serine protease inhibitor, is currently being investigated for reduction 
of edema in rodents following TBI (Cui and Zhu, 2014). Decompressive craniectomies are 
common in clinical practice (Nirula et al., 2014). Decompressive craniectomies can prevent the 
intracranial pressure rise and potential herniation associated with edema (Bor-Seng-Shu et al., 
2013). Decompressive cranectomies are not without risk and a recent report showed 83% of 
patients developed hygromas and 50% of patients developed aseptic bone resorption (Pechmann 
et al., 2014). Continued work is necessary to find viable alternatives for the treatment of edema. 
A primary complication of ischemic hypoxia following TBI is hemispheric hypodensity 
(Foster et al., 2014). Ischemic hypoxia can cause the toxic release of hypoxia-inducible factor 1-
alpha (Schaible et al., 2014), leading to inflammatory cascades (Qutub and Popel, 2008). 
Outcomes from the inflammatory cascade include axonal injury and central myelin damage (van 
der Eerden et al., 2014). Point in time monitoring revealed that ~10% of TBI patients experience 
some ischemic hypoxia (Padayachy et al., 2012). Ischemic hypoxia following TBI is associated 
with poorer functional independence measures (Cullen et al., 2009). Applying techniques for 
brain oxygen optimization in clinical care has produced the most successful treatment results 
(Mangat, 2012). Continuous neurophysiologic recordings are imperative for appropriate patient 
management (Amantini et al., 2012). In extreme circumstances, red blood cell transfusion may 
be required (Kramer and Le Roux, 2012). Experimental treatment with mild hypothermia has 
produced profound preclinical neuroprotection in a variety of TBI models (Fujita et al., 2012a; 
Miyauchi et al., 2014) and initial human clinical trials (Lee et al., 2010) have proved promising. 
Blood-brain Barrier Disruption: Neuroinflammation and Reactive Oxygen Species  
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The neurovascular unit can become damaged with TBI. The neurovascular unit controls 
blood flow to the brain, nutrient delivery, and maintenance of BBB integrity (Hartmann et al., 
2014). The BBB is an anatomical structure that plays a key role in normal brain physiological 
regulation. The BBB is composed in part of astrocyte podocytes, a basement membrane, 
pericytes, and the endothelium connected with tight junction proteins. (Badaut and Bix, 2014). 
With regard to TBI, little is known about the role of BBB disruption in disease pathology (Alves, 
2014). 
Neurovascular inflammation can lead to the formation of ROS (Abdul-Muneer et al., 
2014). Neuronal injury can occur when ROS exceeds the brain’s defense and clearance 
mechanisms (Adibhatla and Hatcher, 2010). ROS are generated from mitochondrial damage as 
well as the nicotinamide adenine dinucleotide phosphate-oxidase system at the plasma 
membrane (Zhang et al., 2012). ROS can eventually contribute to disruption of the BBB, edema, 
and neuroinflammation (Pun et al., 2009). ROS contribute to downregulation of tight junction 
proteins at the microvessel interface (Abdul-Muneer et al., 2013). In addition, formation of ROS 
ultimately triggers glial cell activation producing additive injury to the brain parenchyma (Roth 
et al., 2014).  Oxidative stress stimulates the release of inflammatory factors: interleukin-1beta, 
tumor necrosis factor-alpha, and transforming growth factor-beta (Abdul-Muneer et al., 2014). 
ROS also disrupt the vasculatures ability to self-regulate and constrict (DeWitt and Prough, 
2009). Ultimately, ROS depression of cerebral metabolism can have long-term consequences 
manifesting in chronic neurodegeneration and behavioral abnormalities (Tavazzi et al., 2005). 
Proton therapy through use of hydrogen infused saline can limit the damage to endothelial cells 
by preventing BBB disruption and the formation of ROS (Ji et al., 2012). Another means of 
limiting oxidative stress is maintenance of mitochondrial homeostasis (Pandya et al., 2009). 
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Uncoupling the mitochondrial oxygen cascade early following TBI has proved beneficial in 
limiting ROS formation and calcium overload (Pandya et al., 2007). Cerebral microdialysis has 
been proposed as a diagnostic test for detecting the concentration of free radicals within the brain 
(Hillered et al., 2005). 
BBB disruption is common amongst TBI patients. Approximately 44% of patients who 
experience severe TBI have BBB breakdown (Ho et al., 2014). In addition to being effected by 
ROS, BBB breakdown itself can lead to enhanced neuroinflammation and the formation of ROS 
(See Fig. 3) (Abdul-Muneer et al., 2014). Damage to the BBB also leads to the release of 
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neurotoxic proteins into the brain parenchyma (Helmy et al., 2011a; Helmy et al., 2011b). 
Prolonged inflammation can eventually contribute to myelin loss (Glushakova et al., 2014). 
Omega-3 supplementation in rodents can limit BBB breakdown by inhibiting matrix 
metalloproteinase 9 activity (Russell et al., 2014). Targeting estrogen receptors may also be a 
viable therapeutic target due to decreased BBB permeability following TBI in female rats (Asl et 
al., 2013). 
Tight junctions between endothelial cells maintain vascular integrity, but are often 
sheared following TBI (Xu et al., 2014a). Blast TBI, in particular, causes a rapid blood pressure 
spike leading to disruption of the tight junction proteins at the BBB (Yeoh et al., 2013). 
Alternatively, astrogliosis can also lead to BBB modulation over time (Liu et al., 2014c). 
Astrocytes support endothelial cell function at the neurovascular unit and direct control of 
permeability (Molino et al., 2014). Astrocytes and neurons help support the basement membrane 
surrounding the endothelial cells (Schiera et al., 2003). Podocytes from astrocytes contain 
vascular endothelial growth factor, which can be released when the BBB is damaged (Saito et al., 
2011). The biomarker, pituitary adenylate cyclase activating polypeptide, offers promising 
diagnostic potential for determining BBB disruption (Bukovics et al., 2014). Currently, digital 
imaging quantification is the primary method of diagnosis (Biancardi et al., 2014). 
Secondary Effects of Traumatic Brain Injury 
Shortly after TBI, biochemical mechanisms assist in repairing cells that survive the 
primary insults of TBI. On the other hand, those same mechanisms can cause injured cells to die 
in order to preserve energy for other cells undergoing the energy-dependent repair process. The 
brain plays a game of checks and balances (using energy as currency) to determine which 
neuronal cells are worth saving after TBI. Programmed cell death, or apoptosis, is a necessary 
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mechanism following neuronal injury and may be beneficial to the CNS. However, the resulting 
effects from an apoptotic event can cause further damage within the brain through the process of 
neuroinflammation (Abdul-Muneer et al., 2014).  
Even after mild TBI neuronal apoptosis is evident around perivascular regions, indicative 
of cerebral vascular injury (Abdul-Muneer et al., 2013). Brain damage from TBI was reported to 
be associated with decreased mitochondrial membrane potential and increased release of 
cytochrome C in rodents—both indicative of cellular apoptosis (Wang et al., 2014). Cleaved-
caspase-3 and caspase-3 enzyme activity was reportedly increased in TBI animals versus control 
(Clark et al., 2000). Models of TBI have also shown upregulation of caspase gene expression 
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(Larner et al., 2004). These results indicate that caspase activity contributes to brain tissue loss, 
and that caspase inhibition may prove to be an effective treatment strategy for TBI. 
The secondary effects of TBI can be attenuated with therapeutic interventions given at 
the right time following neurotrauma. The series of molecular, neurochemical, cellular, and 
pathophysiological mechanisms resulting from TBI can be targeted with drug therapy designed 
to manipulate the signaling mechanisms of various cellular and subcellular processes. The 
secondary mechanisms of TBI include: neuroinflammation, oxidative stress, endoplasmic 
reticulum (ER) stress, glutamate excitotoxicity, calpain processing, apoptosis and tau 
hyperphosphorylation (see Fig. 4). The timing and duration of each event is dependent on the 
type and severity of the TBI in question; therefore, each treatment strategy could be 
individualized to the specific type of TBI. The aforementioned secondary mechanisms are 
described in more detail below. 
Endoplasmic Reticulum Stress, Excitotoxicity and Calpain Processing 
TBI occurs over a very short duration, and is often mild in nature, compared to other 
neural injuries. TBI often goes undetected and chronic deficits often take years to develop 
(Omalu et al., 2011a; Omalu et al., 2011b). TBI harms neurons by perturbing Ca2+ homeostasis 
in an energy-independent process. The damage done by TBI makes membranes more permeable 
to Ca2+ and even to extracellular proteins (Arun et al., 2013). What is known is that neural injury, 
in particular TBI, causes massive neuronal depolarization and a resulting large influx of Ca2+. 
Cells which withstand the immediate physical injury from TBI, will have disrupted intracellular 
Ca2+ levels and oxidative stress (Malhotra and Kaufman, 2007). As described previously, 
oxidative stress can induce neuroinflammation, which is known to cause neuronal death and is 
associated with chronic disease pathology (Cernak and Noble-Haeusslein, 2010). 
20 
 
ER stress has been implicated in a variety of TBI models (Rubovitch et al., 2011a; 
Farook et al., 2013; Begum et al., 2014). ER stress then triggers the unfolded protein response 
(UPR) as an endogenous means of cellular repair. TBI-induced Ca2+ perturbations cause proteins 
to unfold, and when the ER becomes overwhelmed and struggles to re-fold the unfolded proteins, 
the UPR ensues (Larner et al., 2006). In the short-term, the UPR can promote cell survival 
through three separate mechanisms: (1) attenuation of global protein translation, (2) upregulation 
of stress response genes, and (3) degradation of unfolded proteins (Mori, 2000). Apoptosis and 
neurodegeneration are the end-game consequence if ER stress and the UPR are prolonged 
(Deniaud et al., 2008; Moreno et al., 2012). The UPR has only recently been addressed by TBI 
investigators because of its new found link to neurodegeneration (Moreno et al., 2013). The 
timing and duration of the UPR and how exactly it develops into a neurodegenerative phenotype 
warrants further investigation. 
Another secondary mechanism of TBI also involving calcium disruption is glutamate 
signaling and the phenomenon known as excitotoxicity. TBI triggers a massive depolarization 
which promotes excessive glutamate release (Katayama et al., 1990). This disrupted regulation in 
glutamate signaling plays a role in the pathophysiology of TBI through the initiation of 
secondary injury cascades (Bullock et al., 1998).  High extracellular glutamate promotes high 
levels of intracellular Ca2+ following TBI (Truettner et al., 2007). Secondary injury cascades 
initiated by glutamate receptors and the disruption of Ca2+ homeostasis will activate calcium-
dependent proteases, disrupt energy-dependent processes, and produce oxidative stress (Faden et 
al., 1989; Yi and Hazell, 2006). Using drug therapy to regulate glutamate release may help to 
attenuate the secondary effects of TBI exposure. 
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Loss of microvascular integrity and BBB compromise are often related to brain injuries 
involving Ca2+ perturbations. In brain trauma models acute and sustained activation of the 
calpain family of proteases has been implicated in neuronal death and TBI (Liu et al., 2014a). 
Calpains are acutely activated following TBI within the injured hippocampus and frontal cortex 
(Ringger et al., 2004). Calpain activation has been observed in degenerating dendrites and 
atrophic neurons after TBI, providing evidence that calpain activation may participate in 
neuronal loss after neurotrauma (Huh et al., 2006). Activation of Ca2+-dependent proteases, such 
as calpain, is a predicted outcome of membrane depolarization and loss of Ca2+ homeostasis. Its 
regulation of cytoskeletal dynamics contributes to plasticity (Greer et al., 2013) and is consistent 
with injury deficits in axonal architecture and disruption of synaptic plasticity (Dapul et al., 
2013). Animals exposed to TBI can exhibit damaged axonal hillocks, suggesting detrimental 
changes to their synaptic function (Baalman et al., 2013).  Moreover, calpain-dependent 
processes in TBI models have been suggested to attenuate overall electrophysiological responses 
(Park et al., 2013) and invoke more neuronal death (Schafer et al., 2009). 
Chronic Effects of Traumatic Brain Injury 
Alteration of cerebral blood flow has been linked to delayed neuronal death in the 
contusion penumbra (Engel et al., 2008). Hemorrhagic shock causes immediate reduction in 
mean arterial pressure with continued apoptosis over time due to perpetual lack of perfusion 
(Dennis et al., 2009). At extended time points TBI continues to cause disruption in the 
autoregulation of cerebral vasculature (Pop and Badaut, 2011). A primary mechanism is 
temporal changes in V1a vasopressin receptors (Szmydynger-Chodobska et al., 2004). 
Vasopressin receptor stimulation contributes to cerebral edema that leads to increased 
intracellular uptake of H2O from the blood (Marmarou et al., 2014). The disruption in vascular 
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supply can contribute to perivascular nerve damage (Ueda et al., 2006). In addition, systemic 
hypotension can contribute to chronic neurodegeneration (Long et al., 2009). Persistent 
activation of calpain proteases is another mechanism by which persistent hypotension leads to 
neuronal pathology (Newcomb et al., 1999). Calpains cleave the contractile components of 
vascular smooth muscles inhibiting their ability to contract (Neuhof and Neuhof, 2014). 
Not surprisingly, cerebral hypotension has been associated with neurodegenerative 
diseases such as Alzheimer’s disease and Parkinson’s disease (Le Heron et al., 2014). A genetic 
mutation in Neurogenic locus notch homolog protein 3 increases the risk for small vessel disease 
following TBI and has been linked as well to Alzheimer’s disease (Marchesi, 2014). 
Interestingly, microvasular defects may be linked to Alzheimer’s disease due to the increased 
incidence of neurological disease in TBI patients (Dennis et al., 2009). Preventative treatment 
approaches are limited, but a few experimental techniques appear promising. Closely regulated 
hypothermia therapy can prevent chronic microvessel changes and contustion expansion (Zhong 
et al., 2009), while compressing the internal jugular vein has also been shown to mitigate axonal 
injury and vascular disruption (Smith et al., 2012; Turner et al., 2012b). Because TBI cannot be 
predicted a post-injury therapy that mitigates the detrimental chronic effects is therefore needed.  
Tau protein hyperphosphorylation and amyloid beta oligomers are well-known markers 
of neurodegenerative disease. TBI has been shown to hyperphosphorylate tau protein (Goldstein 
et al., 2012), and produce amyloid beta oligomers (Smith et al., 2003), through mechanisms that 
are not completely understood. These neurodegenerative factors are activated immediately 
following TBI and can advance profoundly over time (see Fig. 5). The cellular repair 
mechanisms associated with these factors are more drawn out, and may contribute to 
neurodegenerative disease progression and brain matter loss (Hoozemans et al., 2007; Scheper et 
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al., 2011). Cortical tissue loss and white matter atrophy resulting from TBI are associated with 
cognitive deficits (Huh et al., 2008). Cognitive deficits in rodents have been observed at chronic 
time points following TBI (Petraglia et al., 2014c), indicating neurodegenerative disease 
progression in rodent models of TBI. How the primary effects of TBI manifest into chronic 
disease states is an area of ongoing investigation. The brains of professional athletes and military 
veterans are currently being examined with new imaging modalities to discover underlying 
causes behind neuropsychiatric symptoms such as post-traumatic stress disorder, chronic 
traumatic encephalopathy, and Alzheimer’s disease (Small et al., 2013). Moving forward, TBI 





Primary and secondary mechanisms of TBI are undergoing continued investigation. What 
remain to be determined are the tertiary mechanisms that mark the transition from acute injury to 
chronic neurodegeneration. Studying the broader role of cerebrovascular changes and how these 
changes interact with neurons and glia must be carefully considered in future investigations. 
Chronic mechanisms might very well deal with the vasoregulation of cerebral vessels and how 
microvessels respond to inflammatory markers. In addition, the theory of ‘inflamm-aging’ is 
likely to take precedence, because aged neurons and glia respond differently to injury-induced 
stimuli. How these aged cells interact with concurrently aged and previously injured vascular 
system has not been fully elucidated. Chronic disease states are subject to the effects of both age-
related comorbidities and aging itself.  
Future studies must incorporate a broader approach utilizing more representative models. 
Animal models of TBI have been developed, but therapeutics have not yet translated successfully 
to the clinic. Therefore, an increasing need exists for the development of more clinically relevant 
TBI models, and the use of advanced MRI and PET imaging to map the dynamics of brain injury 
responses. This will enable us to devise more effective therapeutic interventions for the amenable 
secondary effects. Further studies utilizing BBB compromise following TBI could be 
advantageous for pharmaceutical researchers attempting to alter brain mechanisms. In addition, 
the balance between protein phosphatases vs. kinases will need to be heavily investigated. 
Marking the transition to amyloidopathy and/or tauopathy will provide important insight into 
effective treatment windows. More importantly, understanding chronic mechanisms of injury 






































Study I: Validate neural injury in the rat model of traumatic brain injury over time 
 
Blast-induced traumatic brain injury represents a leading cause of injury in modern warfare with 
injury pathogenesis poorly understood.  Preclinical models of blast injury remain poorly 
standardized across laboratories and the clinical relevance unclear based upon pulmonary injury 
scaling laws.  Models capable of high peak overpressures with short durations may better 
replicate clinical exposure when scaling principles are considered.  In this work we demonstrate 
a tabletop shock tube model capable of high peak overpressures of short duration. By varying the 
thickness of the polyester membrane, peak overpressure could be controlled. Blast exposure was 
shown to decrease total activity and histology revealed markers of neuronal degeneration, 
increased glial activation, and Blood-brain barrier disruption. This work demonstrates one of the 
first examples of blast-induced brain injury in the rodent when exposed to a blast wave scaled 
from human exposure based on scaling principles derived from pulmonary injury lethality 
curves. 
 
Study II: Characterize traumatic brain injury in the rat by investigating primary injury 
effects, secondary injury cascades, neurophysiology and neurobehavioral dysfunction 
 
Traumatic brain injury resulting from blast exposure is the most common injury of military 
combatants. Animal modeling of blast-induced traumatic brain injury has demonstrated severe 
histopathological effects accompanied by loss of long-term synaptic plasticity and cognitive 
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performance due to tissue damage. Here we use a scaled blast model that was specifically 
developed to assess the neuropathological, neurophysiological, and biochemical effects of 
exposure to blast forces not severe enough to cause overt physiological deficits or behavioral 
changes. We find that mild blast exposure induces no observable macroscopic histological 
effects, but instead causes microvascular injury, axonal damage, and neuroinflammation in 
various brain regions including hippocampus. Hippocampal deficits in short term plasticity and 
synaptic excitability were observed after mild blast exposure. Biochemical analysis revealed that 
mild blast exposure invokes markers of excitotoxicity and neuronal injury in hippocampus. Thus 
mild blast exposure causes subtle but deleterious neurological effects in the absence of major 
behavioral deficits, suggesting that subclinical exposures to blast forces may initiate 
neuropathology. 
 
Study III: Investigate the effects of endoplasmic reticulum stress modulation on cellular 
fate and impulsive-like behavior in rats exposed to traumatic brain injury 
 
Neuronal injury following blast-induced traumatic brain injury increases the risk for 
neuropsychiatric disorders, yet the pathophysiology remains poorly understood. Blood-brain-
barrier disruption, endoplasmic reticulum stress, and apoptosis have all been implicated in 
neurotrauma. Microvessel compromise is a primary effect of neurotrauma and is postulated to 
cause subcellular secondary effects. What remains unclear is how these secondary effects progress 
to personality disorders in humans exposed to head trauma. To investigate this we exposed male 
rats to a clinically relevant traumatic brain injury model we have recently developed. The study 
examined initial Blood-brain barrier disruption, endoplasmic reticulum stress mechanisms, 
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apoptosis and impulsive-like behavior. The endoplasmic reticulum stress inhibitor, salubrinal, was 
administered (1mg/kg i.p.) to investigate its’ effects on neuronal injury and impulsive-like 
behavior associated with neurotrauma. Results would provide evidence that neurotrauma involves 
endoplasmic reticulum stress and suggest a promising molecular target for the attenuation of 
neuronal injury and amelioration of neuropsychiatric symptoms after neurotrauma. 
 
Study IV: Investigate the effects of endoplasmic reticulum stress modulation on 
neuroinflammation and risk-taking behavior in rats exposed to repetitive traumatic brain 
injury 
 
TBI is the leading cause of trauma related morbidity in the developed world. TBI has been 
shown to trigger secondary injury cascades including endoplasmic reticulum stress, oxidative 
stress, and neuroinflammation. The link between secondary injury cascades and behavioral 
outcome following TBI is poorly understood and warrants further investigation. Using our 
validated rodent blast TBI model, we examined the secondary injury cascades following single 
injury and how these effects may contribute to risk-taking behavior after repetitive TBI. We 
targeted these pathways with the cellular stress modulator, salubrinal, and investigated its role in 
decreasing neuroinflammation and risk-taking behavior after blast injury. Overall, these results 
would suggest a novel approach to treat neuroinflammation and neuropsychiatric symptoms 
following neurotrauma. 
 




Chronic neurodegeneration following a history of neurotrauma is frequently associated 
with neuropsychiatric and cognitive symptoms. In order to enhance understanding about the 
underlying pathophysiology linking neurotrauma to neurodegeneration, a multi-model pre-
clinical approach must be established to account for the different injury paradigms and 
pathophysiologic mechanisms. We investigated the development of tau pathology and behavioral 
changes using a multi-model and multi-institutional approach, comparing the pre-clinical results 
to tauopathy patterns seen in post-mortem human samples from athletes diagnosed with chronic 
traumatic encephalopathy (CTE). We utilized a scaled and validated blast-induced traumatic 
brain injury model in rats and a modified pneumatic closed-head impact model in mice.  Tau 
hyperphosphorylation was evaluated by western blot and immunohistochemistry.  Elevated plus 
maze and Morris water maze were employed to measure impulsive-like behavior and cognitive 
deficits respectively.  This study provides a multi-model example of replicating tau and 
behavioral changes in animals and provides a foundation for future investigation of CTE disease 












Chronic traumatic encephalopathy (CTE) is a serious neuropsychological disease identified in a 
growing number of soldiers and athletes exposed to repetitive traumatic brain injuries (TBIs). 
This progressive neurodegenerative disease is distinguished neuropathologically by 
neurofibrillary tau tangles with a predilection for perivascular and subcortical areas near reactive 
astrocytes. The disease is currently diagnosed post-mortem by pathologic identification of the 
neurofibrillary tangles. There is a need for pre-mortem diagnosis in an effort to understand 
disease pathophysiology and to develop targeted treatments. In order to accomplish this 
objective, it is necessary to discover the mechanistic link between acute neurotrauma and the 
development of chronic neurodegenerative and neuropsychiatric disorders such as CTE. The role 
of endoplasmic reticulum (ER) stress is important to investigate since protein kinase-like ER 
kinase (PERK), a key marker of ER stress, is co-localized with hyperphosphorylated tau in 
pretangle neurons. The long-term goal of this work is to understand how ER stress modulates 
and/or causes the neurofibrillary tau tangles seen in CTE. The central hypothesis is that ER stress 
contributes to the neuropathological findings of CTE, and that modulation of ER stress will 
improve outcomes. The significance of this proposal is that by examining and manipulating ER 
stress, a disease mechanism associated with tau hyperphosphorylation, we will aid in finding 
diagnostic and therapeutic treatment options which will have a substantial impact on overall 
understanding of acute brain injuries as well as chronic neurodegenerative diseases.  
By understanding the role that ER stress plays in the progression of CTE, it will facilitate 
the development of urgently needed diagnostics and therapeutics. New imaging modalities and 
biomarkers specifically focused on the identification of ER stress proteins will potentially prove 
to be an invaluable resource for diagnosing CTE following bTBI. In addition, ER stress 
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modification using a drug such as salubrinal will not only provide an effective treatment option 
but more importantly a preventative solution to mitigate CTE progression. The far reaching 
implications of this proposed research will improve health outcomes and disease management 
not only for CTE but also for related neurodegenerative diseases.Regardless of the time course of 
activation mediated by the different arms of the ER stress pathway, the valuable information 
obtained about the transition phase between cell survival and cell death will provide a strong line 
of evidence for exactly when the process of neurodegeneration begins following blast injury. 
Understanding the role of ER stress in bTBI will improve our ability to locate pharmacologic 
targets to treat and ideally prevent CTE. 
TBI has profound and measurable effects on cerebral vasculature. Due to the variable 
expression of TBI in the hospital setting, as characterized by the Glasgow Coma Scale and 
advanced imaging, individual treatment approaches are a necessity. Understanding complication 
of TBI such as subarachnoid hemorrhage, vasospasm, and ischemia are necessary in appropriate 
patient management. Mechanism of injury such as acceleration/deceleration, axonal damage, and 
vascular disruption are also important to keep in mind. The most promising targets include 
secondary injury cascades such as oxidative stress, neuroinflammation, and ER stress. Future 
approaches may target chronic mechanisms involved in the development of neurodegenerative 
disease. Better pre-clinical models are necessary to map more complex systems such as 
glutamate toxicity and calpain mediated cell death. Moving forward, treatment of secondary 
mechanisms affecting vascular dynamics is critical both acutely and chronically. Consideration 
of age and comorbidities remains a constant factor in any form of neuronal injury. 
Neurodegeneration and cellular apoptosis are common following TBI, but improved 
management acutely can prevent the common sequelae of symptoms. In order for successful 
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therapeutic options to translate to the clinic, TBI research needs to move away from the common 
neurocentric approach and change focus towards vascular effects, glial responses and 
neurodegeneration. 
In summary, ER stress, and the UPR, is activated following TBI. The primary effects of 
TBI can produce excess ROS, increased intracellular Ca2+ levels, and induce inflammation; 
however, the timing, severity, and duration all vary from model to model. It is difficult to prevent 
the immediate effects of TBI, but we can attempt to mitigate the secondary effects that follow. 
Preventative therapies, mostly pharmacological agents, have been employed in pre-clinical 
models of neural injury, but nothing has yet to successfully translate to the clinic. The approach 
has been to mediate apoptosis and reduce neurodegeneration. However, the underlying link 
between ER stress, apoptosis and neurodegeneration is not yet fully understood. Research is now 
being focused on the most effective treatment strategies to suppress chronic effects resulting 
from neural injury. Of particular importance is transferring preclinical success to effective 
treatment options for human care. Evidence suggests that combining therapeutic options that 
target multiple injury components at the ideal time window will be the most effective strategy 
going forward. 
Our expectations are that we will determine the role of ER stress in CTE development 
and progression. Furthermore, we will show that appropriate manipulation of the ER stress 
pathway will improve outcomes in preclinical study, thus justifying the need for further studies, 
including those in a clinical population. The significance of this proposal is that by examining 
and manipulating the mechanistic process of this disease we will aid in finding diagnostic and 
therapeutic treatment options, which will have a substantial impact on overall understanding of 
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Blast-induced traumatic brain injury represents a leading cause of injury in modern warfare 
with injury pathogenesis poorly understood.  Preclinical models of blast injury remain poorly 
standardized across laboratories and the clinical relevance unclear based upon pulmonary injury 
scaling laws.  Models capable of high peak overpressures with short durations may better replicate 
clinical exposure when scaling principles are considered.  In this work we demonstrate a tabletop 
shock tube model capable of high peak overpressures of short duration.  By varying the thickness 
of the polyester membrane, peak overpressure can be controlled.  We used membranes with a 
thickness of 0.003, 0.005, 0.007, and 0.010 inches to generate peak reflected overpressures of 
31.47, 50.72, 72.05, and 90.10 PSI, respectively.  Blast exposure was shown to decrease total 
activity and produce neural degeneration as indicated by fluoro-jade B staining.  Similarly, blast 
exposure resulted in increased glial activation as indicated by an increase in the number of glial 
fibrillary acidic protein expressing astrocytes compared to control within the corpus calllosum, the 
region of greatest apparent injury following blast exposure.  Similar findings were observed with 
regards to activated microglia, some of which displayed phagocytic-like morphology within the 
corpus callosum following blast exposure, particularly with higher peak overpressures.  
Furthermore, hematoxylin and eosin staining showed the presence of red blood cells within the 
parenchyma and red, swollen neurons following blast injury.  Exposure to blast with 90.10 PSI 
peak reflected overpressure resulted in immediate mortality associated with extensive intracranial 
bleeding.  This work demonstrates one of the first examples of blast-induced brain injury in the 
rodent when exposed to a blast wave scaled from human exposure based on scaling principles 





Blast-induced traumatic brain injury has been described as the hallmark injury of modern 
warfare (Elder and Cristian, 2009; Nakagawa et al., 2011) with ~25,000 members of the armed 
services (U.S. and Coalition forces) injured or killed by explosive devices in Iraq and Afghanistan 
conflicts in the past decade (Champion et al., 2009).  The prevalence of blast exposure is associated 
with an immense financial and societal burden with estimates of 13-22% of combat veterans 
having sustained a traumatic brain injury (TBI) during time in service (Schneiderman et al., 2008; 
Terrio et al., 2009; Panzer et al., 2012).  Consequently, there is a clear clinical need for increased 
understanding of blast injury pathogenesis and the development of improved therapeutics for the 
treatment, or prevention, of blast-induced brain injury.  Increasing efforts to study blast injury has 
resulted in the propagation of numerous preclinical models of blast injury with the shock tube 
representing the most widely used model type.  Despite the extensive use of shock tube models, 
model parameters such as size of the driver and driven sections, membrane material and thickness, 
and gas used seem to vary across laboratories.  As such, the shock waves produced vary 
significantly in peak overpressure and duration. 
Recent work by Panzer and colleagues has identified potential discrepancies between many 
preclinical models and real-world recorded blast parameters with models often exposing small 
rodents to long duration blasts (Panzer et al., 2012).  Assuming the same scaling principles apply 
as those discovered with regards to pulmonary blast injury, many current rodent models, in which 
overpressure exposure durations frequently exceed 4 ms and in some cases as much as 10 ms or 
more, may be subjecting animals to the equivalent of a human exposed to detonation of 27,000-kg 
of TNT from over 70 m away (Panzer et al., 2012).  In other words, many preclinical models may 
be exposing animals to the equivalent of long-duration nuclear blasts in humans rather than the 
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more common high explosive blasts (Bass et al., 2012).  Therefore, a preclinical blast model 
capable of delivering high peak overpressures over short durations may be of value, particularly 
should similar scaling laws exist in brain, as is the case in pulmonary-based work. 
In this work we demonstrate the ability to model blast injury with clinically relevant peak 
overpressure and duration based on scaling laws from humans to rodents with a novel, tabletop 
shock tube model.  Furthermore, we show the ability to model blast injury of varying severity with 
different PET membranes that result in reflected peak overpressures ranging from 31-90 PSI while 
consistently being of short duration (< 3 ms).  Animals exposed to blast-induced traumatic brain 
injury across this range of pressures exhibit alterations in total activity as well as clear histological 




All procedures involving live animals were approved by the Institutional Animal Care and 
Use Committee of West Virginia University and were performed according to the principles of the 
Guide for the Care and Use of Laboratory Animals.  This worked used thirty 350 gram male 
animals acquired from Hilltop Lab Animals (Hilltop Lab Animals, Inc.).  Animals were acclimated 
for 1 week prior to experimental use and were housed under 12-hour light/12-hour dark conditions 
with food and water available ad libitum.   
Design of Blast Model 
A 4-piece, machined aluminum shock tube apparatus was constructed and driven using 
compressed nitrogen gas.  The driver and driven sections were separated by clear mylar 
membranes (Ridout Plastics Co.) of varying thickness (0.003”-0.010”) to achieve a range of peak 
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overpressure exposures.  A tapered design of the driver section (Figure 1) was included in an effort 
to minimize wave reflection and alterations of the blast wave by the expansion wave.  This feature 
is similar in nature to blast tubes utilizing explosives in which the explosive is often detonated in 
a conical or parabolic-shaped driver section.  The driver section was kept short in length in an 
effort to reduce the amount of gas required for membrane rupture and subsequent blast duration.  
The overpressure duration and impulse are reduced as described previously due to the shortened 
driver section (Bass et al., 2012).  For additional details concerning design of the blast model, 
please see Supplemental Information.   
Blast Waveform Acquisition & Analysis  
Shock wave pressures were detected using piezoelectric sensors (PCB Piezotronics) that 
were placed in both reflected and incident positions at the exit of the shock tube (Figure 1).  Data 
was acquired and processed using the National Instruments input module (NI 9223) connected to 
the National Instruments receiver USB chassis (CDAQ-9171).  Signals were recorded using a 
custom-designed Labview 12.0 program and the NI data acquisition system (National Instrument) 
with a sampling rate of 500 kHz as described previously (Chavko et al., 2011; Ahlers et al., 2012). 
Blast Exposure 
Prior to blast exposure, animals were anesthetized by intraperitoneal injection of ketamine 
(90 mg/kg; Webster Veterinary) and xylazine (5 mg/kg; Webster Veterinary).  Animals were 
oriented with the long axis of the animal perpendicular to the blast front.  In other words, the blast 
was delivered side-on to the head only as the thorax and abdomen were protected using rigid 
shielding, creating an experimental setup (Figure 1) similar to that used by Shridharani and 
colleagues (Shridharani et al., 2012).  With the animal placed directly at the exit of the tube, the 
effect of expansion waves on the planar conditions of the blast front is minimized as described by 
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Bass and colleagues (Bass et al., 2012).  Animals (n=38) were divided into the following groups: 
control (n=10), 0.003 membrane blast exposure (n=6), 0.005 membrane blast exposure (n=10), 
0.007 membrane blast exposure (n=9), and 0.010 membrane blast exposure (n=3).  Immediately 
following blast exposure, animals were returned to a holding cage equipped with a homeothermic 
heating blanket equipped with a rectal thermometer to maintain body temperature at 37 C.  Once 
basic reflexes were restored, animals were returned to the home cage. 
Total Activity Measurements 
Animal activity was measured using an automated activity monitoring system (San Diego 
Instruments).  Rats were given 1 hour to acclimate to the testing room prior to initiation of testing.  
Each testing chamber consisted of a 16 x 16 photobeam array surrounding a Plexiglass chamber 
to record lateral movements.  A separate 8 photobeam array to detect rearing activity was located 
above the 16 x 16 array.  Activity was quantified over a 30 minute period 24 hours post-blast 
exposure with total activity, ambulatory, and fine activity reported based on default settings of the 
data acquisition software (PAS, San Diego Instruments). 
Histological Preparations 
At 72 hours post-blast exposure, a total of 24 animals (6 control and 6 from each blast 
exposure group) were anesthetized as described above and perfused transcardially with cold 0.9% 
saline followed by 10% formalin for a total of ten minutes.  The brain was then extracted and 
placed into fresh 10% formalin for a minimum of 24 hours.  After 24 hours of fixation, the brain 
was blocked into sections and paraffin embedded as previous described (Turner et al., 2012c).  
Briefly, tissues were processed using the Tissue-Tek VIP 5 automatic tissue processor (Sakura 
Finatek) and embedded in paraffin using the Tissue-Tek TEC 5 embedding system (Sakura 
Finatek).  Tissues were sliced using a Leica RM2235 microtome (Leica Microsystems) and slices 
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mounted on slides for staining. Standard protocols were utilized for staining with hematoxylin and 
eosin (H&E), fluorojade-B (Millipore), which was used as a marker of neural degeneration, glial 
fibrillary acidic protein (Dako), which was used as a marker of reactive astrocytes, and ionized 
calcium binding adapter molecule (Wako), which was used as a marker of activated microglia. 
Images were acquired from the S1BF region of the cortex, corpus callosum, striatum, 
hippocampus, and cerebellum.  Imaging was performed using a Zeiss Axio Imager 2 for all 
brightfield and fluorescent images shown. 
Histological Quantification 
Stereology and the optical fractionator technique were used to quantify histological results 
as previously described. (Schmitz and Hof, 2005; Smith et al., 2012; Turner et al., 2012b) Briefly, 
a region of interest encompassing the corpus callosum was drawn at low power using an Olympus 
AX70 microscope and StereoInvestigator software.  The software then selected random 75-m 
counting frames with a depth of 6 m, and the object of interest marked by an observed blinded to 
treatment.  The volume of the region of interest previously identified is then determined by the 
software and the number of cells marked by the observer returned. 
Quantitative real-time PCR 
A total of 8 animals were used for quantitative real-time PCR and included 4 control 
animals and 4 animals exposed to blast using the 0.005 membrane.  Total RNA was extracted from 
the brain tissue (cortex, striatum, hippocampus, and cerebellum) of saline perfused animals using 
Trizol reagent (Invitrogen) according to the manufacturer’s instructions.  Sample concentration 
was determined by spectral absorption and the purity confirmed using a 260/280 ratio of 1.8-2.0.  
Samples of cDNA were prepared via reverse transcription using commercially available kits 
(Applied Biosystems).  Sample reactions included MultiScribe TM Reverse Transcriptase and 
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random primers, with thermal cycle conditions set as follows: step 1 at 25 C for 10 minutes, step 
2 at 37 C for 120 minutes, step 3 at 85 C for 5 seconds, and step 4 at 4 C for 10 minutes.  For 
PCR amplification, TaqMan Universal PCR Master Mix and the following probes were obtained 
from Applied Biosystems: 18s (Hs99999901_s1) for use as an endogenous control gene, GFAP 
(Rn00566603_m1), and Iba-1 (Rn00574125_g1).  The reaction mixture was prepared based on 
manufacturer’s instructions and the following thermal cycling conditions used: initial holding at 
50 C for 2 minutes to allow for optimal AmpErase UNG activity, followed by a first denaturing 
step at 95 C for 10 minutes, then 45 cycles at 95 C for 15 seconds, and at 60 C for 1 minute. 
Changes in gene expression were determined using the CT method and a threshold value of 0.2.  
Threshold cycle values of each gene were normalized to 18s rRNA. 
Data Analysis 
Data were analyzed using GraphPad Prism 5.0 (GraphPad Software, Inc.).  A one-way 
ANOVA with posthoc Tukey’s was used to compare across control and various blast-exposed 
groups.  For gene expression work a student’s t-test was utilized for comparing control and the 
blast-exposure group (0.005 membrane).  A P < 0.05 was considered statistically significant for 
all data analyzed. 
 
RESULTS 
Blast Model Design 
The model is capable of producing a characteristic Friedlander-type blast across a range of 
peak overpressures with short duration of exposure. The ideal blast wave in an open area, also 
known as the Friedlander curve, consists of a near-instantaneous pressure rise followed by an 
exponential decay of the overpressure (Bass et al., 2012).  With all membranes tested utilizing the 
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shock tube apparatus (Figure 2.1), ideal blast waves were obtained with a representative curve 
shown (Figure 2.2a).  Peak overpressure increased in a linear fashion with membrane thickness 
with both reflected (r2 = 0.92) and incident (r2 = 0.93) sensor orientations allowing for the 
simulation of multiple peak overpressures in the experiment (Figure 2.2b,c).    
Injury Severity 
High peak overpressure blast, even of short duration, is associated with high mortality and 
extensive intracranial bleeds. While reflected pressures of 31.47  3.049 and 50.72  3.368 PSI 
failed to produce any mortality, exposure to 72.05  1.212 PSI blast was associated with mortality 
in 3 of 9 experimental animals (33%) while 90.10  1.030 PSI blast exposures produced mortality 
in all 3 animals tested (100%).  Surviving animals failed to exhibit large hematomas at 72 hours 
post-blast (Figure 2.3a,b) but evidence of microvascular dysfunction and the potential for 
intraparenchymal bleeds was present (Figure 2.3c,d).  Animals exposed to survivable moderate 
peak overpressures in this work did display small hematomas immediately following blast 
exposure (Figure 2.3c), consistent with the work of Reneer and colleagues (Reneer et al., 2011).  
Mortality was associated with the production of intracranial bleeds in the cortex, particularly on 
the contrecoup side as well as in the brainstem (Figure 2.3e,f).  Similar findings have been 
observed utilizing explosives such as TNT in rat models in which animals placed in close range 
exhibit increased mortality rates associated with brain contusions, lacerations, and hematomas 
(Cheng et al., 2010). 
Vascular Injury 
Blast-induced brain injury results in the presence of intraparenchymal red blood cells, 
swollen neurons, and activated microglia. To further examine the effect of blast exposure on neural 
injury and microvascular dysfunction, particularly considering the presence of hematomas and 
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parenchymal blood on gross examination, brain sections underwent hematoxylin and eosin (H&E) 
staining.  The intraparenchymal blood was confirmed with H&E staining and red blood cells have 
clearly passed into the parenchyma and are no longer confined to the vasculature (Figure 2.4a).  
Evidence of neural injury and swollen, red axons was apparent in some animals (Figure 2.4b).  The 
presence of red neurons indicates a potential anoxic/ischemic insult (de Lanerolle et al., 2011), 
consistent with the presence of microvascular dysfunction observed following blast exposure 
(Svetlov et al., 2012).  The presence of activated microglia, capable of releasing an array of 
inflammatory mediators, was also seen with blast exposure and prompted further investigation of 
astro- and microgliosis. 
Neurodegeneration 
Neural degeneration occurs in a dose-response manner consistent with blast severity. Blast-
induced brain injury resulted in increased neural degeneration measured using Fluoro-Jade B 
staining in the S1BF region of the cortex on both the coup (F(3,23) = 47.03, P < 0.0001) and 
contrecoup (F(3,23) = 110.7, P < 0.0001) sides when analyzed by one-way ANOVA (Figure 2.5a-
d).  Post hoc tests revealed that blast-induced brain injury produced increases in neural 
degeneration compared to control at 31.47  3.049 PSI on the contrecoup side (q = 4.51, P < 0.05), 
50.72  3.368 PSI on both coup (q = 10.29, P < 0.0001) and contrecoup (q = 13.69, P < 0.0001) 
sides, and 72.05  1.212 PSI on both coup (q = 15.13, P < 0.001) and contrecoup (q = 23.76, P < 
0.0001) sides (Figure 2.5e-f).  Neural degeneration following blast exposure was also observed 
within other brain regions including the striatum, hippocampus, cerebellum and regions 




Blast injured brains demonstrate increased glial activation with increasing peak over-
pressure. Reactive astrocytes, identified by GFAP staining, were elevated significantly within the 
corpus callosum on the coup (F(3,23) = 26.08, P < 0.0001) and contrecoup (F(3,23) = 8.03, P < 
0.001) sides of the brain following blast-induced neurotrauma, consistent with findings from other 
blast injury models (Svetlov et al., 2012), when analyzed using one-way ANOVA (Figure 2.6a-d).  
Post hoc tests showed that blast injury resulted in elevated astrocyte reactivity at 50.72  3.368 
PSI on the contrecoup side (q = 5.13, P < 0.01) and at 72.05  1.212 PSI on both the coup (q = 
11.28, P < 0.0001) and contrecoup (q = 6.03, P < 0.01) sides (Figure 2.6e-f).   
Similar findings were observed concerning microglial activation, identified with Iba-1 
staining, with increased levels of microglial activation relative to control on both coup (F(3,23) = 
83.12, P < 0.0001) and contrecoup (F(3,23) = 25.37, P < 0.0001) sides (Figure 2.7a-d).  Again, 
although microglial presence was detected throughout the brain and appeared increased 
throughout, microglial activation was most prominent throughout the corpus callosum and internal 
capsule, consistent with other studies (de Lanerolle et al., 2011).  Notably, microglia appeared 
more rounded or amoeboid, typical of phagocytic microglia, within these white matter tracts 
consistent with white matter damage observed in human subjects following trauma (Johnson et al., 
2013c).  Previous reports in swine exposed to blast and assessed primarily at 2 weeks failed to 
identify extensive microglial activation, a potential reason for the discrepancy between studies (de 
Lanerolle et al., 2011).  Post hoc tests revealed increased microglial activation following 31.47  
3.049 PSI blast on the contrecoup side (q = 4.71, P < 0.05), 50.72  3.368 PSI blast on both coup 
(q = 8.37, P < 0.0001) and contrecoup (q = 7.85, P < 0.0001) sides, and 72.05  1.212 PSI blast on 
both coup (q = 20.49, P < 0.0001) and contrecoup (q = 11.92, P < 0.0001) sides as well (Figure 
2.7e-f).  The clear neuroinflammatory response, characterized by a graded glial response based on 
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peak overpressure exposure, observed in this work is consistent with findings by Cernak and 
colleagues in which mild and moderate blast exposure produced increases in GFAP, as well as 
ED1, a marker of microglia, at numerous time points (Cernak et al., 2011).  Importantly, activated 
microglia in other blast exposure studies have been associated with changes in neuron appearance 
such as darkened dendrites (Kaur et al., 1995) and in vitro work has demonstrated a mild activation 
of microglia following overpressure exposure with pulse duration altering microglial gene 
expression (Kane et al., 2012).  
Gene expression of GFAP (Figure 2.8a) was increased at 24 hours following blast exposure 
in the cortex (t = 2.412, P < 0.05) but not in the striatum (t = 0.022, P > 0.05), hippocampus (t = 
1.084, P > 0.05), or cerebellum (t = 0.634, P > 0.05).  The lack of difference in GFAP gene 
expression in regions outside of the cortex was in contrast to the visible differences seen in these 
regions at 72 hours based on immunohistochemistry (Supplemental Information).  The reason for 
this discrepancy is not entirely clear but may be due to consideration of the entirety of brain 
sections for gene expression studies when immunohistochemistry reveals findings largely located 
at the interface of regions and the gray-white matter junction.  Another possibility explaining the 
discrepancy between immunohistochemical and gene expression findings is the time of analysis.  
Only one time point for each assay was included and therefore, changes in gene expression could 
have occurred rapidly following blast and already declined to baseline by 24 hours.  No difference 
in Iba-1 gene expression (Figure 2.8b) was detected in the cortex (t = 0427, P > 0.05), striatum (t 
= 0.900, P > 0.05), hippocampus (t = 0.380, P > 0.05), or cerebellum (t = 0.448, P > 0.05), 




Blast-induced traumatic brain injury produces deficits in total activity regardless of 
severity. Total activity of the experimental subjects was decreased at 24 hours post-blast in all 
injured groups.  The total activity level post-injury did not vary based on injury severity with all 
injury groups demonstrating similar impairments (Figure 2.9a).  The deficits in total activity 
were due to a decrease in ambulatory activity associated with blast exposure (Figure 2.9b).  Blast 
exposure did not alter measures of fine activity (Figure 2.9c). 
 
DISCUSSION 
Efforts to model blast injury have been plagued by the lack of standardization across 
laboratories and the appropriate scaling of blast parameters to the animal species used based on 
data obtained from human studies.  Preclinical studies are varied with regards to animal placement 
within or outside of the shock tube, orientation to the blast front, protection of the thorax, and blast 
parameters, namely peak overpressure and duration of exposure.  Studies in soldiers revealed 
common IED exposures producing blast injury result from detonation of 105-mm and 155-mm 
artillery rounds at a distance of 5-10 meters.  Use of the Conventional Weapons Effects Program 
(CONWEP) (Hyde, 2004) allows for interpretation of these exposures in relation to blast wave 
parameters with a peak overpressure of 50-1000 kPA (7.25-145.03 PSI) and an exposure duration 
of 2-10 ms (Panzer et al., 2012).  As such, utilizing these parameters and scaling appropriately to 
preclinical animal species used may represent a more clinically relevant blast exposure and allow 
for improved elucidation of blast-induced injury pathophysiology and evaluation of proposed 
therapeutics. 
The concept of scaling blast injury to animal models is based largely upon previous works 
assessing pulmonary injury and primary blast survival across animal species.  Richmond and 
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colleagues identified, in various species, the effect of blast duration on lethality with longer 
duration blasts requiring a lower peak overpressure to produce mortality when compared to short 
duration blasts that required a significantly higher peak overpressure (Richmond et al., 1968).  A 
clear relationship between mass and blast parameters associated with lethality exists, particularly 
with regards to the more clinically relevant short duration blast (Richmond et al., 1968).  In fact, 
classical work by Bowen and colleagues investigated pulmonary injury in relation to blast 
exposure and created a model system in which scaling is based upon the height of burst divided 
by the cubed root of the mass (Bowen et al., 1968).  This has been simplified to an equation 
utilizing the cubed root of the reference mass (human) divided by mass of the experimental subject 
(Bass et al., 2012; Panzer et al., 2012; Shridharani et al., 2012).  The scaling equations developed 
have displayed significant utility in development of injury risk functions based upon the high level 
of agreement with pre-existing experimental data concerning blast survival and injury risk.  As 
such, while scaling of blast injury and associated blast parameters based on subject weight has not 
been related to neural injury (Park et al., 2011), scaling represents a logical step forward in more 
closely replicating clinically relevant exposures in laboratory models (Panzer et al., 2012; Rafaels 
et al., 2012; Risling and Davidsson, 2012).     
To address the question of how scaling affects blast-induced brain injury a shock tube 
capable of producing a range of peak overpressures with short durations was designed and utilized 
within this work.  Notably, the model produced clear neuropathological changes indicative of 
neural degeneration and glial reactivity.  These findings were consistent with work by Goldstein 
and colleagues in which single-blast exposure produced neurodegenerative changes consistent 
with chronic traumatic encephalopathy (CTE) (Goldstein et al., 2012) as well as other work 
utilizing scaling principles (Shridharani et al., 2012).  Similarly, neuropathological changes were 
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observed throughout the cortex as previously described (Goldstein et al., 2012) but were most 
prominent with the corpus callosum and internal capsule, consistent with previous findings in other 
blast injury models (Park et al., 2011).  It remains unclear why specific brain regions may be more 
susceptible to blast-induced brain injury but one logical explanation is that of spallation.  Spallation 
refers to the interface-based disruption that occurs between tissues of different densities upon a 
compression wave in the denser medium reflecting at the interface resulting in displacement and 
fragmentation of the denser medium into the less dense medium (Cernak and Noble-Haeusslein, 
2010; Covey and Born, 2010; Yeh and Schecter, 2012).  Spalling has been identified as a leading 
cause of endothelial injury and activation of microglia (Duckworth et al., 2012), consistent with 
our findings.  Similarly, endothelial damage results in a loss of tight junction integrity and 
consequently the potential for increased blood-brain barrier permeability and microvascular injury 
(Duckworth et al., 2012).  Notably, increased BBB permeability has been found as late as one 
month following blast-induced brain injury in a preclinical rodent model, indicating the presence 
of lasting microvascular dysfunction (Rubovitch et al., 2011b).  Furthermore, blast-induced BBB 
disruption has been observed to occur more extensively on the contralateral side, as well as at 
fluid-tissue interfaces such as that surrounding the lateral ventricles (Readnower et al., 2010), 
consistent with the findings reported within this study in which the contralateral side was more 
severely injured in comparison to the ipsilateral side based on standard markers of neural 
degeneration, astrocyte reactivity, and microglial activation (Garman et al., 2011). 
In addition to the neuropathological findings, the model utilized in this work produced 
deficits in total activity at 24 hours post-blast, regardless of experimental group.  How blast-injury 
models affect behavioral functions in rodents is poorly understood but of clear interest based on 
clinical findings associated with blast that include retrograde amnesia, confusion, loss of 
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conscioussness, depression, post-traumatic stress disorder (PTSD), vertigo, balance disorders, 
anxiety, apathy, and difficulty concentrating and performing executive functions (Taber et al., 
2006; Rubovitch et al., 2011b; Magnuson et al., 2012; Risling and Davidsson, 2012; Scheibel et 
al., 2012).  Previous reports have demonstrated impairment on the accelerating rotarod following 
direct cranial blast injury (Kuehn et al., 2011) and on the balance beam following whole body blast 
exposure (Ahlers et al., 2012) while others have shown that shielding of the torso prevents neural 
injury and associated behavioral deficits following blast (Koliatsos et al., 2011).  Cognitive 
abilities, particularly reference memory, may also be impaired following blast injury.  The latency 
to find the platform using the Morris Water Maze may be related to and correlate with maximum 
peak overpressure exposure (Saljo et al., 2011).  Other hippocampal-based learning and memory 
tasks such as the Barnes maze and Y-maze have also been utilized successfully in the study of 
functional deficits induced post-injury with blast subjects performing significantly worse in both 
acquisition and memory tasks (Koliatsos et al., 2011; Goldstein et al., 2012).  The same can be 
said of the passive avoidance task with animals showing anterograde memory deficits but not 
retrograde amnesia following blast-induced brain injury (Ahlers et al., 2012).  Previous studies 
have also revealed deficits following whole-body blast injury by assessing memory and social 
interaction through the social recognition memory test (Koliatsos et al., 2011).  Evaluation of 
cognitive abilities at 30 days post-blast in a mouse model has revealed persistent deficits in the 
novel object recognition test as well (Rubovitch et al., 2011b).  This serves as one functional test 
capable of detecting sustained deficits following blast injury.  Other assessments capable of 
detecting neural injury in the chronic period following blast exposure include the accelerating 
rotarod, active avoidance, and open field activity (Cernak et al., 2011).  Furthermore, the novel 
object recognition test appears exceptionally sensitive to neural dysfunction and memory 
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impairments, even in the absence of histological changes following blast exposure as described by 
Baalman, et al (Baalman et al., 2012).  While the significance of these findings is unclear and how 
these findings translate from one model to another, let alone to the clinical population, there is a 
clear need for further studies in standardized, clinically-relevant models. 
It is clear that future studies, in addition to understanding the effect of scaled blast 
exposure on functional ability and behavior-related changes, need to better characterize the 
inflammatory processes associated with blast exposure and how these relate to neural injury and 
neurodegeneration.  While it is unlikely blast exposure can be completely prevented, particularly 
in civilians exposed to terrorist-type attacks, it may be possible to improve therapeutic options.  
The need for improved therapeutics is particularly clear in the military in which evacuation of 
blast-exposed troops is often delayed by hours to several days due to the nature of conflict.  As 
such, secondary responses within the brain often occur and may represent a potential target as 





Figure 2.1.  Experimental setup utilized in this work demonstrating the novel shock tube apparatus 
for simulating blast-induced brain injury and data acquisition procedures.  The shock tube utilizes 
a tapered driver section to reduce wave reflection and alterations of the shock wave by the 
expansion wave.  The driver section was kept short to reduce the volume of gas required to produce 
membrane rupture and therefore, reduced overpressure duration and impulse.  The abdomen and 

























Figure 2.2.  A.) Sample shock wave recording (reflected sensor) representing a classical 
Friedlander wave of short duration.  B.) Peak reflected overpressure recorded as a function of 

















Figure 2.3.  Gross examination of single blast-exposed brains.  A.) Brain of a perfused control 
animal, B.) 31.47  3.049 PSI (reflected) blast-exposed brain at 72 hours post-blast following 
perfusion demonstrating no apparent hematomas or gross changes, C.) Presence of hematomas 
and contusion immediately following exposure to 50.72  3.368 PSI (reflected) blast on the 
contrecoup side, D.) At 72 hours post-blast, 72.05  1.212 PSI (reflected) blast exposure results in 
the appearance of parenchymal blood and an overall husky appearance on the contrecoup side, E.) 
Immediately following 90.10  1.030 PSI (reflected) blast, clear evidence of bleeds on the cortex, 
and F.) Immediately following 90.10  1.030 (reflected) PSI blast, brainstem bleeds were apparent 























Figure 2.4.  Blast exposure, particularly at high peak overpressures, was associated with 
microvascular damage and neural injury on H&E staining.  A.) Presence of red blood cells within 
the parenchyma at 72 hours following 72.05  1.212 PSI (reflected) blast.  B.) Swollen, red neuron 
at 72 hours following 72.05  1.212 (reflected) PSI blast.  Red neurons typically are associated 
with anoxic/ischemic injury indicating the presence of secondary damage, likely related to 





























Figure 2.5.  Blast exposure produced neural degeneration within the S1BF region of the cortex at 
72 hours post-exposure as indicated with fluoro-jade B staining.  A.) 31.47  3.049 PSI (reflected) 
blast on the coup side, B.) 50.72  3.368 PSI blast on the coup side, C.) 31.47  3.049 PSI blast 
on the contrecoup side, and D.) 72.05  1.212 PSI blast on the contrecoup side.  Quantification of 
Fluoro-Jade B (FJB) positive neurons using stereology demonstrated a graded response based on 
peak overpressure exposure in the S1BF region of the cortex on coup (F(3,23) = 47.03, P<0.0001) 
and contrecoup (F(3,23) = 110.70, P<0.0001) sides (E and F, respectively).  Post hoc analysis 
showed that blast exposure resulted in increased neural degeneration relative to control with 31.47 
 3.049 PSI on the contrecoup side (q = 4.51, P < 0.05), 50.72  3.368 PSI on both coup (q = 
10.29, P < 0.0001) and contrecoup (q = 13.69, P < 0.0001) sides, and 72.05  1.212 PSI on both 






Figure 2.6.  Blast exposure produced extensive astrocyte reactivity within the corpus callosum at 
72 hours post-exposure as indicated with glial fibrillary acidic protein (GFAP) staining.  A.) 31.47 
 3.049 PSI blast on the coup side, B.) 72.05  1.212 PSI blast on the coup side, C.) control (no 
blast exposure) on the contrecoup side, and D.) 72.05  1.212  PSI blast on the contrecoup side.  
Quantification of Glial Fibrillary Acidic Protein (GFAP) positive astrocytes using stereology 
demonstrated a graded response based on peak overpressure exposure in the corpus callosum 
on the coup (F(3,23) = 26.08, P<0.0001) and contrecoup (F(3,23) = 8.03, P<0.001) sides (E and F, 
respectively).  Post hoc analysis showed that blast exposure resulted in increased astrocyte 
reactivity relative to control with 50.72  3.368 PSI on the contrecoup side (q = 5.13, P < 0.01) 





Figure 2.7.  Blast exposure produced microglial changes within the corpus callosum at 72 hours 
post-exposure as indicated with ionized calcium-binding adapter molecule 1 (Iba-1) staining.  A.) 
Control (no blast exposure) on the coup side, B.) 50.72  3.368 PSI blast on the coup side, C.) 
31.47  3.049 PSI blast on the contrecoup side, and D.) 72.05  1.212  PSI blast on the contrecoup 
side.  Quantification of Ionized Calcium-binding Adapter Molecule 1 (Iba-1) positive microglia 
using stereology demonstrated a graded response based on peak overpressure exposure in the 
corpus callosum on the coup (F(3,23) = 83.12, P<0.0001) and contrecoup (F(3,23) = 25.37, 
P<0.0001) sides (E and F, respectively).  Post hoc analysis showed that blast exposure resulted in 
increased microglial activation relative to control with 31.47  3.049 PSI blast on the contrecoup 
side (q = 4.71, P < 0.05), 49 PSI blast on both coup (q = 8.37, P < 0.0001) and contrecoup (q = 
7.85, P < 0.0001) sides, and 72.05  1.212 PSI blast on both coup (q = 20.49, P < 0.0001) and 











Figure 2.8.  Effect of 50.72 PSI blast exposure on gene expression at 24 hours post-injury.  A.) 
Gene expression of glial fibrillary acidic protein (GFAP) was increased within the cortex (t = 
2.412, P < 0.05) but not in the striatum, hippocampus, or cerebellum.  B.) Gene expression of 
ionized calcium binding adapter molecule (Iba-1) was not changed within any of the brain regions 































Figure 2.9.  Effect of blast exposure on total, ambulatory, and fine activity levels at 24 hours post-
injury.  A.) Total activity was significantly altered with blast exposure (F(3,23) = 6.55, P<0.05) 
with post hoc analysis identifying a reduction relative to control with 31.47  3.049 PSI blast (q = 
4.50, P<0.05), 50.72  3.368 PSI blast (q = 5.28, P<0.05), and 72.05  1.212 PSI blast (q = 5.40, 
P<0.05).  B.) Ambulatory activity was reduced with blast exposure (F(3,23) = 6.74, P<0.05) with 
post hoc analysis identifying a reduction relative to control with 31.47  3.049 PSI blast (q = 4.59, 
P<0.05), 50.72  3.368 PSI blast (q = 5.34, P<0.05), and 72.05  1.212 PSI blast (q = 5.47, P<0.05) 
exposures.  C.) Fine activity failed to demonstrate differences across any group comparisons 
















Characterization of neural injury and neurobehavioral dysfunction 




























Traumatic brain injury resulting from blast exposure is the most common injury of 
military combatants. Animal modeling of blast-induced traumatic brain injury has demonstrated 
severe histopathological effects accompanied by loss of long-term synaptic plasticity and 
cognitive performance due to tissue damage. Here we use a scaled blast model that was 
specifically developed to assess the neuropathological, neurophysiological, and biochemical 
effects of exposure to blast forces not severe enough to cause overt physiological deficits or 
behavioral changes. We find that mild blast exposure induces no observable macroscopic 
histological effects, but instead causes microvascular injury, axonal damage, and 
neuroinflammation in various brain regions including hippocampus. Hippocampal deficits in 
short term plasticity and synaptic excitability were observed 7-days after mild blast exposure. 
Biochemical analysis revealed that mild blast exposure invokes markers of excitotoxicity and 
neuronal injury in hippocampus. Thus mild blast exposure causes subtle but deleterious 
neurological effects in the absence of major behavioral deficits, suggesting that subclinical 













Blast-induced traumatic brain injury (bTBI) occurs when a shock wave penetrates the skull 
and causes physical damage to neurons, glia and the vasculature. Explosion-derived shock waves 
have made bTBI the hallmark injury of American combatants (Huber et al., 2013). Diagnosis of 
bTBI is comorbid with increased incidence of neuropsychiatric disorders and long-term physical, 
cognitive, behavioral, and emotional changes (Tompkins et al., 2013). Furthermore, 
neurodegenerative disorders have been suggested as pathological outcomes of bTBI (Goldstein et 
al., 2012; Miller, 2012). While strong blasts may cause severe and acute brain injury or death, it is 
possible that exposure to mild forces result in delayed or more subtle effects. Thus, better 
understanding of the time- and force intensity-dependent factors that contribute to blast-induced 
pathophysiology is needed. 
As animal models of bTBI have been developed over the past decade (Rubovitch et al., 
2011b; Elder et al., 2012; Goldstein et al., 2012; Turner et al., 2013b), studies of blast exposure 
have descriptively characterized more overt pathological effects. Histopathology including 
profound neuronal injury and neuroinflammation has been demonstrated in rodent models of bTBI 
(de Lanerolle et al., 2011; Abdul-Muneer et al., 2013). Furthermore, bTBI has been suggested to 
result in suppression of synaptic plasticity in rat hippocampus (Miyazaki et al., 1992; Li et al., 
2013a). Moreover, common biochemical and molecular mechanisms of brain injury have been 
demonstrated in a variety of bTBI models (Goldstein et al., 2012; Kochanek et al., 2013; Sosa et 
al., 2013; Turner et al., 2013b). Severe TBI elicits clear loss of neurological function, although the 
subsequent behavioral effects of blast-exposure and their persistence remain controversial (Cernak 
et al., 2001; Elder et al., 2012; Budde et al., 2013; Klemenhagen et al., 2013). While these more 
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profound effects demonstrate the ability to accurately model severe bTBI, the threshold for 
pathogenesis in response to mild force remains poorly defined.   
Here we investigate the histological, functional, and biochemical effects caused by 
exposure to mild blast. The results suggest that even mild blast forces may induce a variety of 
deleterious effects, which may not be reflected in behavioral or lower resolution imaging 
assessments. These results should inform the evaluations of patients exposed to mild or 





All procedures involving animals were approved by the Institutional Animal Care and Use 
Committee of West Virginia University and were performed according to the principles of the 
Guide for the Care and Use of Laboratory Animals (IACUC protocol # 13-0708). Male Sprague-
Dawley rats (n = 74) were acquired from Hilltop Lab Animals (Hilltop Lab Animals, Inc., 
Scottsdale, PA). At the time of blast exposure the rats were 12 weeks old and weighed ~300-350 
g. Animals were acclimated for 1 week prior to experimental use and were housed under 12-hour 
light/12-hour dark conditions with food and water available ad libitum. 
Blast Exposure 
Prior to blast exposure, animals were anesthetized with 4% isoflurane (Halocarbon, River 
Edge, NJ). The blast was delivered to the right side of the head with the animal’s body oriented 
perpendicular to the blast tube, and with the peripheral organs protected by a polyvinyl chloride 
pipe shield. The animals were exposed to a mild blast (0.005” membrane; incident peak 
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overpressure of ~15 psi.), which was suggested to cause neural injury but no mortality in previous 
work (Turner et al., 2013b). Control subjects were placed in proximity to the blast paradigm but 
were not subjected to blast force. Immediately following blast exposure, animals were returned to 
a holding cage equipped with a homeothermic heating blanket equipped with a rectal thermometer 
to maintain body temperature at 37˚C. Once basic reflexes were restored, animals were returned 
to the home cage. For histological, neurophysiological, biochemical and behavioral paradigms, 
analyses were conducted after post-blast intervals of 6 h, 1, 2, 3, or 7 days.  
Neuropathology 
Neuropathological studies were conducted at 1, 2, 3, or 7 d (n = 6), with a control group. 
Animals were euthanized by CO2 asphyxiation and perfused transcardially with ice-cold 0.9% 
saline followed by 10% formalin for a total of 10 min. The brains were then dissected and placed 
in fresh 10% formalin for 72 h. Brains were then block-sectioned into 5 coronal slabs, paraffin-
embedded, and serially sectioned at 5 μm at Bregma level of 2.20, 1.00, -2.80, -7.30 and -11.30 
mm. Standard protocols were utilized for staining with hematoxylin and eosin (H&E) (Fischer et 
al., 2008), and Fluoro-Jade B (FJB, Millipore Corporation) (Schmued and Hopkins, 2000). For the 
immunohistochemical analysis, paraffin-embedded sections were labeled with SMI-31 to detect 
phosphorylated neurofilaments (1:500; Covance, Emeryville, CA), glial fibrillary acidic protein 
(GFAP) to detect astrocyte activation (1:1200; Chemicon) and ionized Ca2+ binding adapter 
molecule (Iba1) to detect microglial activation (1:1000; Wako) and visualized by 
immunoperoxidase method (Sinclair et al., 1981). Briefly, 5 μm sections were deparaffinized, 
subjected to microwave antigen retrieval (citrate buffer, pH 6.0), permeabilized with 0.3% 
(vol/vol) Triton, quenched free of endogenous peroxidases, and blocked with a cocktail of normal 
goat serums (2.5% (vol/vol) each) prior to overnight incubation of primary antibodies at 4°C. 
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Bound primaries were detected by sequential incubation with biotinylated-secondary antisera and 
streptavidinperoxidase. Diaminobenzidine chromagen was used to detect immunoperoxidase 
signal (DAKO). 
Neurophysiology 
Neurophysiological studies were conducted on experimental and control rats 1, 3, or 7 d 
post-blast (n = 6). Following rapid decapitation and dissection, brains were placed into ice-cold 
solution (75 mM sucrose, 87 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 7 
mM MgCl2, 0.5 mM CaCl2 and 10 mM glucose), and transverse hippocampal slices (350 µm) were 
prepared using a vibratome (Leica Microsystems Inc., VT1000S). Slices recovered in oxygenated 
Kreb’s buffer (125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 1.1 mM MgCl2, 
2 mM CaCl2 and 25 mM glucose) and maintained at 30˚C for 30 min before recording. A 
Multiclamp 700A amplifier with a Digidata 1322 and pClamp 10 software (Axon, Molecular 
devices, LLC) was used to for the electrophysiological recordings. Slices for recordings were 
placed into a perfusion chamber on the upright microscope stage (Axioscop 2, Carl Zeiss, Inc). 
The perfusion bath was maintained at 30˚C during the recordings (TC-324B Automatic 
Temperature Controller, Warner Instruments Corporation). Field excitatory postsynaptic 
potentials (fEPSP) from CA1 were evoked by square current pulses (0.1 ms) at 0.033 Hz with a 
bipolar stimulation electrode (FHC, Bowdoinham, ME) placed at the Schaffer collaterals (~250-
300 µm) from the recording electrode. Results were obtained using a stimulus intensity to induce 
50% of the maximal fEPSP slope, with the same intensity used to explore the paired pulse ratio 
(PPR) at different intervals. The intensity was established through the input-output curve, the 
maximal stimulation was considered when a population spike appeared in the fEPSP. A stable 
baseline was recorded for at least 15 min prior to high frequency stimulation (HFS, 4 trains, 100 
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Hz, 1 s duration, separated by 20 s). Long-term potentiation (LTP) was assessed for at least 60 min 
after HFS. The time-course showing baselines and LTP is expressed as a percent of change from 
the baseline fEPSP slope. The PPF plot was constructed by dividing the second fEPSP slope over 
the first (fEPSP2/fEPSP1). The input-output curve was constructed by normalizing recordings for 
each slice, assigning the maximal fiber volley amplitude (obtained with the maximal stimulation) 
to the value of 1.0, and the plots were derived for the respective fEPSP slopes. All recordings were 
taken in the absence of any drug. Data were analyzed with Clampfit 10 software (Axon, Molecular 
devices, LLC). Prism 6 (GraphPad Software, Inc.) was used to make graphs and statistical analysis. 
Immunoblotting 
Brain dissection, tissue removal and lysate preparation, and immunoblotting were 
performed as previously described (Sahin et al., 2004; Plattner et al., 2006). Rats (n ≤ 6) for 
immunoblotting were sacrificed at 6 h, and 1, 2, 3 and 7 d post-blast exposure. Cell lysates from 
hippocampal dissections were prepared and equal amounts of lysates were run on 7% acrylamide 
gels or 10-20% gradient acrylamide gels. The blots were probed with the following antibodies: 
p35/25 (Cell Signaling Technology; C64B10), α-Fodrin (cleaved spectrin) (Enzo Life Sciences; 
BML FG6090), pTauT205 (Sigma; T 6694), total Tau (DAKO). Signal was detected with HRP-
conjugated secondary antibodies and enhanced chemiluminescence (GE Healthcare, Piscataway, 
NJ). Images were analyzed using densitometry with background subtraction and ImageJ software 
(NIH, Bethesda, MD). The resulting bands were normalized to GAPDH (10-20% gels), ß-tubulin 
(7% gels), or total Tau. 
Locomotion 
All behavior was carried out with the experimenter blind to treatment groups. Locomotion 
trials were conducted at 48 h post blast. Rats (n = 7) were left in their home cage surrounded by a 
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PAS-Home Cage locomotor recording apparatus (San Diego Instruments, CA). The rats were left 
to explore for 24 h and ambulatory, fine and total beam breaks were collected with Vision PASF 
Software (San Diego Instruments). Ambulatory beam breaks were counted as the simultaneous 
breaking of multiple beams within 0.2 s, and Fine beam breaks were counted as single beam breaks 
at intervals greater than 0.2 s. The two forms of beam breaks were combined to compare total 
beam breaks. The locomotion was subdivided into 24 bins of 1 h each. 
Fear Conditioning 
The fear conditioning behavioral paradigm used here was essentially as previously 
described (Plattner, 2014). Rats (n = 7) were left to explore the conditioning box (Med Associates) 
for 2 min, followed by a 30 s period with tone representation (90 dB, 10 kHz), which co-terminated 
with a mild foot shock (2 s, 0.7 mA, constant current). Rats remained in the chamber 2 min after 
shocking before returning to their home cage. Conditioning boxes were thoroughly cleaned after 
each animal. To test context-dependent fear memory, rats were reintroduced 24 h post-shock into 
the conditioning box for 5 min. Freezing responses (motionless except respirations) were recorded 
using a 5 s interval time-sampling method. Control animals were subject to isoflurane exposure 
(4%) on the same day as the bTBI rats. 
Statistical Analysis 
Data were analyzed using GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, CA). One-
way ANOVA with post-hoc Newman-Keuls multiple comparison tests were used to compare 
across groups for the neurophysiological data. Student’s t-tests were used to compare behavioral 





To study the threshold effects of bTBI it is important to define the relationship between 
force intensity and injury severity in a general sense. Previously we characterized this relationship 
with regard to general neuropathology and function using a scaled blast model that we developed 
(Turner et al., 2013b). This study defined incident peak overpressure of 15 psi exposure as the 
threshold for induction of neuropathological effects, consistent with those reported in other studies 
(Goldstein et al., 2012; Mez et al., 2013; Sosa et al., 2013). Based on these findings we chose to 
expose young adult male rats to a single threshold shock wave (Figure 3.1A). To assess effects 
over relatively acute periods following blast exposure, delays including 6 h, and 1, 2, 3 and 7 d 
were chosen (Figure 3.1B) for histology, neurophysiology, biochemical, and behavioral analyses.  
Neuropathological effects of mild bTBI 
Gross examination of postmortem brains from each time point following blast exposure 
revealed no macroscopic evidence of contusion, necrosis, hematoma, hemorrhage, or focal tissue 
damage (Figure 3.2A-C), confirming the force intensity used as mild or threshold. However 
detailed microscopic examination showed a variety of notable deleterious effects in blast-exposed 
rats. Small hemorrhagic foci, which showed the presence of the intraparenchymal red blood cells 
(Figure 3.2D) and robust reactive astrogliosis (Figure 3.2E), were observed in the left corpus 
collosum at 48 h post-blast and in the striatum at 72 h post-blast. Furthermore, the extravasation 
of blood plasma was confirmed in a small number of venule- (Figure 3.2F) and arteriole-like 
(Figure 3.2G) microvessels of the cerebral cortex or striatum at all time points post-blast. These 
observations are consistent with a growing perception of the microvasculature as an important 
target of bTBI research (Sajja et al., 2013). 
Diffuse axonal injury, one of the primary neuropathological characteristics of TBI, was 
observed at all time points post-blast. Phosphorylated neurofilament immunostaining was 
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enhanced in the deep layer of cerebral cortex and lateral septal nucleus (Figure 3.2H), as well as 
in the ventrolateral part of thalamus (Figure 3.2J), compared to control subjects (Figure 3.2I, K). 
These effects were accompanied by beaded or irregularly swollen dystrophic axons (Figure 3.2L) 
and axonal bulbs (Figure 3.2M). These malformations in axonal architecture denote potential 
compromise in neuronal circuitry.  Furthermore these effects may denote neurofilament 
compaction or diffuse axonal injury which has been implicated in TBI neuropathogenesis 
(Blennow et al., 2012). 
As was observed above, the effects of blast on fine microvasculature and axonal structure 
were accompanied by elevated reactive astrocytes and microglia throughout the cerebrum, 
especially in the striatum, cortex, amygdala and hippocampus, as well as in the thalamus. Reactive 
astrocytes were observed in a greater abundance in the cerebral cortex 72 h post-blast (Figure 
3.2N), compared to control subjects (Figure 3.2O). Reactive microglia were also observed in 
greater abundance in the striatum 72 h post-blast (Figure 3.2P), compared to control subjects 
(Figure 3.2Q). In contrast, brainstem and cerebellum were relatively devoid of neuroinflammation. 
The hippocampus is often the target of neurodegenerative pathology (Nagy et al., 1997), 
and neurophysiological function of hippocampal circuitry is often related to cognitive performance 
(Wiescholleck and Manahan-Vaughan, 2013b, a). Therefore, to better understand the effects of 
mild blast exposure, and given the overall pathology observed in mild blast-exposed rats, 
hippocampus pathology was examined. Postmortem coronal sections of hippocampus from each 
time point post-blast were well preserved (Figure 3.3A). Furthermore, H&E staining showed no 
signs of typical degenerating or ischemic neurons in the hippocampus following blast injury 
(Figure 3.3B). FJB staining also showed no signs of neurodegeneration in the hippocampus of 
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bTBI rats (Figure 3.3C).  However, brains from bTBI rats showed other evidence of microscopic 
neuropathology in the hippocampus.  
For example, the hippocampal subfield CA3 exhibited intense immunoreactivity for 
phosphorylated neurofilaments. SMI-31-immunoreactive. Staining displayed an accumulation of 
phosphorylated neurofilaments in the cytoplasm of several pyramidal neurons (Figure 3.3D). 
These effects were completely absent in control subjects (Figure 3.3E). A small number of mild 
swollen dystrophic axons were observed in the CA1 stratum pyramidale (Figure 3.3F) or radiatum 
at all time points post-blast. One axonal bulb was seen in the hippocampal hilus at 7 d post-blast 
(Figure 3.3G). Brains subjected to bTBI also demonstrated obvious reactive astrogliosis and 
microgliosis throughout the hippocampus. Reactive astrocytes were observed in a greater 
abundance in the CA1 field 72 h post-blast (Figure 3.3H), compared to control subjects (Figure 
3.3I). Reactive microglia were also observed in greater abundance in the CA1 subfield 72 h post-
blast (Figure 3.3J), compared to control subjects (Figure 3.3K). Thus neuropathological effects 
observed in the hippocampus were consistent with the neuropathology observed in other brain 
regions. 
Neurophysiological effects of mild bTBI 
To understand the physiological consequences of the neuropathology resulting from mild 
blast-exposure, neurophysiological studies were conducted in acutely prepared hippocampal brain 
slices. To assess hippocampal circuitry, functional LTP was assessed in the Schaffer collateral-
CA1 circuitry. HFS induced robust LTP in control and bTBI rats, with tetanic stimulus resulting 
in a 166 ± 11% potentiation of fEPSP slope compared to baseline in control subjects at 60 min 
post-stimulus (p < 0.03, paired Student’s t test). Despite the neuropathology revealed in our 
histological assessment, mild blast exposure had no significant effect on LTP induction after 60 
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min at any of the post-blast delay time points examined (Figure 3.4A). In contrast, assessment of 
synaptic responses during the first 2 min following HFS revealed that post-tetanic potentiation 
(PTP) was attenuated in rats after a 7-day post-blast delay (p < 0.05, ANOVA, Newman-Keuls 
post hoc) (Figure 3.4B; top).  
In support of this observation, short-term plasticity as a function of paired pulse ratio (PPR) 
was also examined. A significant reduction in PPR was observed during the first 2 min following 
paired pulsation in the control subjects (p < 0.03, Mann-Whitney test) (Figure 3.4B; bottom). 
However 7 d post-blast subjects did not exhibit this form of plasticity. Thus blast exposure results 
in a reduced probability of neurotransmitter release from presynaptic terminals compared to 
control subjects. This reduction in synaptic response, in the absence of effects on LTP, suggests 
that mild blast exposure selectively affects short term plasticity at high frequency of stimulation 
and is consistent with disruption of axonal conduction, as has been proposed as an outcome of 
blast injury (Baalman et al., 2013). 
As another approach to assess short-term plasticity, paired pulse ratio (PPR) of synaptically 
induced fEPSPs was also examined. A significant reduction in PPR was observed during the first 
2 min following paired pulsation in the control subjects (p < 0.03, Mann-Whitney test) (Figure 
3.4B; bottom). However 7 d post-blast subjects did not exhibit this form of plasticity. Thus blast 
exposure results in a reduced probability of neurotransmitter release from presynaptic terminals 
compared to control subjects.  
To assess hippocampal synaptic excitability, field potential recordings were used to derive 
input-output curves (Figure 3.4C). Rats that underwent a 7 d post-blast delay exhibited a 
significant decrease in maximal response (p < 0.01, nonlinear regression using a polynomial 
quadratic function; p < 0.03, maximal stimulation in control vs. 7 d post-blast, Mann-Whitney 
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test), indicating a reduction in synaptic response intensity. To better understand this deficit, paired 
pulse facilitation (PPF), was assessed at different intervals (Figure 3.4D). Interestingly, no 
difference in PPF was observed across a range of inter-pulse intervals for rats subjected to different 
post-blast delay periods compared to control subjects. These results indicate that while mild blast 
exposure resulted in deficits of short-term plasticity and synaptic responses, they caused no 
important changes to basic synaptic transmission at presynaptic terminals.   
Overall, these results show subtle deficits in the neurophysiological function of 
hippocampal circuitry in response to mild blast exposure. While long-term plasticity was not 
significantly altered, the changes in short-term plasticity and synaptic excitability are consistent 
with other reports of neurophysiological deficits following traumatic brain injury (Miyazaki et al., 
1992; Reeves et al., 2005; Colley et al., 2010), or more specifically, blast exposure (Park et al., 
2013). 
Excitotoxic effects of mild bTBI 
TBI causes massive neuronal depolarization resulting in large influx of ions. In response 
to activation of voltage-gated Ca2+ channels, high levels of glutamate are released, triggering 
excitotoxicity. Swelling of neurons, oxidative stress, and free radical production, all affect 
neuronal viability, contribute to neuronal death, and are associated with TBI pathology (Cernak 
and Noble-Haeusslein, 2010). Following initial trauma, a delayed and spreading process of injury 
occurs. At the subcellular level, mitochondrial dysfunction and disruption in Ca2+ homeostasis are 
hallmarks of TBI (Wang et al., 2006). Over-activated cellular proteases such as calpain may 
contribute to injury progression (Werner and Engelhard, 2007). The effects of mild bTBI on these 
parameters were examined in hippocampal lysates from blast exposed rat brain by quantitative 
immunoblotting. First, levels of cleaved spectrin were assessed as a marker of calpain activity 
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(Figure 3.5A). Calpain levels were significantly elevated at 3 and 7 d post-blast in comparison to 
controls.  
Another important calpain substrate is p35, the activating cofactor for the protein kinase 
Cdk5 (Angelo et al., 2006). Calpain-dependent cleavage of p35 produces the truncated protein 
p25. Cdk5/25 engenders aberrant activity and contributes to neuronal cell death (Hisanaga and 
Endo, 2010). Consistent with an increase in calpain activity, as indicated by spectrin cleavage, p25 
levels were significantly elevated at 3 and 7 d following mild bTBI (Figure 3.5B).  
The hyperphosphorylation of the microtubule-associated protein, tau, and the resulting 
formation of neurofibrillary tangles may characterize TBI (Smith et al., 2013). Furthermore, 
Thr205 tau is a substrate of Cdk5/p25 (Maccioni et al., 2001). Interestingly, mild bTBI induced 
acute elevations in phospho-Thr205 tau with significant increases detected at 6, 24, and 48 h after 
mild bTBI (Figure 3.5C). Moreover, by 72 h, the levels were significantly below that of control 
subjects.  Taken together these results demonstrate that effectors of excitotoxicity are invoked by 
mild blast exposure, and may underlie the pathological and neurophysiological deficits detected. 
Behavioral effects of mild bTBI  
To further assess the functional outcomes of mild blast injury we employed a well-
established fear conditioning protocol (Plattner, 2014). In this behavioral paradigm, normal 
subjects can predict aversive outcomes through association with a neutral context in which an 
aversive stimulus was previously presented (Maren, 2001). The conditional response to the neutral 
context (fear conditioning box) has long been associated with hippocampal function and injury 
(Corcoran and Maren, 2001). Importantly, no changes in contextual fear response were observed 
3 and 7 d following mild blast exposure (Figure 3.6A). Furthermore, mild blast-exposed rats 
exhibited no effects on locomotion in fine (Figure 3.6B), ambulatory (Figure 3.6C) and total 
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(Figure 3.6D) activity over a 24 h period in comparison to control subjects. Thus, the 
neuropathological, neurophysiological, and biochemical effects of mild blast exposure did not 
manifest in behavioral changes at the relatively early post-blast time points examined.  
 
DISCUSSION 
Here we used a bench-top model of bTBI that we developed (Turner et al., 2013b) to 
explore the threshold of blast-exposure-induced brain injury. While rodent models of bTBI have 
been used to demonstrate neuronal injury (Goldstein et al., 2012) and death (Turner et al., 2013b), 
here we show that mild blast exposure elicited no macroscopic tissue damage or detectible 
behavioral effects. However, close examination revealed axonal injury accompanied by damage 
to microvasculature, with the blood brain barrier compromised at sparse foci throughout the brain. 
These effects are consistent with the loss of hemodynamics, edema, and hemorrhage that 
characterize more severe TBI. Interestingly, microvascular defects may characterize 
presymptomatic phases of Alzheimer’s disease, suggesting a possible link between these effects 
and increased incidence of neurological disease in blast exposed individuals (Dennis et al., 2009). 
Numerous studies have demonstrated that neurotrauma can affect synaptic plasticity 
(Bach-y-Rita, 2003; Page and Yablon, 2003; Griesbach et al., 2004), including in developing rat 
brains (Li et al., 2013a). Suppression of LTP has been demonstrated in more severe models of 
bTBI (Miyazaki et al., 1992; De Beaumont et al., 2012). Other traumatic brain injury models have 
shown decreased hippocampal LTP levels with attenuated cognitive function (Titus et al., 2013). 
In contrast, the mild blast forces used here had no detectable effect on LTP. Furthermore, the 
overall functional synaptic properties were not dramatically affected by blast exposure. However, 
mild blast exposure caused deficiencies in PTP following HFS and synaptic excitability. PTP may 
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be mediated by long-lasting increase in presynaptic Ca2+ concentrations that elevate the release 
probability of the presynaptic readily releasable pool of synaptic vesicles (Habets and Borst, 2005). 
The deficiencies in this form of short-term plasticity and synaptic responsiveness may be causally 
linked to the malformations of axonal processes observed histologically. While the effects 
observed may be only weakly represented in evaluations of working memory or cognitive 
performance, future studies, using repetitive mild blast exposures for example, may reveal latent 
consequences on synaptic long-term plasticity or learning and memory. 
Loss of microvascular integrity and blood brain barrier compromise are often related to 
brain injuries involving excitotoxicity. Activation of Ca2+-dependent proteases such as calpain is 
a predicted outcome of membrane depolarization and loss of Ca2+ homeostasis. Spectrin is 
involved in actin binding and maintaining the shape of synapses. Its regulation of cytoskeletal 
dynamics contributes to plasticity (Greer et al., 2013) and may be required for learning (Andres et 
al., 2013). Furthermore, calpain-mediated degradation of neurofilament proteins has been 
implicated in TBI (Blennow et al., 2012). Thus calpain activation and cleavage of spectrin is 
consistent with deficits in axonal architecture and disruption of synaptic plasticity (Ma, 2013). 
Indeed, rats exposed to bTBI can exhibit shortened axon initial segments, suggesting such 
subcellular changes (Baalman et al., 2013).  Moreover, spectrin cleavage in the corpus callosum 
after bTBI has been suggested to attenuate overall electrophysiological responses (Park et al., 
2013) and neuronal death (Schafer et al., 2009). 
Calpain-dependent conversion of p35 to p25 results in dysregulation of Cdk5, causing 
relocation of the protein kinase and redirection towards aberrant substrates that mediate neuronal 
injury (Plattner et al., 2006). While many of the substrates by which aberrant Cdk5 mediates 
neurotoxicity remain to be delineated, one example is phospho-Thr205 tau, which increased at the 
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onset of p25 generation in response to mild blast exposure. The long-term effects of bTBI include 
tau hyperphosphorylation and neurofibrillary tangle accumulation (Goldstein et al., 2012; Weiner, 
2013). Thus exposure to moderate blast forces may initiate subtle but still meaningful 
neuropathological processes.  
Preclinical studies of the effects of blast exposure in the past decade have focused 
predominantly on the hippocampus as an area critical to learning and memory and neuropsychiatric 
sequela (Taber et al., 2006; Cernak and Noble-Haeusslein, 2010; Budde et al., 2013; Huber et al., 
2013; Scheper and Hoozemans, 2013; Tweedie et al., 2013). Findings suggest that the exposure to 
bTBI triggers early hippocampal cell damage which increases the incidence of depression and 
anxiety related behaviors (Kamnaksh et al., 2012). Effects in other brain regions are also being 
explored with regard to excitotoxic effects or contributions to the development of mood disorders 
(Combes, 2013; Sajja et al., 2013). Taken together, the results presented here demonstrate that 
mild blast exposure causes a panoply of deleterious neurological effects in the absence of major 
behavioral deficits.  It remains to be determined if mild blast exposures and the subclinical effects 






Figure 3.1. Blast pressure recording and experimental design.  A. Recording of Friedlander 
short-duration shock wave to which rats in this study were exposed. B. Schematic portraying 
experimental design which includes time points for animal sacrifice for the neuropathology, 
neurophysiology, and immunoblotting assays, or days after blast exposure for behavioral testing. 







Figure 3.2. Mild blast exposure had no effect at the macroscopic level, but causes 
microvascular injury, axonal damage, and neuroinflammation. A-C. Absence of 
macroscopic tissue damage 7 d post-blast. Dorsal (A), ventral (B) and anterior-posterior coronal 
4 mm brain section (C) views are shown. D. Microvascular injury and dysfunction 72 h post-
blast indicated by small hemorrhagic focus (center) in the corpus collosum. E. Robust reactive 
astrogliosis in the same area as in D. F. Extravasation of blood plasma in a venule-like 
microvessel in the left deep layer of cerebral cortex 72 h post-blast. G. Extravasation of blood 
plasma in an arteriole-like microvessel in the right nucleus accumbens 48 h post-blast. H & I. 
Axonal injury indicated by increased phosphorylated neurofilament immunostaining in the left 
lateral septal nucleus 7 d post-blast (H); compared to control (I). J & K. Axonal injury also 
indicated in thalamus 72 h post-blast (J); compared to control (K). L. Beaded, irregularly 
swollen dystrophic axons (arrow) in the left lateral septal nucleus 24 h post-blast. M. Axonal 
bulb (arrow) at the interface between cerebral cortex and corpus callosum 72 h post-blast. N & 
O. Neuroinflammation indicated by increased astrocyte activation in the deep layer of cerebral 
cortex 72 h post-blast (N); compared to the same area from control (O). P & Q. 
Neuroinflammation also indicated by increased number of reactive microglia in striatum 72 h 
post-blast (P); compared to the same area from control (Q). H&E staining (D,F,G). SMI 31 
immunostaining (H-M). GFAP immunostaining (E,N,O). Iba1 immunostaining (P,Q). Scale 





Figure 3.3. Mild blast exposure does not induce macroscopic changes to the hippocampus, 
but does induce microscopic hippocampal pathology as indicated by axonal damage and 
neuroinflammation. A. Absence of macroscopic hippocampal tissue damage 7 d post-blast. B. 
Absence of overt neuronal injury in hippocampus 7 d post-blast. Insert shows no significant 
pathology for CA3 field. C. Absence of FJB-positive neurons in the hippocampus 7 d post-blast. 
Insert shows no degenerating neurons for CA3 field. D & E. Increased phosphorylated 
neurofilament immunostaining in the hippocampal CA3 field 48 h post-blast (D); compared to 
the same area from control rats (E). F. Mild swollen atrophic axon in hippocampal CA1 stratum 
pyramidale 48 h post-blast. G. Axonal bulb in the hippocampal hilus 7 d post-blast (arrow). H & 
I. Increased astrogliosis in the hippocampal CA1 field 72 h post-blast (H); compared to the same 
area from control (I). J & K. Increased number of microglia in CA1 72 h post-blast (J); 
compared to the same area from control (K). H&E staining (B). FJB staining (C). SMI 31 
immunostaining (D-G). GFAP immunostaining (H & I). Iba1 immunostaining (J & K). Scale 














Figure 3.4. Mild blast exposure causes neurophysiological deficits in hippocampus. A. 
Assessment of blast effects on LTP. B. Time-course shows plot of fEPSP slopes (percent baseline). 
Each point represents average from two traces. Insets show representative traces from control 
recordings (a: baseline, b: PTP, c: LTP). Horizontal arrows show PTP difference between control 
and 7 d post-blast. Deficits in short-term plasticity following HFS are induced by mild blast 
exposure. C.  The upper panel summarizes fEPSP slopes during the first 2 min post-HFS. The 
lower panel shows effects on PPR during the first 2 min post-HFS at 7 d post-blast. Input-output 
curves measuring fEPSP slopes against normalized fiber volley amplitudes. A significant 
reduction in maximal response was observed 7 d post-blast. Inset shows representative traces from 
control recordings at different stimulation intensities. D. Paired pulse ratio at different intervals 
shows no change in short-term synaptic plasticity following blast. (Mean ± SEM; n=6, *p < 0.05, 






Figure 3.5. Mild blast exposure invokes markers of excitotoxicity and neuronal injury in 
hippocampus. A-C. Quantitative immunoblot analyses of hippocampal lysates from control and 
blast-exposed rats at the indicated post-blast interval are shown for the calpain-cleaved form of 
spectrin (A), p25, the calpain-cleaved form of the Cdk5 activator, p35 (B), and phospho-Ser205 






Figure 3.6. Mild blast exposure has no effect on contextual fear conditioning or locomotor 
activity. A. Contextual fear conditioning trials revealed no significant difference in the percent 
freezing at 3 and 7 d post-blast compared to control subjects. B-D. Analysis of 24 h home cage 
locomotion revealed that mild blast exposure showed no effect on ambulatory (B), fine (C), or 
total locomotion (D) compared to control subjects. Data represent means  s.e.m.; n = 7; Student’s 
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Neuronal injury following blast-induced traumatic brain injury increases the risk for 
neuropsychiatric disorders, yet the pathophysiology remains poorly understood. Blood-brain-
barrier disruption, endoplasmic reticulum stress, and apoptosis have all been implicated in rodent 
models of neural injury. Microvessel compromise is a primary effect of neural injury and is 
postulated to cause subcellular secondary effects apoptosis. What remains unclear is how these 
secondary effects progress to personality disorders in humans exposed to head trauma. To 
investigate this we exposed male rats to a clinically-relevant blast model we have recently 
developed. The study examined initial vascular disruption using Evan’s blue, secondary injury 
mechanisms, apoptosis, and impulsive-like behavior measured with elevated plus maze. Evan’s 
blue extravasation was observed immediately following blast injury, and persisted for at least 6 h. 
Data showed increased mRNA abundance of stress response genes at 3 h, with subsequent 
increases in cellular stress markers C/EBP homologous protein, and growth arrest and DNA 
damage-inducible protein 34, at 24 h. Caspase-12 and Caspase-3 were both cleaved at 24 h 
following blast injury. The endoplasmic reticulum stress inhibitor, salubrinal, was administered 
(1mg/kg i.p.) to investigate its’ effects on neuronal injury and impulsive-like behavior associated 
with neurotrauma. Salubrinal reduced protein expression of cellular stress markers, and diminished 
Caspase-3 cleavage, suggesting apoptosis attenuation. Interestingly, salubrinal also ameliorated 
impulsive-like behavior indicative of head trauma. These results suggest salubrinal to play a role 
in the regulation of apoptosis and the pathology of chronic disease. These observations provide 
evidence that endoplasmic reticulum stress is a promising molecular target for the attenuation of 





Blast-induced traumatic brain injury (bTBI) has been described as the ‘hallmark injury’ 
of recent wars in Iraq and Afghanistan (Goldstein et al., 2012). The Defense and Veterans Brain 
Injury Center estimates that approximately 270,000 blast exposures have occurred over the past 
decade (Farrell-Carnahan et al., 2013). Many blast exposures cause concussive or sub-concussive 
brain damage and are associated with the shearing of axons (Rosenfeld and Ford, 2010) and the 
compromise of brain micro-vessels (Chen et al., 2013b). Often these injuries go undetected in 
soldiers and civilians due to poor understanding of the underlying mechanisms of blast injury 
and the diagnostic limitations preventing the detection of pathophysiologic changes in living 
patients (Stern et al., 2011). 
Blast exposure can cause blood brain barrier (BBB) dysfunction (Abdul-Muneer et al., 
2013; Chen et al., 2013b) and induce short-term inflammatory cascades that promote 
intracellular Ca2+ accumulation (Arun et al., 2013; Abdul-Muneer et al., 2014). Although bTBI is 
considered a diffuse injury, a majority of damage from our model is localized to the prefrontal 
cortex (PFC) (Turner et al., 2013b), where the brain impacts the skull on the contra coup side of 
exposure (Zhu et al., 2010; Zhu et al., 2013). Ca2+ perturbations are known to cause endoplasmic 
reticulum (ER) stress and trigger the unfolded protein response (UPR) (Zhang and Kaufman, 
2008; Walter and Ron, 2011). Although the UPR has been reported in a model of controlled 
cortical impact TBI (Farook et al., 2013), the mechanisms of cellular fate are not yet fully 
elucidated. 
Neuropsychiatric behaviors measured in animal models, such as impulsive-like 
behaviors, are a strong indicator of damage to the rodent PFC (Bidzan et al., 2012; Johnson et al., 
2013a). Similar personality disorders are often observed in human bTBI patients as well, 
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providing an important research parallel (Vaishnavi et al., 2009). We propose that our clinically-
relevant blast model allows us to investigate the process of ER stress and how this response 
relates to apoptosis and neuropsychiatric disorders.  
A common downstream component of the UPR is the C/EBP homologous protein 
(CHOP), which becomes upregulated during sustained cellular stress to maintain ER homeostasis 
(Walter and Ron, 2011). The levels of CHOP dictate whether a cell can effectively repair itself, 
or proceed to apoptosis by regulating pro- and anti-apoptotic mechanisms (McCullough et al., 
2001; Galehdar et al., 2010). Acute phase activation of the protein kinase R-like ER kinase 
(PERK) UPR pathway, and its’ downstream component growth arrest and DNA damage-
inducible protein 34 (GADD34), helps to maintain CHOP within an ideal range to promote 
cellular repair (Salminen and Kaarniranta, 2010).  
Under sustained ER stress, intracellular Ca2+ accumulation can trigger apoptosis through 
a separate cascade involving calpain-mediated Caspase-12 cleavage (Nakagawa et al., 2000). 
This mechanism is considered separate from the UPR (Badiola et al., 2011), even though both 
apoptotic cascades share Caspase-3 cleavage as a final common step in undergoing apoptosis 
(Szegezdi et al., 2006). Using our model, we are interested in determining the mechanism by 
which bTBI triggers apoptosis and how this relates to the pathology of chronic disease.  
This study investigates acute BBB disruption, ER stress mechanisms, apoptosis and impulsive-
like behavior following a single blast injury. It has been proposed that bTBI pathophysiology is 
partly mediated by alterations in BBB permeability (Chen et al., 2013c), which may induce ER 
stress and trigger the UPR (Begum et al., 2014). The ER stress modulator, salubrinal (SAL), has 
been used to investigate downstream components of the PERK pathway (Sokka et al., 2007). Our 
hypothesis is that SAL manipulation of the PERK pathway would maintain CHOP expression 
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within a protective threshold. Balancing CHOP expression should regulate apoptosis and 
mitigate impulsive-like behavior indicative of blast injury (Kamnaksh et al., 2011). Therefore, 





All procedures involving animals (N = 144) were approved by the Institutional Animal 
Care and Use Committee of West Virginia University and were performed according to the 
principles of the Guide for the Care and Use of Laboratory Animals. This work used young adult 
male Sprague-dawley rats acquired from Hilltop Lab Animals (Hilltop Lab Animals, Inc.) and 
weighed ~300-350g at the time of blast and sacrifice. Animals were acclimated for 1 week prior 
to experimental use and were housed under 12 h light/dark conditions with food and water 
available ad libitum. 
Blast Overpressure Exposure 
Prior to blast exposure, animals were anesthetized with 4% isoflurane (Halocarbon). The 
blast was delivered to the right side of the head with the animal’s body oriented perpendicular to 
the blast tube, and with the peripheral organs protected by a polyvinyl chloride pipe shield. The 
animals were exposed to a mild blast (0.005” membrane; ~15 psi on incident recordings; ~50 psi 
on reflected recordings), which was determined, in previous work, to produce microscopic 
neuronal injury to the contra coup (left) side of the brain, with no signs of hemorrhagic injury 
under gross examination (Turner et al., 2013b). Immediately following blast exposure, animals 
were returned to a holding cage equipped with a homeothermic heating blanket equipped with a 
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rectal thermometer to maintain body temperature at 37 °C. Once basic reflexes were restored, 
animals were returned to the home cage. 
Salubrinal Administration 
A stock solution of SAL (Tocris) was made in 0.5% dimethyl sulfoxide (DMSO). Such a 
low concentration of DMSO was chosen to avoid neurological effects (Methippara et al., 2012). 
SAL was diluted to 100uM to effectively manipulate the UPR (Boyce et al., 2005). A DMSO 
concentration of 0.5% was administered to control and bTBI rats 30 min prior to anesthesia. SAL 
was aliquoted for each intraperitoneal injection at a dose of 1 mg/kg (Sokka et al., 2007; Liu et 
al., 2014b). SAL was administered 30 min prior to anesthesia (SAL), or anesthesia followed by 
blast exposure (SAL+bTBI). 
Blood Brain Barrier Permeability Assessment  
Animals in the BBB assessment group (N = 16) were evaluated at three time points 
following blast exposure: 0.5, 6, 24 h, and control (n = 4). Following blast exposure, BBB 
permeability was assessed using Evan’s Blue (EB; Sigma). EB binds to albumin and is a marker 
used to detect BBB permeability (Yen et al., 2013). We had previously shown changes in BBB 
permeability and tight junction protein expression with our model (Lucke-Wold et al., 2014c). 
Animals were anesthetized with 4% isoflurane and maintained with 2% isoflurane throughout the 
procedure. Saline containing EB (2%, 5ml/kg) was administered intravenously (femoral vein) 30 
min before perfusion. The rats were then transcardially perfused with 0.9% saline for 15 min and 
brains excised for raw imaging. The PFC was then dissected out and separated by hemisphere. 
The samples were weighed and homogenized in 0.5 ml of 50% trichloroacetic acid (Sigma). The 
samples were then incubated for 24 h at 37°C before being centrifuged at 10,000 x g for 10 min 
at 4°C. The supernatant was measured by absorbance spectroscopy at 620nm. Calculations were 
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based on an external standard reading and extravasated dye was expressed as ng EB / mg brain 
tissue. 
Quantitative Real-time Polymerase Chain Reaction  
Rats (N = 48) for the gene analysis group were randomly divided into one of two groups: 
time course (n = 24) and control (n = 24). The time course group consisted of six time-points 
post-bTBI: 1.5, 3, 6, 12, 24, and 72 h (n = 4). The control group (anesthetized only) used rats for 
all six time point from the time course study (n = 4). All animals were anesthetized with 4% 
isoflurane and euthanized via decapitation in protease/phosphatase cocktail (Plattner et al., 
2006). Brains were rapidly removed with the PFC dissected out, separated by hemisphere and 
flash frozen in liquid nitrogen. Total RNA was isolated in TRI-Reagent (Sigma) and was tested 
for quantity and quality using a Nanodrop 2000c spectrophotometer (Thermo 
Scientific). Reverse transcription was conducted using a high capacity reverse transcription kit 
(Applied Biosystems). Real-time PCR analyses were performed using a 7500 Real-Time PCR 
system (Applied Biosystems) in combination with TaqMan® chemistry using the following 
oligonucleotide primer sets: activating transcription factor 4 (atf4) (Rn00824644_g1), CHOP 
(ddit3) (Rn00492098_g1), GADD34 (ppp1R15A) (Rn00591894_m1), Glial fibrillary acidic 
protein (gfap) (Rn00566603_m1) with 18s rRNA (Hs99999901_s1) used as an endogenous 
control (Applied Biosystems). Changes in gene expression were determined using the (ΔΔCt) 
method with a threshold cycle value of 0.2 normalized to 18s rRNA. 
Western Blotting 
Rats (N = 20) for the protein analysis group were randomly divided into four different 
experimental groups: (1) control, (2) SAL, (3) bTBI 24 h, and (4) SAL+bTBI 24 h (n = 5). 
Animals were euthanized and had tissue prepared as previously described. Protein samples were 
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prepared by sonication in hot (85-95o C) 1% sodium docecyl sulfate (SDS; Sigma) as previously 
described (O'Callaghan and Sriram, 2004). The protein concentration of each sample was 
measured using a bicinchoninic acid (BCA) protein assay kit (Pierce). Samples were run using 
30-50 μg of protein/well, depending on the primary antibody, using pre-cast Bolt® Bis-Tris Plus 
gels (Life Technologies) in combination with 2X Lammeli sample buffer. Gels were run using 
the Bolt® Mini tank system (Life Technologies) and transferred to polyvinylidene fluoride 
membranes (Bio-Rad) using wet electrophoretic transfer cells (Bio-Rad). Membranes were 
incubated with the following primary antibodies all raised in rabbit: CHOP 1:1000 (Cell 
Signaling), Caspase-12 1:1000 (Cell Signaling), Caspase-3 1:750 (Cell Signaling), and GADD34 
1:1000 (Pierce) overnight at 4o C. Anti-rabbit IgG horseradish peroxidase (HRP)-linked antibody 
(Cell Signaling) was used as a secondary antibody at a concentration of 1:2000 with gentle 
shaking for 2 h at room temperature. The rabbit monoclonal antibody β-actin (Cell Signaling) 
was used as an endogenous control for all samples at a concentration of 1:10,000. Molecular 
weight determination was conducted using the SeeBlue® Plus2 Pre-stained Standard (Life 
Technologies). Imaging was conducted using LumiGLO chemiluminescent substrate (Cell 
Signaling) according to manufacturer’s instructions. Images were converted to 8-bit and 
analyzed using densitometry with background subtraction and normalized to β-actin using 
ImageJ software (NIH). 
Immunohistochemistry Preparation 
Rats (N = 12) used for the immunohistochemistry (IHC) group were randomly divided 
into three experimental groups: (1) control, (2) bTBI 24 h, and (3) SAL+bTBI 24 h (n = 4). 
Histological samples were prepared as previously described (Lucke-Wold et al., 2014c). Briefly, 
the animals were anesthetized by inhalation of 4% isoflurane and maintained with 2% isoflurane 
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throughout the procedure. Animals were then transcardially perfused with 0.9% ice-cold saline 
for 5 min followed by 10% formalin for 15 min. The brains were subsequently removed and 
placed in 10% formalin solution for 24 h. Following fixation, the PFC was sectioned on a brain 
block at 4mm increments. Sections were then processed with a Tissue Tek VIP 5 automatic 
processor (Sakura Finetek), and embedded with Tissue Tek TEC (Sakura Finetek) as previously 
described (Turner et al., 2012b). Slices (10µm) were prepared with the Leica RM2235 
microtome (Leica Microsystems), mounted onto slides, and heat fixed for fluorescent staining. A 
total of 46 coronal sections were prepared per animal. 
Immunohistochemistry Staining 
Paraffin was dissolved from slides with 5 min washes in xylene, 100% EtOH, and 95% 
EtOH followed by 5 min rehydration in dH2O. The slides were then quenched with 10% 
methanol and 10% H2O2 in Dulbecco’s phosphate buffered saline (DPBS) for 15 min. After 
quenching, slides were rinsed three times in DPBS for 5 min each. The slides were then placed in 
permeabilizing solution (1.8% L-lysine, 4% horse serum, and 0.2% Triton X-100 in DPBS) for 
30 min. Slides were allowed to dry and the brain slices were circumscribed. Tissue was 
incubated with primary antibody in DPBS with 4% horse serum overnight. Tissues were washed 
three times in DPBS and incubated in secondary fluorescent antibody for 3 h. Tissues were then 
rinsed three times in DPBS and dried overnight. Vectashield mounting media was used to fix the 
coverslip (Vector Labs). When staining for co-localization, a second set of primary and 
secondary antibodies were used prior to fixing the coverslip. Primary antibodies were GFAP 
rabbit mAB (Dako) 1:500, CHOP mouse mAB (Cell Signaling) 1:1600, Caspase-3 rabbit 
polyAB (Abcam) 1:1000, Caspase-12 mouse polyAB (Cell Signaling) 1:1000, and microtubule 
associated protein 2 (MAP2) rabbit mAB (Millipore) 1:1000. Secondary antibodies were diluted 
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1:100 in DPBS and included Alexa Fluor 488 goat anti-rabbit (Life Technologies), Alexa Fluor 
594 goat anti-rabbit (Life Technologies), Alexa Fluor 488 goat anti-mouse (Life Technologies), 
and Alexa 594 goat anti-mouse (Life Technologies). Imaging was performed with a Zeiss Axio 
Imager 2 (Carl Zeiss Microscopy). 
Immunohistochemistry Quantification 
Corrected total cell fluorescence (CTCF) was calculated using ImageJ software (NIH). 
Briefly, 12 randomly selected areas of the left PFC were outlined and measured, with fluorescent 
density compared to background readings. Slides from each region were randomly selected by an 
observer blinded to the experimental groups. The density was adjusted per mean area to give 
corrected total cell fluorescence (Lucke-Wold et al., 2014c). For co-localization quantification, 
the ImageJ plugin titled Just Another Co-localization plugin was utilized to calculate a Pearson’s 
coefficient as well as an overlap coefficient for each sample (Beerten et al., 2012). 
Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick End Labeling 
Slides for staining were prepared, sectioned and mounted as previously described. We 
used an apoptosis detection kit to assess the left PFC at 24 h following blast exposure. Staining 
for apoptosis was completed using the TACS 2 TdT-Dab in situ Apoptosis Detection kit 
(Trevigen) according to manufacturer’s instructions.  In brief, paraffin embedded slices were 
deparaffinized and rehydrated with five minute incubations in xylenes, 100% EtOH, 95% EtOH, 
and deionized water each.  The slices were then immersed in phosphate buffered saline for 10 
minutes followed by treatments with Proteinase K, quenching solution, labeling buffer, and 
labeling reaction mixture. The sample was then covered in Strep-HRP solution for ten minutes, 
washed, and then immersed in 3,3'-Diaminobenzidine (DAB) solution for seven minutes.  The 
slices were counterstained with 1% methyl green and dehydrated with 10 dips in deionized 
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water, 95% EtOH, 100% EtOH, and xylenes.  The slides were coverslipped using Permount™ 
(Sigma) mounting media and glass coverslips. For quantification of DAB staining, regions of the 
PFC were randomly selected for rats from the different treatment groups. An observer blinded to 
experimental group, randomly selected 100 total cells. The number of positive cells was reported 
as a fraction of total cells counted. 
Elevated Plus Maze 
Impulsive-like behavior can be measured with increased exploratory behavior in a rodent 
model of anxiety (Mosienko et al., 2012). Four groups of rats (N = 48) were subject to behavioral 
analysis: control, SAL, bTBI 7 d, and SAL+bTBI 7 d (n = 12). The elevated plus maze (EPM) 
was set at a height of 60 cm from the floor. The two open arms intersected perpendicular to the 
two closed arms. Each arm was 50 cm x 10 cm. The closed arms were encased by black siding 
30 cm tall. Each rat was placed in the middle of the elevated plus maze facing an open arm and 
tracking was performed for 5 min with AnyMaze™ software (Version 4.7, Stoelting), which 
pinpointed the location of the animal’s head and body continuously throughout the testing trial. 
The percent time spent in the open arms, speed, closed arm entries and movement were all 
recorded and quantified. Increased percent time spent in the open arms was considered a sign of 
impulsive-like behavior, as previously described (Mosienko et al., 2012; Johnson et al., 2013a). 
Data Analysis 
Data were analyzed using GraphPad Prism 5.0 (GraphPad Software, Inc.). All data points 
are shown as mean ± s.e.m. Statistical differences between control and experimental groups were 
determined by using ANOVA with a Dunnett’s, Tukey’s or Bonferroni’s post-hoc tests. A two-
tailed Student’s t-test was used when comparing two conditions only. For DAB staining, a chi-
square analysis was used to compare between groups. A power analysis was conducted for all 
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experiments with an α of 0.05 and a β of 0.2 (DSS Research Power Analysis). Sample sizes were 
determined by the sample effect with behavioral data being set at 0.4 and all other data being set 
at 0.3. A value of p < 0.05 was considered statistically significant for all data analyzed. 
 
RESULTS 
The physical force of bTBI can shear axons (Raghupathi and Margulies, 2002), and 
rupture micro-vessels (Arun et al., 2013). These primary effects can cause neurons to rapidly 
depolarize  and activate voltage gated Ca2+ channels, thereby increasing intracellular Ca2+ 
(Gurkoff et al., 2013). Studies using other models of neurotrauma have shown marked BBB 
dysfunction (Abdul-Muneer et al., 2014), ER stress activation (Farook et al., 2013), and 
apoptosis (Sabirzhanov et al., 2014). SAL is known to prevent the dephosphorylation of 
eukaryotic initiation factor 2 alpha (eIF2α) (Boyce et al., 2005); however, this agent may directly 
affect other mechanisms of ER stress (Zhang et al., 2014a) or apoptosis (Kessel, 2006). Figure 
4.1 portrays how bTBI may trigger the UPR, as well as the proposed effects of SAL.  
Contra Coup Vascular Disruption 
The suggestion has been made previously that BBB disruption, or loss of micro-vessel 
endothelium integrity, may be an inciting event for the molecular changes frequently induced 
following neurotrauma (Abdul-Muneer et al., 2013; Arun et al., 2013). This may be particularly 
relevant in models of blast injury in which a pressure wave, and associated surge in vascular 
flow to the brain, may induce microvascular changes manifested as BBB disruption (Sosa et al., 
2013). Following BBB disruption, EB binds to albumin and diffuses into the brain in a location-
specific manner consistent with disruption (Yang et al., 2013). Recently, we have shown changes 
in BBB permeability and tight junction protein expression using our blast model (Lucke-Wold et 
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al., 2014c). To further address these issues, we used EB extravasation to assess the brain 
vasculature of the PFC following blast exposure.  
One-way ANOVA revealed a significant difference in EB absorbance in the left PFC 
following blast exposure (F (3,12) = 31.350, p < 0.001). Dunnett’s post-hoc analyses revealed 
bTBI significantly increased EB absorbance in the left PFC at 0.5 h (q = 8.844, p < 0.001) and 6 
h (q = 3.491, p < 0.05) (Figure 4.2A). Raw images of extracted brains at varying time points 
(0.5, 6, and 24 h) demonstrate BBB disruption, particularly prominent in the left PFC (Figure 
4.2B). The images provide vivid proof of a contra coup style of injury following bTBI. Because 
our model’s blast exposure produced no signs of hemorrhagic transformation under gross 
examination at this severity (Turner et al., 2013b), we are certain that these findings indicate a 
loss in BBB integrity on a microscopic scale.  
Blast upregulates stress response markers 
To investigate gene changes following blast exposure, we performed quantitative real-
time PCR. A time course was employed to measure acute and sub-acute changes in mRNA 
abundance of four stress response genes (atf4, ddit3, ppp1R15A and gfap). Atf4 encodes for 
ATF4, ddit3 encodes for CHOP, ppp1R15A encodes for GADD34, and gfap encodes for GFAP. 
Two-Way ANOVA revealed significant differences in left PFC atf4 mRNA abundance between 
treatment, time, and interaction (p < 0.05). Blast exposure significantly increased the mRNA 
abundance of atf4 in the left PFC at 3 h (t = 7.694, p < 0.001) (Bonferroni’s post-hoc analysis) 
(Figure 4.3A). Two-Way ANOVA also revealed significant differences in left PFC ddit3 mRNA 
abundance between treatment, time, and interaction (p < 0.05). Bonferroni’s post-hoc analysis 
revealed a significant increase in left PFC ddit3 mRNA abundance at 3 h post-bTBI (t = 7.989, p 
< 0.001) (Figure 4.3B). To further validate our blast model induces a contra coup form of injury 
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we also measured mRNA abundance of atf4 and ddit3 in the right PFC. Indeed no differences 
were observed in the right PFC for atf4 (Figure 4.3C), or ddit3 (Figure 4.3D). Left PFC mRNA 
abundance for both atf4 and ddit3 quickly returned to baseline by 6 h and remained at this level 
through 72 h, implying an acute phase stress response (Figure 4.3A-B). 
Two-Way ANOVA revealed significant differences in the left PFC ppp1R15A mRNA 
abundance between time and interaction (p < 0.05). Blast exposure significantly increased the 
mRNA abundance of ppp1R15A in the left PFC at 6 h (t = 6.022, p < 0.001) (Bonferroni’s post-
hoc analysis) (Figure 4.3E). Two-Way ANOVA also revealed significant differences in left PFC 
gfap mRNA abundance between treatment and time (p < 0.05). Bonferroni’s post-hoc analysis 
revealed a significant increase in left PFC gfap mRNA abundance at 24 h post-bTBI (t = 4.081, p 
< 0.01) (Figure 4.3F). Results indicate blast exposure imparts downstream upregulation of UPR 
marker, GADD34, with trailing astrocyte activation at a later time point. Astrocyte activity is 
indicative of neuroinflammation and early stages of cell death. 
Salubrinal attenuates ER stress markers 
SAL is a research tool known to inhibit the UPR in vitro (Boyce et al., 2005) and in vivo 
(Sokka et al., 2007). In particular, SAL prevents the dephosphorylation of eIF2α by the 
GADD34 phosphatase complex formation (Hetz et al., 2013). We used this tool prior to blast 
exposure to alter ER stress and to examine any effects modulating the UPR. Western blot was 
used to compare CHOP expression in the left and right PFC to further support contra coup injury 
indicative of bTBI (Zhu et al., 2010; Zhu et al., 2013). A significant increase in CHOP 
expression was measured in the left PFC at 24 h post-bTBI (t = 2.625, p < 0.05) (Figure 4.4A), 
but not in the right PFC (t = 1.487, p > 0.05) (Figure 4.4B) (Two-Tailed Student’s t Test). A 
significant difference in CHOP expression was observed with a One-Way ANOVA (F (3,12) = 
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5.775, p < 0.01). At 24 h, a significant increase in CHOP expression was seen in the left PFC of 
bTBI rats (t = 3.705, p < 0.05), but was attenuated in the left PFC of SAL+bTBI rats (t = 3.105, p 
< 0.05) (Bonferroni’s post-hoc analysis) (Figure 4.4C). These findings indicate SAL given alone 
does not alter the constitutively active form of CHOP; however, stress-activated CHOP can be 
attenuated when SAL is administered prior to blast exposure.  
ER stress markers Caspase-12 and GADD34 were investigated to determine if SAL had 
any effects on cellular fate following blast exposure. One-Way ANOVA revealed a significant 
difference in the proteolytic processing of Caspase-12 (F (3,16) = 10.230, p < 0.001) at 24 h post-
bTBI. Caspase-12 cleavage significantly increased in the left PFC of bTBI rats (t = 3.696, p < 
0.05), as well as in the left PFC of SAL+bTBI rats (t = 3.393, p < 0.05) (Bonferroni’s post-hoc 
analysis) (Figure 4.4D). A One-Way ANOVA revealed a significant difference in GADD34 
protein expression (F (3,16) = 5.216, p < 0.05) following blast exposure. GADD34 protein 
expression significantly increased in the left PFC of bTBI rats at 24 h (t = 3.136, p < 0.05). This 
effect was mitigated when SAL was administered prior to blast exposure (t = 3.107, p < 0.05) 
(Bonferroni’s post-hoc analysis) (Figure 4.4E). Findings suggest SAL may control cellular fate 
through the modulation of ER stress in a bTBI model. 
Salubrinal modulates ER-mediated apoptosis 
CHOP, Caspase-12 and Caspase-3 are all markers of ER-mediated apoptosis (Nakagawa 
and Yuan, 2000; Nakagawa et al., 2000; Tabas and Ron, 2011). Caspase-12 is initially cleaved 
by ER stress through a perturbation in Ca2+ homeostasis; thereby, activating Caspase-3 and 
triggering apoptosis (Bernales et al., 2012). To further confirm that bTBI increases CHOP 
expression, we conducted IHC fluorescent staining in the left PFC and measured corrected total 
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cell fluorescence (CTCF). We also measured CTCF for Caspase-12 and Caspase-3 in the left 
PFC.  
Consistent with Western blot findings, IHC analyses showed a significant difference in 
CTCF for CHOP after blast exposure (One-Way ANOVA; F (2,12) = 34.390, p < 0.001). 
Bonferroni’s post-hoc analyses revealed bTBI significantly increased CHOP CTCF (t = 8.099, p 
< 0.001), while SAL pre-administration reduced CHOP CTCF (t = 5.592, p < 0.001) in the left 
PFC at 24 h (Figure 4.5A). IHC analyses also showed that bTBI portrays a significant difference 
in CTCF for Caspase-12 (One-Way ANOVA; F (2,12) = 22.03, p < 0.001), and Caspase-3 (One-
Way ANOVA; F (2,12) = 12.490, p < 0.01).  Bonferroni’s post-hoc analyses revealed a significant 
increase in CTCF for Caspase-12 at 24 h in the left PFC of bTBI rats (t = 6.066, p < 0.001), as 
well as SAL+bTBI rats (t = 5.366, p < 0.001) (Figure 4.5B). SAL also attenuated (t = 3.967, p < 
0.01) the increased Caspase-3 CTCF (t = 4.615, p < 0.01) at 24 h post-bTBI in the left PFC 
(Figure 4.5C). These findings suggest SAL plays an important role in the control of cellular fate 
through CHOP- and Caspase-3-dependent mechanisms following blast exposure. 
We employed IHC colocalization to determine cell-specific UPR activation. CHOP 
displayed a moderate colocalization with the neuron-specific MAP2 in the left PFC at 24 h post-
bTBI (Pearson’s coefficient, r = 0.536) (Figure 4.6). CHOP displayed a weak colocalization 
with MAP2 in the control (Pearson’s coefficient, r = 0.371) and SAL+bTBI groups (Pearson’s 
coefficient, r = 0.233) (Figure 4.6). The results suggest blast exposure increases CHOP protein 
expression in neurons of the left PFC at 24 h, and also supports the protein and gene data shown 
previously for CHOP. 
IHC colocalization was also used to determine if CHOP and Caspase-12 activation occur 
in the same cells. We observed a very weak colocalization between CHOP and Caspase-12 in the 
99 
 
left PFC of control rats (Pearson’s coefficient, r = 0.177). We discovered a moderate 
colocalization between CHOP and Caspase-12 at 24 h in the left PFC of bTBI rats (Pearson’s 
coefficient, r = 0.537) (Figure 4.7), as well as a moderate colocalization in the left PFC of 
SAL+bTBI rats (Pearson’s coefficient, r = 0.677) (Figure 4.7). These results suggest CHOP and 
Caspase-12 to be active within the same cell after blast exposure. Colocalization strengths also 
suggest SAL may not have a direct effect on Caspase-12 cleavage. 
Salubrinal mitigates Caspase-3 cleavage 
We wanted to determine if SAL had an effect on Caspase-3 cleavage. Caspase-3 cleavage 
is one of the final steps of the apoptotic cascade and is a common indicator used to assess cell 
death after TBI (Clark et al., 2000). One-Way ANOVA revealed a significant difference in 
Caspase-3 cleavage at 24 h post-bTBI (F (3,16) = 5.533, p < 0.01). Caspase-3 cleavage 
significantly increased in the left PFC of bTBI rats (t = 3.251, p < 0.05), but was not significantly 
increased in the left PFC of SAL+bTBI rats (t = 1.200, p > 0.05) (Bonferroni’s post-hoc analysis) 
(Figure 4.8A). These results suggest blast exposure elicits cell death through apoptosis. The 
results also suggest that ER stress plays an important role in the control of cellular fate following 
blast injury. 
We wanted to determine if our blast model produced cell death, and if SAL pre-
administration would reduce bTBI-induced cell death. To do this we employed a terminal 
deoxynucleotidyl transferase-mediated dUTP nick end labeling assay that utilizes DAB to stain 
cells undergoing the initial stages of apoptosis. We noticed cell membrane blebbing following 
blast exposure in the left PFC, which indicates early signs of apoptosis (Clark et al., 1997). DAB 
staining revealed increased apoptosis in bTBI rats compared to control rats (Figure 4.8B,C). 
Interestingly, SAL+bTBI rats displayed less DAB positive staining compared to bTBI rats 
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(Figure 4.8D). The ratio of positive stained cells for control = 3/100, bTBI = 26/100, and 
SAL+bTBI = 3/100. χ2 = 33.456 with 2 degrees of freedom and p < 0.001. 
Impulsive-like behavior ameliorated by salubrinal 
We assessed the percent time spent in the open arms of the EPM to measure changes in 
impulsive-like behavior (Mosienko et al., 2012). Track plots from the Anymaze™ analysis were 
included for each experimental group to visually support the behavioral changes (Figure 4.9A). 
A One-Way ANOVA exhibited a significant difference in the percent time spent in the open 
arms at 7 d post-bTBI (F (3,44) = 4.250, p < 0.05). Tukey’s post-hoc analysis revealed a 
significant increase in the percent time spent in the open arms between bTBI rats and SAL alone 
rats (q = 3.816, p < 0.05). SAL given prior to bTBI significantly reduced the percentage of time 
spent in the open arms compared to the 7 d post-bTBI group (q = 4.657, p < 0.05) (Tukey’s post-
hoc analysis) (Figure 4.9B). No significant differences were observed between groups in speed 
(p > 0.05) (Figure 4.9C), closed arm entries (p > 0.05) (Figure 4.9D), or total movement (p > 
0.05) (Figure 4.9E) (Tukey’s post-hoc analysis). Overall, these results indicate blast exposure 
may increase impulsive-like behavior, and that ER stress modulation may play a role in the 
manipulation of this type of behavior. 
 
DISCUSSION 
Data from the current study provides evidence that blast exposure disrupts the BBB and 
increases PERK-mediated ER stress in the left PFC. Impulsive-like behavior, a neuropsychiatric 
symptom associated with PFC damage (Johnson et al., 2013a), was demonstrated by rats exposed 
to bTBI through their increased exploration in the open arms of the EPM. IHC results confirm 
bTBI increases the expression of neuronal apoptosis. ER stress modulation, influences cellular 
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fate and ameliorates impulsive-like behavior indicative of blast exposure. Overall, these results 
suggest a possible mechanistic link between ER stress, apoptosis and neuropsychiatric disease. 
Previous groups have shown that disruptions in the BBB by various insults such as ischemic 
stroke and epilepsy can cause increased micro-vessel permeability (Kaya and Ahishali, 2011). 
The external forces of TBI can cause rapid depolarization of neuronal cell membranes; 
thereby, activating voltage gated Ca2+ channels and increasing intracellular Ca2+ levels (Gurkoff 
et al., 2013; Begum et al., 2014). Until recently, it was unknown to what extent blast injury 
disrupts the BBB. A mild exposure (~15psi on incident recordings) from our clinically-relevant 
blast model previously exhibited no signs of brain hemorrhage under gross examination (Turner 
et al., 2013b). A new study showed BBB disruption at 6 h following a mild intensity blast (~17.8 
psi) in Sprague-Dawley rats (Abdul-Muneer et al., 2013). Our results indicate a more acute 
disruption in BBB permeability shown at 0.5 h, which is an earlier documentation of BBB 
disruption following bTBI. The rapid increase in permeability from blast injury is thought to 
result from an intracranial pressure spike (Chen et al., 2013c), and may be an important primary 
effect driving cellular stress (Arun et al., 2013). 
Increased intracellular Ca2+ triggered ER stress and activated the UPR in other models of 
neuronal injury (Osada et al., 2009). Similarly, mild neurotrauma was shown to activate other 
adaptive arms of the UPR in mice (Rubovitch et al., 2011a). The UPR is unique in that 
depending on the time and duration of the response, different arms of the pathway are activated 
(Rubovitch et al., 2011a). If the UPR lasts too long, a switch from neuroprotection to apoptosis 
occurs (Nakagawa et al., 2000; Urra et al., 2013). Apoptosis is not purely detrimental to the 
damaged brain considering the heightened energy demands following neurotrauma. By limiting 
energy expended on severely damaged cells, the brain can preserve function to surviving cells.  
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Blast-induced CHOP elevation, along with increased Caspase-12 and Caspase-3 
cleavage, suggests a neuronal shift from the repair response to apoptosis. Modulation of the ER 
stress response with SAL has been shown to attenuate CHOP expression (Zhang et al., 2014a) 
and limit apoptosis in other models of neuronal injury (Sokka et al., 2007; Nakka et al., 2010). 
SAL’s effects on Caspase-12 remain controversial where some studies claim SAL mitigates 
Caspase-12 cleavage (Liu et al., 2012), while other studies claim SAL promotes cleavage (Gao et 
al., 2013). Furthermore, it is important to note that Caspase-12 is regulated through a calpain-
dependent process (Nakagawa and Yuan, 2000) independent from the PERK-mediated UPR 
(Badiola et al., 2011). In our bTBI model, we show that SAL mitigates CHOP expression and 
reduces Caspase-3-mediated cell death with no effect on Caspase-12 cleavage. This suggests that 
SAL may not have a direct effect on Caspase-12 cleavage, but still plays a role in the control of 
cellular fate. Our findings, along with the findings of others, provide evidence for new ways to 
examine cellular stress and apoptosis in models of neuronal injury. 
Neurotrauma is also intimately associated with post-injury changes in behavior 
(Schroeter et al., 2007). Blast exposure increases impulsive-like behavior in adult male Sprague 
Dawley rats as shown in the EPM data. This finding may correlate with acute behavioral findings 
seen in soldiers following head injury (Menon et al., 2010). Interestingly, SAL attenuated the 
percentage of time spent in the open arms of the EPM following bTBI. These findings suggest 
that SAL may have a modulatory effect on impulsive-like behavior indicative of PFC damage 
through modulation of ER stress. While significant advances have been made in understanding 
the acute pathophysiology of blast exposure, it remains unclear how bTBI leads to the 
development of neuropsychiatric disorders (Tweedie et al., 2013). 
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Emerging evidence indicates that the UPR may be one potential mechanism linking acute 
neuronal injury and chronic disease pathology (Scheper and Hoozemans, 2013). In various 
models of neurodegenerative disease, evidence of PERK-mediated ER stress activation has been 
implicated (Costa et al., 2012; Ho et al., 2012; Nijholt et al., 2012). Moreover, experimental 
work using other models of neurotrauma have shown elevated UPR markers (Farook et al., 2013; 
Begum et al., 2014) and behavioral deficits (Goldstein et al., 2012; Petraglia et al., 2014c). Based 
on our findings, the elevation of UPR markers concurrently with Caspase-3 cleavage suggests 
neuronal apoptosis, which has been implicated as an early indicator of chronic disease pathology 
(McKee et al., 2009). As such, our study provides a correlative link between blast-induced UPR 
activation and neuropsychiatric disorder development. Future studies, likely using genetically 
altered animals, or additional pharmacologic inhibitors, are required to examine the precise role 
of ER stress in the development of chronic disease following neurotrauma. Similarly, 
investigating PERK-mediated ER stress in pathologic clinical specimens will further clarify the 
potential role of the pathway in neuropsychiatric disease development.  
Long-term studies utilizing both a single and repetitive injury model are warranted in 
order to examine not only chronic disease processes associated with ER stress but also the effect 
of repetitive injury on the activation of the ER stress response. Finally, the contribution of the 
other two adaptive arms of the UPR following blast injury remains to be elucidated. All three 
adaptive arms of the UPR share CHOP as a signal mediator and is of particular interest due to the 
overlapping nature of the pathways and the potential for modulation of signaling in a biphasic 
manner. We are also interested in the role of axonal shearing as a result of blast exposure. We 
have shown previously that a majority of damage from our blast model occurs in the corpus 
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callosum (Turner et al., 2013b). This is considered another primary effect of blast exposure and 
warrants future investigation using our model.  
Blast exposure disrupts the BBB and triggers ER stress in the left PFC. Rats exposed to 
blast exhibit more impulsive-like behavior and display markers of neuronal apoptosis. When 
bTBI rats were given the ER stress modulator, SAL, markers of apoptosis and impulsive-like 
behavior were both attenuated. The cells that survive the initial primary injury of bTBI are those 
that we seek to protect from secondary injury mechanisms. Future studies linking ER stress to 







Figure 4.1. Schematic shows primary and secondary effects of blast injury. Blast-induced 
traumatic brain injury (bTBI) can burst brain microvessels and shear axons. Both primary effects 
lead to increased intracellular calcium levels which triggers a variety of secondary effects 
including endoplasmic reticulum (ER) stress. ER stress activates the unfolded protein response 
(UPR) which consists of three separate adaptive arms that play a time-dependent role in 
maintaining cellular homeostasis. Following neural injury the protein kinase-like ER kinase 
(PERK)-mediated UPR is considered the acute phase adaptive arm. This mechanism, along with 








Figure 4.2. Blood brain barrier disruption observed in the contra coup brain after bTBI. 
(A) Blood Brain Barrier (BBB) disruption as evidenced by increased Evan’s Blue absorbance in 
the left prefrontal cortex (PFC) at 0.5 h post-bTBI (***p < 0.001 vs. Ctrl) and 6 h post-bTBI (*p 
< 0.01 vs. Ctrl) (values represent mean ± s.e.m.) (n = 4). (B) Raw images of Evan’s Blue bound 













Figure 4.3. Blast exposure upregulates stress response genes atf4, ddit3, ppp1R15A and gfap. 
Real-time quantitative PCR time course showed a significant increase in mRNA abundance in 
the left PFC post-bTBI of stress response genes (A) atf4 (activating transcription factor 4) 
(ATF4) at 3 h (***p < 0.001 vs. Ctrl at 3 h) and (B) ddit3 (CHOP) at 3 h (***p < 0.001 vs. Ctrl 
at 3 h). No real differences were observed in mNRA abundance in the right PFC for (C) atf4 (p > 
0.05) and (D) ddit3 (p > 0.05). A significant increase in mRNA abundance was also observed in 
the left PFC for UPR gene (E) ppp1R15A (GADD34) at 6 h (***p < 0.001 vs. Ctrl at 6 h), and 
astrocyte activation marker (F) gfap (GFAP) at 24 h (**p < 0.01 vs. Ctrl at 24 h) (values 










Figure 4.4. SAL attenuates ER stress markers in the contra coup PFC after bTBI (A) 
Immunoblots show a significant increase in CHOP expression at 24 h post-bTBI in the left PFC 
(*p < 0.05 vs. Ctrl). (B) No significant differences were observed in the right PFC (p > 0.05 vs. 
Ctrl). (C) CHOP expression was significantly increased at 24 h post-bTBI compared to SAL 
administered alone (*p < 0.05 vs. SAL). SAL administration prior to blast exposure attenuated 
CHOP expression (#p < 0.05 vs. bTBI). (D) A significant increase in Caspase-12 cleavage was 
observed at 24 h in bTBI rats (*p < 0.05 vs. SAL), as well as in SAL+bTBI rats at 24 h (*p < 
0.05 vs. SAL). (E) GADD34 protein expression was significantly increased at 24 h post-bTBI 
(*p < 0.05 vs. SAL). SAL administration prior to blast exposure attenuated GADD34 protein 














Figure 4.5. SAL modulates fluorescence of apoptosis markers after bTBI. Column of panels 
display immunofluorescence of apoptosis markers: CHOP (green), Caspase-12 (red) and 
Caspase-3 (red) (top to bottom). Row of Panels are separated by experimental group: CTRL, 
bTBI and SAL+bTBI (left to right). All images are from the left PFC region and display the blue 
nuclear counterstain 4',6-diamidino-2-phenylindole (DAPI). Images are displayed at 20x; arrows 
demarcate insets at 40x. (Scale bars = 50µm). (A) Immunohistochemistry (IHC) shows bTBI 
augmented CHOP fluorescence in the left PFC at 24 h (***p < 0.001 vs. Ctrl). SAL 
administration prior to bTBI attenuated CHOP fluorescence at 24 h (###p < 0.001 vs. 24 h) (B) 
IHC shows bTBI increased Caspase-12 fluorescence in the left PFC at 24 h (***p < 0.001 vs. 
Ctrl). SAL+bTBI rats also displayed increased Caspase-12 fluorescence at 24 h (***p < 0.001 
vs. Ctrl) (C) IHC also shows bTBI augmented Caspase-3 fluorescence in the left PFC at 24 h 
(***p < 0.001 vs. Ctrl). SAL administration prior to bTBI mitigated Caspase-3 fluorescence at 
24 h (##p < 0.01 vs. 24 h) (values represent mean ± s.e.m.) (n = 4; 12 randomly selected areas 














Figure 4.6. SAL reduces CHOP and MAP2 colocalization after blast exposure. Column of 
panels display immunofluorescence of UPR marker CHOP (green), neuron-specific marker 
MAP2 (red), nuclear counterstain DAPI (blue), and those three markers merged (yellow) (left to 
right). Row of panels are separated by experimental group: CTRL, bTBI and SAL+bTBI (top to 
bottom). All images are from the left PFC region with colocalization determined by levels of 
yellow in merged images. Images are displayed at 20x; arrows demarcate insets at 40x. (Scale 














Figure 4.7. CHOP and Caspase-12 colocalize regardless of SAL administration prior to 
bTBI. Column of panels display immunofluorescence of UPR marker CHOP (green), Caspase-
12 (red), nuclear counterstain DAPI (blue), and those three markers merged (yellow) (left to 
right). Row of panels are separated by experimental group: CTRL, bTBI and SAL+bTBI (top to 
bottom). All images are from the left PFC region with colocalization determined by levels of 
yellow in merged images. Images are displayed at 20x; arrows demarcate insets at 40x. (Scale 













Figure 4.8. SAL reduces apoptosis in the left PFC following blast exposure. (A) Caspase-3 
cleavage increased in the left PFC of bTBI rats at 24 h (*p < 0.05 vs. SAL), but was not 
increased in SAL+bTBI rats at 24 h (p > 0.05 vs. SAL) (values represent mean ± s.e.m.; 
normalized to β-actin) (n = 5). (B,C) Evidence of increased cell membrane blebbing, an indicator 
of early apoptosis, was observed at 24 h in the left PFC of bTBI rats compared to control rats. 
(D) Membrane blebbing was reduced in the left PFC of SAL+bTBI rats. Images displayed at 







Figure 4.9. SAL ameliorates impulsive-like behavior indicative of PFC damage after Blast. 
(A) A motion capture track plot of one animal from each experimental group during a single 
elevated plus maze (EPM) trial using AnyMaze Software™. (B) Percentage of time spent in the 
open arms of the EPM was significantly increased in bTBI rats compared to SAL only rats at 7 d 
(*p < 0.05 vs. SAL). SAL administration prior to bTBI decreased the percent time spent in the 
open arms of the EPM (#p < 0.05 vs. bTBI) (values represent mean ± s.e.m.) (n = 12). No 
significant differences were observed between groups for (C) Speed, (D) Closed-Arm Entries, or 














Salubrinal reduces oxidative stress, neuroinflammation and 
impulsive-like behavior in a rodent model of traumatic brain injury 
 
 

























Traumatic brain injury is the leading cause of trauma related morbidity in the developed 
world. TBI has been shown to trigger secondary injury cascades including endoplasmic 
reticulum stress, oxidative stress, and neuroinflammation. The link between secondary injury 
cascades and behavioral outcome following neurotrauma is poorly understood and warrants 
further investigation. Using our validated rodent blast injury model, we examined the secondary 
injury cascades following single injury and how these effects may contribute to risk-taking 
behavior after repetitive blast. We targeted these pathways with the cellular stress modulator, 
salubrinal, and investigated its role in decreasing neuroinflammation and risk-taking behavior 
after blast injury. Single blast increased multiple markers associated with secondary injury 
cascades including janus-N-terminal kinase phosphorylation, nuclear factor kappa beta activity, 
inducible nitric oxide synthase protein expression, pro-inflammatory markers, and superoxide 
levels at 24 hours post-injury. After repeat blast, we observed elevated neuroinflammation and 
neurodegeneration, in addition to risk-taking behavior measured on the elevated plus maze. 
Salubrinal administration attenuated secondary injury cascades acutely, and prevented risk-
taking behavior following repetitive blast. Overall, these results suggest a link between 
secondary injury cascades and risk-taking behavior that can be modulated by salubrinal 
administration. Overlapping components of cellular stress were targeted by salubrinal and 









An estimated 3.2 million Americans are currently living with disabilities from traumatic 
brain injury (TBI) (Zaloshnja et al., 2008). Risk-taking behavior is one of the most common 
neuropsychiatric symptoms associated with brain injury and results from damage to the frontal 
cortex (Schwarzbold et al., 2010; Adhikari et al., 2011; Logsdon et al., 2014; Michael et al., 
2015). Risk-taking behavior is a key finding in patients diagnosed with chronic traumatic 
encephalopathy (CTE) and presents early in disease progression (Banks et al., 2014; Rebetez et 
al., 2015). CTE is a progressive tauopathy that develops in patients with a history of 
neurotrauma. The diagnosis of CTE is increasing but prospective studies are limited (Stein et al., 
2014). Currently, no therapies for risk-taking behavior are available for patients diagnosed with 
progressive neurodegenerative disease. 
The underlying mechanistic causes linking neurotrauma to subacute neuropsychiatric 
symptoms are still poorly understood (Lucke-Wold et al., 2014b). Neuroinflammation has 
emerged as a possible contributory factor to behavior change (Faden et al., 2015).  Preclinical 
models have shown that TBI is associated with a significant inflammatory burden (Kumar et al., 
2014). Furthermore, it has been shown that neuroinflammation can persist years after injury in 
the brains of retired athletes (Coughlin et al., 2014). Recent clinical evidence ties 
neuroinflammation to neurobehavioral dysfunction (Cho et al., 2013; Wu et al., 2014). We 
propose that by targeting neuroinflammation, we can possibly improve behavior after TBI. In 
this paper, we investigate how cellular stress modulation may contribute to changes in the 
inflammatory burden and neurobehavioral dysfunction in a rodent model of blast TBI.  
The endoplasmic reticulum (ER) stress mechanisms have been shown to play a 
significant role in acute and chronic disease pathology following TBI (Zhang et al., 2012; Abdul-
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Muneer et al., 2014; Begum et al., 2014; Lucke-Wold et al., 2015b). We recently showed that 
markers of ER stress were increased in the brains of athletes diagnosed with CTE (Lucke-Wold 
et al., 2015c). Janus-N-terminal kinase (JNK) is a common downstream component of ER stress 
(Urano et al., 2000), which is activated following TBI (Otani et al., 2002; Szmydynger-
Chodobska et al., 2010).  JNK is also a known tau kinase (Tran et al., 2012). Simultaneous to ER 
stress activation, oxidative stress occurs and generates free radicals, which play a role in cell 
death and disease pathology following TBI (Toklu and Tumer, 2015). Free radicals damage 
cellular membranes, increase carbonyl formation, and can contribute to cell death and 
neurobehavioral dysfunction (Ferguson et al., 2010).  
ER stress may also cause a direct increase in oxidative stress acutely following injury due 
to accumulated unfolded proteins (Chaudhari et al., 2014). ER stress and oxidative stress have 
both been associated with increased neuroinflammation after TBI (Deslauriers et al., 2011; 
Bellezza et al., 2014; Hayashi, 2015). Integral to the process of neuroinflammation is activation 
and nuclear translocation of nuclear factor kappa B (NFB) (Bracchi-Ricard et al., 2013). NFκB 
is known to promote pro-inflammatory cytokines, such as, tumor necrosis factor alpha (TNF) 
and interleukin 1 beta (IL-1) (Algattas and Huang, 2014). These inflammatory cytokines can 
signal changes that damage neuronal cell membranes and intracellular organelles (Abdullah and 
Bayraktutan, 2014). NFκB activity is also known to promote inducible nitric oxide synthase 
(iNOS) (Algattas and Huang, 2014), which may, under persistent conditions, contribute to 
neurodegeneration and neurobehavioral dysfunction (Jayakumar et al., 2014). Therefore, 
neuroinflammation may be a promising target for improving TBI outcome.  
Salubrinal (SAL) is a modulator of cellular stress known to inhibit protein phosphatase 1 
(Boyce et al., 2005). SAL has been shown to be neuroprotective in models of stroke (Nakka et 
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al., 2010) and TBI (Logsdon et al., 2014; Dash et al., 2015). In the present study, we investigated 
the effects of SAL on oxidative stress and neurodegeneration following blast exposure. We also 
measured SAL’s effects on neuroinflammation in the frontal cortex. Moreover, we examined 
whether SAL ameliorated risk-taking behavior, a neurobehavioral dysfunction associated with 
damage to the frontal cortex (Schwarzbold et al., 2010; Adhikari et al., 2011; Logsdon et al., 
2014). Modulating intracellular stress may positively influence the extracellular inflammatory 




Fifty-one (51) male Sprague-Dawley rats (Hilltop Lab Animals) at 2-3 months of age 
were used in this study. Rats were acclimated for 1 week prior to use and housed under 12 hour 
light/dark conditions with food and water available ad libitum. Animal experiments were 
performed according to the principles of the Guide for the Care and Use of Laboratory Animals. 
The West Virginia University Animal Care and Use Committee approved all procedures 
involving rats. 
Salubrinal 
SAL (Tocris Biosciences) was dissolved in 0.5% DMSO and delivered via intraperitoneal 
(i.p.) injection at a dose of 1 mg/kg (Sokka et al., 2007; Liu et al., 2014b). 
Blast overpressure exposure 
Blast exposure was induced as previously described (Turner et al., 2013b). Blast pressure 
with a 0.005” membrane (15 psi incident wave; 50 psi reflected wave) was determined, from our 
previous work, to exhibit neural injury markers with no mortality (Turner et al., 2013b; Logsdon 
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et al., 2014; Lucke-Wold et al., 2014c). Following blast exposure, rats were returned to a holding 
cage equipped with a homeothermic heating pad. Once basic reflexes were restored, rats were 
returned to their home cage. 
Experimental groups 
A detailed timeline shows the course of injury and treatment for each group of rats 
(Figure 5.1). Rats were randomly assigned to one of three treatment groups. Group 1 rats served 
as sham controls (anesthetized with 4% isoflurane). Following anesthesia, rats were injected with 
vehicle (0.5% DMSO; i.p.) 5 minutes after being placed on blast table. Group 2 rats served as 
our experimental control group, in which anesthetized rats were oriented similarly to sham rats 
and subsequently exposed to blast. Rats were injected with vehicle 5 minutes after each blast 
exposure. Group 3 served as our experimental group. Rats received blast exposure as group 2, 
but SAL (1 mg/kg; i.p.) was administered 5 minutes after each blast exposure (Rubovitch et al., 
2015).  
There was two blast TBI subgroupings: a single blast TBI (sTBI) and a repeated blast 
TBI (rTBI). Rats in the rTBI group received a blast every other day over two weeks, for a total of 
six blast injuries. This repetitive schedule was determined by our previous work that showed 
markers of ER stress activation (Lucke-Wold et al., 2015b), and from other TBI models that 
showed markers of neuroinflammation and neurodegeneration (Mouzon et al., 2012; Mouzon et 
al., 2014).  
Twenty-four (24) sTBI rats were randomly divided into the three treatment groups and 
euthanized for biochemical analysis at 24 hours post-blast (n=4 rats per group), and 
immunohistochemistry (IHC) at 72 hours post-blast (n=4 rats per group). Twenty-seven (27) 
rTBI rats were randomly divided into the three treatment groups and were subject to behavioral 
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testing 72 hours after the repetitive blast schedule (n=9 rats per group). Four rTBI rats from each 
experimental group were euthanized for IHC after behavioral testing was complete. 
Tissue preparation   
Rats used for biochemical analysis were euthanized and their brains were rapidly 
removed in an ice-cold HaltTM protease/phosphatase inhibitor cocktail mix (Thermo Scientific). 
The striatum was dissected out from each hemisphere, flash frozen in liquid nitrogen, and stored 
at −80 °C for later measurement of carbonyl and reactive oxygen species (ROS) levels. The 
frontal cortex was dissected out from each hemisphere, flash frozen in liquid nitrogen and stored 
at −80 °C for later measurement of protein expression and mRNA abundance. Rats used for IHC 
were anesthetized with 4% isoflurane and perfused transcardially with ice-cold saline. Following 
perfusion, brains were removed, flash frozen in isopentane (−60 °C) and stored at −80 °C for 
IHC preparation. 
Carbonyl measurement 
For carbonyl measurement, striatal tissue samples from sTBI rats (n=4 rats per group) 
were assayed using an OxyBlot Protein Oxidation Detection kit (Millipore). Striatal tissues from 
each treatment group were sonicated in 6% sodium docecyl sulfate (SDS). Control samples were 
mixed with derivation control solution and experimental samples were mixed with 2,4-
dinitrophenylhydrazine. Samples were incubated for 15 minutes followed by addition of 
neutralization solution. Samples were loaded (20 ul per well) and electrophoresed on a 10% 
acrylamide gel and immunoblotted as outlined in the Western blot methods below.  
ROS measurement 
For ROS detection, striatal tissue from sTBI rats were homogenized and cells were 
isolated by incubation in collagenase at 2 mg/ml for 30 minutes. Cells were separated by enzyme 
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digestion and manual disruption by repeated pipetting. Cells were strained through a 70 um 
nylon cell strainer followed by centrifugation at 400 x g for 5 minutes. Pellets were resuspended 
to a concentration of 1.0 x 106 cells/ml in Dulbecco's Modified Eagle Medium (DMEM).  
Total ROS and superoxide levels were detected using a Total ROS/Superoxide Detection kit 
(Enzo Life Sciences) according to manufacturer’s instructions. In brief, 100 μl of suspended cells 
were added to each well of a dark-sided 96 well plate with a clear bottom. Cells were incubated 
overnight at 37°C in DMEM. The following day, media was removed and 100 μl of 
ROS/Superoxide Detection Solution was added to each well and incubated in the dark for 1 
hour. Detection of total ROS (green) and superoxide (red/yellow) fluorescence was detected at 
an excitation wavelength of 488/520 nm and an emission wavelength of 550/610 nm, 
respectively. Data were collected using Gen5 software (BioTek). Concentrations were 
determined based on a known standard curve.  
Western blot 
Protein samples from sTBI and rTBI rats were prepared in 1% SDS and Western blot 
analysis was performed as previously described (Lucke-Wold et al., 2014c). Primary antibodies 
(and dilution factors) were rabbit anti-pJNK monoclonal antibody (mAB) (Thr183/Tyr185) 
(1:500), rabbit anti-binding immunoglobulin protein (BiP) mAB (1:1000), rabbit anti-JNK mAB 
(1:1000) (Cell Signaling); mouse anti-NFκB p65 polyclonal antibody (pAB) (1:200), rabbit anti-
iNOS pAB (1:200) (Santa Cruz). A rabbit anti-β-actin mAB (1:10,000) (Cell Signaling) was 
used as an endogenous control to normalize protein loading.  Secondary antibodies were 
IRDye® 800CW (goat anti-rabbit) and IRDye® 680RD (goat anti-mouse) (LI-COR 
Biosciences). Images were collected using the Odyssey Classic Infrared Imaging System (LI-
COR Biosciences). Images were converted to gray scale, and detected bands were quantified 
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using Image Studio Lite Software (LI-COR Biosciences). Bands were normalized to β-actin 
values to measure relative intensity. 
Quantitative real-time polymerase chain reaction  
RNA samples from sTBI and rTBI rats were prepared in TRIzol® reagent (Life 
Technologies) and confirmed for quality (1.8-2.1 absorbance ratio). Reverse transcription was 
conducted and real-time PCR analyses were performed on cDNA using the following 
oligonucleotide primer sets: TNFα (Rn01525859_g1), IL-1β (Rn00580432_m1), and 18s rRNA 
(Hs99999901_s1; endogenous control) (Life Technologies). Changes in mRNA abundance were 
determined by the ΔΔCt method with a threshold cycle value of 0.2 normalized to 18s rRNA. 
Histology  
Whole brains from sTBI and rTBI rats were mounted on a Leica CM3050S cryostat 
(Leica Microsystems) set to −20 °C. Coronal sections of the frontal cortex were sliced at a 
thickness of 20 μm and mounted onto glass slides for IHC staining as previously described 
(Lucke-Wold et al., 2015b). Briefly, brain slices were circumscribed, and incubated overnight 
with primary antibodies: iNOS (Santa Cruz), glial fibrillary acidic protein (GFAP), C/E 
homology protein (CHOP), BiP, and pJNK (Cell Signaling). The next day, an Alexa Flour® 
secondary antibody (Invitrogen) was applied to slides for 3 hours, and coverslip mounted with 
Vectashield® 4',6-diamidino-2-phenylindole (DAPI) nuclear counterstain (Vector) . If staining 
for colocalization, a second set of primary and secondary antibodies were applied prior to fixing 
the coverslip. Fluorojade B (FJB) (Millipore), and ROS (Enzo Life Sciences) staining was 
performed in accordance with manufacturer’s instructions. 
Fluorescent imaging was performed using a Zeiss Axio Observer Z1. For fluorescent 
staining, 10 cells per slide were randomly selected, outlined, and measured with ImageJ software 
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(NIH) by an observer blinded to experimental group. Density was adjusted per mean area to give 
corrected total cell fluorescence normalized to background. Co-localization quantification with 
the Just Another Co-localization plugin for ImageJ was used to determine overlap coefficient or 
Pearson’s coefficient. Overlap coefficient was calculated using k^2 = k1*k2 with values adjusted 
to threshold. 
Elevated plus maze 
Risk-taking behavior was assessed in rTBI rats using the Elevated plus maze (EPM). The 
EPM was set at a height of 60 cm above the floor. The two open arms intersected perpendicular 
to the two closed arms. Each arm was 50 cm x 10 cm. The closed arms were encased by black 
siding 30 cm tall. Each rat was placed in the middle of the EPM facing an open arm and tracking 
was performed for 5 minutes using AnyMaze™ software (Stoelting), which pinpointed the 
location of the rat’s head and body continuously throughout the testing trial. 
Statistical analysis 
Data were analyzed using a one-way analysis of variance (ANOVA) followed by 
Newman-Keul's post hoc tests for between groups comparison. For colocalization studies, 
Pearson’s coefficient was obtained for control sections. Overlap coefficient was obtained for 
experimental groups to determine the extent of same-cell protein expression. Sample sizes were 
determined using a power analysis with an α of 0.05, a β of 0.2, and a sample effect of 0.4 for 




SAL reduces oxidative stress after sTBI 
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Figure 5.2A shows a significant difference in carbonyl levels between groups after sTBI 
(F(2,9) = 10.21; P < 0.01). A significant increase in carbonyl levels was measured in sTBI rats as 
compared to control rats (q = 6.26; P < 0.01). SAL administration significantly reduced carbonyl 
levels (q = 4.23; P < 0.05) when compared to vehicle-treated sTBI rats. 
Figure 5.2B shows a significant difference in superoxide levels between experimental 
groups after sTBI (F(2,9) = 7.68; P < 0.05). A significant increase in superoxide levels was 
measured in sTBI rats when compared to control rats (q = 4.92, P < 0.05). SAL administration 
significantly reduced superoxide levels as compared to vehicle-treated sTBI rats (q = 4.68, P < 
0.01). Figure 5.2C shows no difference in total ROS levels (F(2,9) = 0.16; P > 0.05). 
SAL attenuates neurodegeneration after sTBI 
Figure 5.3A shows a significant difference in corrected total cell fluorescence for GFAP 
at 72 hours post-sTBI (F(2,29) = 35.23; P < 0.001). A significant increase in GFAP fluorescence 
was observed in sTBI rats compared to control rats (q = 10.07, P < 0.001). SAL administration 
significantly reduced GFAP fluorescence when compared to vehicle-treated sTBI rats (q = 7.58, 
P < 0.001).  
Figure 5.3B shows a significant difference in corrected total cell fluorescence for FJB at 
72 hours post-sTBI (F(2,29) = 7.43; P < 0.01). A significant increase in FJB fluorescence was 
observed in sTBI rats compared to control rats (q = 5.18, P < 0.05). SAL administration 
significantly reduced FJB fluorescence when compared to vehicle-treated sTBI rats (q = 3.32; P 
< 0.05). 
SAL mitigates neuroinflammation after sTBI 
Figure 5.4A indicates a significant difference between experimental groups in JNK 
phosphorylation after sTBI (F(2,9) = 9.04; P < 0.01). A significant increase in JNK 
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phosphorylation at 24 hours was observed in sTBI rats as compared to control rats (q = 5.79; P < 
0.01). SAL administration significantly attenuated JNK phosphorylation when compared to 
vehicle-treated sTBI rats (q = 4.31; P < 0.05). No difference in total JNK protein expression was 
observed at 24 hours post-sTBI (P > 0.05). 
Figure 5.4B shows no significant difference in BiP expression between experimental 
groups (F(2,9) = 0.93; P > 0.05). 
Figure 5.4C shows a significant difference in NFκB p65 expression between 
experimental groups at 24 hours after sTBI (F(2,9) = 4.67; P < 0.05). NFκB p65 expression was 
significantly increased in sTBI rats compared to control rats (q = 4.101; P < 0.05). SAL 
administration significantly reduced NFκB p65 expression when compared to vehicle-treated 
sTBI rats (q = 3.24; P < 0.05).  
Figure 5.4D shows a significant difference in iNOS expression at 24 hours after sTBI 
(F(2,9) = 6.81; P < 0.05). A significant increase in iNOS expression was measured in sTBI rats 
compared to control rats (q = 4.92; P < 0.05). SAL administration significantly reduced iNOS 
expression when compared to vehicle-treated sTBI rats (q = 3.97; P < 0.05).  
Figure 5.4E shows a significant difference in IL-1β mRNA abundance at 24 hours post-
sTBI amongst the treatment groups (F(2,9) = 5.62; P < 0.05). A significant increase in IL-1β 
mRNA abundance was measured in sTBI rats compared to control rats (q = 4.13; P < 0.05). SAL 
administration significantly reduced IL-1β mRNA abundance when compared to vehicle-treated 
sTBI rats (q = 4.08; P < 0.05). 
Figure 5.4F shows a significant difference amongst the treatment groups in TNFα mRNA 
abundance at 24 hours post-sTBI (F(2,9) = 5.54; P < 0.05). A significant increase in TNFα mRNA 
abundance was measured in sTBI rats compared to control rats (q = 4.49; P < 0.05). SAL 
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administration significantly reduced TNFα mRNA abundance when compared to vehicle-treated 
sTBI rats (q = 3.47; P < 0.05). 
ER stress and neuroinflammation markers colocalize 
Figure 5.5A shows IHC colocalization (yellow) of ER stress marker CHOP (green) with 
ER stress marker BiP (red). Pearson’s coefficient revealed a low correlation in vehicle controls (r 
= 0.21), a high correlation in rTBI + Vehicle (r = 0.82), and a low correlation in rTBI + SAL (r = 
0.20). 
Figure 5.5B shows IHC colocalization (yellow) of ER stress marker CHOP (green) with 
ER stress marker pJNK (red). Overlap Pearson’s coefficient revealed no correlation in vehicle 
controls (r = 0.00), a medium correlation in rTBI + Vehicle (r = 0.61), and no correlation in rTBI 
+ SAL (r = 0.00). 
SAL attenuates neuroinflammation after rTBI 
Figure 5.6A shows IHC colocalization (yellow) of ER stress marker CHOP (green) with 
neuroinflamation marker iNOS (red). Overlap Pearson’s coefficient revealed a low correlation in 
vehicle controls (r = 0.17), a medium correlation in rTBI + Vehicle (r = 0.65), and a low 
correlation in rTBI + SAL (r = 0.22). 
Figure 5.6B shows a significant difference in corrected total cell fluorescence for GFAP 
at 72 hours post-rTBI (F(2,29) = 6.62; P < 0.01). A significant increase in GFAP fluorescence was 
observed in rTBI rats compared to vehicle-control rats (q = 4.69, P < 0.01). A significant 
increase in GFAP fluorescence was also observed in rTBI + SAL rats compared to vehicle-
control rats (q = 4.99, P < 0.05). 
SAL ameliorates risk-taking behavior after rTBI 
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Figure 5.7A shows a significant difference in open arm time at two weeks post-rTBI 
amongst the treatment groups (F(2,24) = 4.72; P < 0.05). A significant increase was measured in 
the time that the rTBI rats spent in the open arms of the EPM compared to control rats (q = 4.09; 
P < 0.05). Interestingly, SAL administration significantly attenuated the open arm time when 
compared to vehicle-treated rTBI rats (q = 3.31; P < 0.05). Figure 5.7B shows no difference in 
the total distance the rats travelled between the experimental groups (F(2,24) = 2.54; P > 0.05). 
Track plots from Anymaze™ were overlaid for each subject to provide a clear visual 
representation of the rats’ behavior during the EPM trials (Figure 5.7C-E). 
Mechanism of blast injury 
Figure 5.8 shows a proposed detailed schematic of the injury cascade following blast 
injury. We propose blast TBI may cause vascular disruption and blood extravasation into the 
brain parenchyma can damage plasma membranes and trigger secondary injury cascades (Uranga 
et al., 2009; Liu et al., 2013; Nisenbaum et al., 2014). The secondary injury cascades may 
contribute to neurodegeneration and neurobehavioral dysfunction. 
 
DISCUSSION  
Blast TBI models cause a primary injury due, in part, to acceleration-deceleration forces 
to the rat’s head (Goldstein et al., 2012). The current study shows an initiation of secondary 
injury cascades including oxidative stress and ER stress following primary injury in addition to 
glial reactivity and neurodegenerative changes. We also show these cellular stress responses 
occurred concurrent with increases in neuroinflammatory markers after blast TBI. 
Neuroinflammation is a common secondary effect of brain injury and has been demonstrated in a 
variety of rodent TBI models (Abdul-Muneer et al., 2013; Cho et al., 2013; Abdul-Muneer et al., 
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2014; Algattas and Huang, 2014; Roth et al., 2014), and has been linked clinically to single and 
repetitive head injuries (Aungst et al., 2014; Webster et al., 2015). While previous studies have 
shown an association between ER stress and neuroinflammation, what remains unknown is 
whether regulation of these responses would affect neurodegeneration and improve 
neurobehavioral outcome (Fenn et al., 2015). Additionally, ER stress activation has been 
proposed to directly increase oxidative stress particularly in the striatum (Malhotra and 
Kaufman, 2007). Using the ER stress modulator SAL, we show a potential link between these 
pathways. Moreover, how brain injury contributes to neuroinflammation and subsequent 
neurobehavioral dysfunction has not yet been elucidated. Using SAL as a modulator, we also 
offer compelling evidence that acute cellular stress cascades, not only closely link to subacute 
neuroinflammation, but also subsequent behavioral alteration. 
An important secondary injury cascade often increased following TBI and intimately 
linked to ER stress is oxidative stress (Cho et al., 2013). We report an increase in oxidative stress 
damage in the striatum following blast exposure, as evidenced by increased carbonyl and 
NADPH-oxidase (NOX)-mediated superoxide levels. Superoxide production is a consequence of 
TBI mainly through activation of the NOX system (Brennan et al., 2009; Zhang et al., 2012; 
Loane et al., 2013). A previous report indicated that NOX and superoxide levels were elevated at 
6 hours after blast TBI and persisted for 72 hours (Ansari et al., 2014). Additionally, NOX-4 
mediated oxidative stress perpetuates damage to neuronal membranes leading to cell death 
(Zhang et al., 2012). A late-onset symptom of CTE is motor dysfunction similar to Parkinson’s 
disease that indicates cell death and damage to the striatum (Stern et al., 2011). In a future study 
we will investigate late-onset motor disturbance associated with the striatal damage reported 
herein. We will further elucidate whether repeat or single injury is necessary for motor deficits. 
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Persistent damage to the cell from oxidative stress can trigger a measurable increase in 
JNK phosphorylation (Quan et al., 2015), and NFκB activity [39, 40], affecting 
neuroinflammation. An increase in both pJNK and NFκB p65 expression were demonstrated in 
this study. JNK can signal NFκB translocation to the nucleus, which may upregulate pro-
inflammatory mediators such as iNOS, TNF and IL-1 (Algattas and Huang, 2014; Ruan et al., 
2015). In line with this ensuing injury cascade following blast, we found increased levels of pro-
inflammatory markers: NFB, iNOS, TNF and IL-1. These pro-inflammatory markers are 
thought to cause a sudden oxidative burst that overwhelms antioxidant defense cascades leading 
to further damage of surrounding brain tissue (Liao et al., 2013). We show repetitive blast TBI 
causes a subacute increase in iNOS fluorescence, suggesting a persistent inflammatory response. 
Consequently, while neuroinflammation is a necessary response to brain injury (Finnie, 2013), 
unabated, persistent neuroinflammation can lead to irreversible neurodegeneration and poor 
injury outcome. 
Furthermore, we recently showed that ER stress is an important secondary injury 
response activated after blast TBI (Logsdon et al., 2014), and human CTE (Lucke-Wold et al., 
2015c). ER stress can also lead to neurobehavioral dysfunction following TBI (Dash et al., 2015; 
Lucke-Wold et al., 2015b). We show ER stress markers CHOP and pJNK fluorescence to be 
increased following repetitive injury. Similar to oxidative stress, the ER stress response has 
significant cross talk with neuroinflammatory pathways through JNK signaling (Prell et al., 
2014). A recent study suggests crosstalk between JNK phosphorylation and NFB activity after 
inflammatory challenge with an ER stressor (Ruan et al., 2015).  
We show, for the first time, that SAL administration post-injury attenuates iNOS protein 
expression and JNK phosphorylation. This is in agreement with a recent study where SAL 
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administration reduced NFB and microglia activation in a model of Alzheimer’s disease 
(Huang et al., 2012). SAL also improved chronic motor performance in a model of spinal cord 
injury (Ohri et al., 2013). In a future study, we will investigate if SAL improves motor 
performance long-term following TBI. Further investigation is needed to see if acute modulation 
of cellular stress pathways will lead to long-term behavioral improvements. Docosahexaenoic 
acid, another less-specific ER stress modulator, improved cognitive performance following TBI 
(Begum et al., 2013; Lucke-Wold et al., 2015b). Based on the results of this study and the 
supporting background information, we propose a novel mechanism of action for the beneficial 
properties of SAL through downstream regulation of NFB activity. In support of this claim, we 
demonstrated that SAL administration after blast attenuated pJNK, NFB, iNOS, TNFα, and IL-
1β expression.  
SAL also decreased markers of glial reactivity after single blast exposure, suggesting a 
protective effect at the blood-brain barrier as previously reported (Logsdon et al., 2014). 
Surprisingly, SAL had no influence on glial reactivity following repetitive blast exposure, 
possibly due to a priming effect of persistent neuroinflammation (Ma et al., 2014). The repetitive 
injury schedule may have reduced the measured glial reactivity at 72 hours compared to a single 
blast exposure. Results suggest that astrocyte activation may not contribute to the subacute 
neurobehavioral dysfunction observed with our repetitive TBI model.    
Abnormal behavioral symptoms can be a manifestation of persistent neuroinflammation, 
and are of particular clinical relevance for patients suffering multiple mild head injuries 
(Sominsky et al., 2015). We showed that rTBI rats displayed risk-taking behavior in the EPM 72 
hours following the last blast. Interestingly, SAL administration reduced risk-taking behavior 
when administered after each blast exposure. 
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At 72 hours following the last blast, IHC results suggest that repetitive blast exposure 
increases markers of ER stress and neuroinflammation in the frontal cortex. The results also 
suggest SAL administration reduced CHOP expression. The Pearson’s coefficient values suggest 
CHOP colocalized with BiP, pJNK and iNOS in the frontal cortex at 72 hours post-rTBI. 
Colocalization strengths also suggest SAL may have an effect on ER stress and 
neuroinflammation within the same cells. These markers have been postulated to cause the 
neuronal demise responsible for neurobehavioral dysfunction. Consequently, and most 
importantly, we suggest that SAL may mitigate subacute markers of neuroinflammation and 
thereby reduce risk-taking behavior mediated by the frontal cortex after repetitive brain trauma. 
These findings have broad reaching implications regarding the importance of targeting 
cellular stress acutely post-injury in order to reduce subacute neuroinflammation and ameliorate 
neurobehavioral dysfunction. We showed that ER stress modulation after blast injury decreases 
acute superoxide formation in the striatum, attenuates neuroinflammatory markers in the frontal 
cortex, and ameliorates sub-acute risk-taking behavior in rats. In doing so, we map a unique 
interconnection between intracellular stress cascades and neuroinflammation. Further pre-clinical 
studies are warranted to determine the role of oxidative stress, ER stress and neuroinflammation 
at subacute time points following brain injury and how these pathways contribute to 
neurobehavioral dysfunction.  
In summary, cellular stress and neuroinflammation are intrinsically interconnected and 
play an important role in injury progression following TBI. We show that blast exposure induced 
markers of oxidative stress, which is known to contribute to the exacerbation of ER stress and 
neuroinflammation. Furthermore, we show that ER stress may be linked neuroinflammation 
through the JNK-mediated NFB pathway. Surprisingly, SAL reduced markers of oxidative 
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stress and ER stress; thereby, reducing markers of neuroinflammation post-blast. The likely 
mechanism is reduction of JNK phosphorylation. Most importantly, SAL ameliorated risk-taking 
behavior when administered after each repetitive blast exposure. Secondary injury modulation 
with key multi-target pharmaceutics offers a promising approach to reduce the long-term 
















Figure 5.1. Experimental design 
Detailed experimental timeline showing: rTBI (repetitive blast) animals at top; sTBI (single 
blast) animals at bottom. SAL (Salubrinal); ROS (Reactive oxygen species); WB (Western blot); 














Figure 5.2. SAL reduced markers of oxidative stress after single blast 
(A) A significant increase in protein carbonyl levels was measured at 24 hours post-sTBI (**P < 
0.01 vs Vehicle); SAL treatment significantly attenuated carbonyl levels (#P < 0.01 vs sTBI). 
(B) A significant increase in superoxide levels was measured at 24 hours post-sTBI (*P < 0.05 
vs Vehicle); SAL treatment significantly attenuated superoxide levels (##P < 0.01 vs sTBI). (C) 
No significant differences were observed in total ROS levels (P > 0.05). One-way ANOVA, 







Figure 5.3. SAL attenuated markers of neurodegeneration after single blast  
(A) We observed a significant increase in GFAP (green) fluorescence at 72 hours post-sTBI 
(***P < 0.001 vs Vehicle); SAL significantly reduced GFAP fluorescence (###P < 0.001) (n = 
4). GFAP images include nuclear counterstain DAPI (blue). (B) We observed a significant 
increase in FJB (green) fluorescence at 72 hours post-sTBI (*P < 0.05 vs Vehicle); SAL 
significantly reduced FJB fluorescence (#P < 0.05). One-way ANOVA, Newman-Keul's post 





Figure 5.4. SAL mitigated markers of neuroinflammation after single blast 
(A) We measured a significant increase in JNK phosphorylation at 24 hours post-sTBI (**P < 
0.01 vs Vehicle); SAL significantly mitigated JNK phosphorylation (#P < 0.05 vs sTBI + 
Vehicle). (B) No significant differences were observed in BiP expression at 24 hours post-sTBI 
(P > 0.05). (C) We measured a significant increase in NFκB p65 expression at 24 hours post-
sTBI (*P < 0.05 vs Vehicle); SAL significantly mitigated NFκB p65 expression (#P < 0.05 vs 
sTBI + Vehicle). (D) We revealed a significant increase in iNOS protein expression at 24 hours 
post-sTBI (*P < 0.05 vs vehicle); SAL significantly mitigated iNOS expression (#P < 0.05 vs 
sTBI + Vehicle). (E) We measured a significant increase in IL-1β mRNA abundance at 24 hours 
post-sTBI (*P < 0.05 vs Vehicle); SAL significantly mitigated IL-1β abundance (#P < 0.05 vs 
sTBI + Vehicle). (F) We measured a significant increase in TNFα mRNA abundance at 24 hours 
post-sTBI (*P < 0.05 vs Vehicle); SAL significantly mitigated TNFα abundance (#P < 0.05). 




Figure 5.5. BiP and pJNK colocalized with CHOP after repetitive blast 
Columns are separated by experimental group: Vehicle, rTBI + Vehicle, and rTBI + SAL (left to 
right). All panels display nuclear counterstain DAPI (blue). (A) BiP (red) merged with CHOP 
(green). (B) pJNK (red) merged with CHOP (green). Colocalization determined by levels of 
yellow in each image (Overlap coefficient; r values). All images are from the frontal cortex 
















Figure 5.6. SAL reduced iNOS fluorescence, but not GFAP, after repetitive blast 
Columns are separated by experimental group: Vehicle, rTBI + Vehicle, and rTBI + SAL (left to 
right). All panels display nuclear counterstain DAPI (blue). (A) iNOS (red) merged with CHOP 
(green). Colocalization was determined by levels of yellow in each image (Overlap coefficient; r 
values). Arrows demarcate iNOS fluorescence. (B) We observed a significant increase in GFAP 
(green) fluorescence at 72 hours post-rTBI (**P < 0.01 vs Vehicle); we also observed a 
significant increase in GFAP post-rTBI with SAL administration (*P < 0.05 vs Vehicle). One-
way ANOVA, Newman-Keul's post hoc. Mean ± S.E.M. n = 4. All images are from the frontal 


















Figure 5.7. SAL ameliorated risk-taking behavior after repetitive blast 
(A) A significant increase was observed in the time that the rats spent in the open arms of the 
EPM at 72 hours post-rTBI (*P < 0.05 vs Vehicle); SAL significantly reduced the time spent (#P 
< 0.05 vs rTBI + vehicle). (B) No significant differences were observed in the total distance 
moved among rats in each group (P > 0.05) One-way ANOVA, Newman-Keul's post hoc. Mean 
± S.E.M. n = 9. (C, D, E) Track plots from Anymaze™ were overlaid for each subject to provide 















Figure 5.8. Blast injury cascade with SAL mechanism of action 
Schematic of blast injury cascade and salubrinal mechanism of action. TBI = Traumatic Brain 
Injury; ER = Endoplasmic Reticulum; IRE1α = Inositol requiring enzyme 1 alpha; BiP = Binding 
immunoglobulin protein; NFκB = Nuclear factor kappa beta; JNK = Janus n-terminal kinase; 
iNOS = inducible Nitric oxide synthase; TNFα = Tumor necrosis factor alpha; IL-1β = 
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Chronic neurodegeneration following a history of neurotrauma is frequently associated 
with neuropsychiatric and cognitive symptoms.  In order to enhance understanding about the 
underlying pathophysiology linking neurotrauma to neurodegeneration, a multi-model pre-
clinical approach must be established to account for the different injury paradigms and 
pathophysiologic mechanisms.  We investigated the development of tau pathology and 
behavioral changes using a multi-model and multi-institutional approach, comparing the pre-
clinical results to tauopathy patterns seen in post-mortem human samples from athletes 
diagnosed with chronic traumatic encephalopathy (CTE).  We utilized a scaled and validated 
blast-induced traumatic brain injury model in rats and a modified pneumatic closed-head impact 
model in mice.  Tau hyperphosphorylation was evaluated by western blot and 
immunohistochemistry.  Elevated plus maze and Morris water maze were employed to measure 
impulsive-like behavior and cognitive deficits respectively.  Animals exposed to single blast 
(~50 PSI reflected peak overpressure) exhibited elevated AT8 immunoreactivity in the 
contralateral hippocampus at 1 month compared to controls.  Animals exposed to repeat blast (6 
blasts over 2 weeks) had increased AT8 and AT270 in the contralateral hippocampus at 1 month 
post-injury compared to controls.  In the modified controlled closed-head impact mouse model, 
no significant difference in AT8 was seen at 7 days, however a significant elevation was detected 
at 1 month following injury in the ipsilateral hippocampus compared to control. Elevated plus 
maze data revealed that rats exposed to single blast and repeat blast spent more time in seconds 
exploring the open arms compared to controls.  Morris water maze testing revealed a significant 
difference between groups in acquisition times on days 22-27.  During the probe trial, single 
blast and repeat blast rats spent less time in seconds exploring where the platform had been 
located compared to controls.  This study provides a multi-model example of replicating tau and 
behavioral changes in animals and provides a foundation for future investigation of CTE disease 






Current limitations in understanding CTE pathophysiology are unlikely to be addressed in 
a clinical population in the near future due to the challenges associated with establishing long-
term, prospective cohort studies in such a population.  Preclinical rodent models serve to fill this 
gap in knowledge for various disorders and could allow for further investigation of the molecular 
mechanisms responsible for CTE, as well as testing the potential of diagnostic and therapeutic 
approaches under development.  Few preclinical models of CTE have been proposed that 
sufficiently demonstrate both the requisite tauopathy and behavioral changes attributed to CTE 
(DeFord et al., 2002; DeRoss et al., 2002; Uryu et al., 2002; Creeley et al., 2004; Longhi et al., 
2005; Friess et al., 2009; Blaylock and Maroon, 2011; Shitaka et al., 2011; Fujita et al., 2012b; 
Goldstein et al., 2012; Mouzon et al., 2012; Turner et al., 2012a; Genovese et al., 2013; Hawkins 
et al., 2013; Klemenhagen et al., 2013; Mannix et al., 2013; Aungst et al., 2014; Bailes et al., 2014; 
Donovan et al., 2014; Lucke-Wold et al., 2014a; Mannix et al., 2014; Mouzon et al., 2014; 
Petraglia et al., 2014b; Petraglia et al., 2014a; Brody et al., 2015). 
The purpose of this paper is to present two preclinical models that successfully reproduce 
some neuropathological and behavioral changes consistent with CTE-like phenotypes, and discuss 
future directions for CTE animal modeling. Brody and colleagues (Brody et al., 2015) present 
several unanswered questions that we expand upon in our accompanying review such as the role 
of 1) inter-injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5) 
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the likelihood and/or 
progression of CTE development.  We recently reported that endoplasmic reticulum stress might 
be a contributing factor linking acute neurotrauma to behavioral deficits (Logsdon et al., 2014). 
144 
 
The quest for elucidating CTE pathophysiology development is ongoing with the goal of targeting 
specific injurious cascades a key priority in order to prevent the emergence of clinical symptoms. 
In this work we present novel models of neurotrauma-induced neurodegeneration in both 
mice and rats following exposure to single or repetitive brain injury, respectively.  These models 
replicate both the tauopathy and some of the behavioral changes implicated in CTE in the clinical 
population.  We believe the blast model is particularly relevant clinically due to utilization of a 
scaled, short-duration blast exposure. This is a striking contrast to long-duration blasts utilized in 
numerous studies that may more closely approximate an atomic blast than a blast from an 
improvised explosive device (Bass et al., 2012; Panzer et al., 2012; Turner et al., 2013b; Panzer et 
al., 2014). Park and colleagues show that by having the animal outside of the tube, the wave is 
directed towards the skull causing neurologic injury without extensive lung injury (Park et al., 
2011).  Extended duration waves generated from long blast tubes are based on lung based scaling. 
When the animals are placed within the tube, the impulse exposure to the skull might not be 
representative of human exposure (Cho et al., 2013). The modified closed-head injury in 
unanesthetized animals described previously by Petraglia and colleagues offers the benefit of 
injuring awake animals, more closely replicating the clinical picture seen in athletes than most 
other TBI models (Petraglia et al., 2014b; Petraglia et al., 2014a).  Further studies are required to 
address injury paradigms that do or do not contribute to CTE development but utilization of these 
models appears promising in not only modeling CTE but also identifying therapeutic targets based 






Animals and Human Samples 
All experiments involving animals were approved by either the Institutional Animal Care 
and Use Committee of West Virginia University or that of the University of Rochester and were 
performed based upon principles of the Guide for the Care and Use of Laboratory Animals.  Fifty 
six (56) young-adult male rats (300-350 grams) were acquired from Hilltop Laboratories 
(Scottdale, PA). All blast procedures were performed at West Virginia University.  Twelve (12) 
young-adult male C57BL/6J mice were acquired from Jackson Laboratories (Bar Harbor, ME) and 
used for modified controlled cortical impact at the University of Rochester.  All animals were 
allowed to acclimate upon arrival for 1 week prior to any experimentation.  At all times animals 
were provided food and water ad libitum and maintained on a 12 hour light-dark cycle. Human 
samples were from deceased professional athletes that were previously diagnosed with chronic 
traumatic encephalopathy (Omalu et al., 2010b). The tissue was collected from the entorhinal 
cortices.  
Experimental Groups 
Fifty six (n = 56) rats were divided into three primary experimental groups for behavior – 
anesthetized controls (n = 24), a single blast injury (n = 16), and repeat blast injuries (n = 16).  
Each of these groups was sacrifed at 1 month following the final blast or sham-injury and after 
undergoing functional assessment. Elevated-plus maze was done at 7 days post-blast (n = 24; 8 
controls, 8 single blast, and 8 repeat blast) and the Morris water maze started at 21 days post-blast 
(n = 32; 16 controls, 8 single blast, and 8 repeat blast).  Following behavioral analysis, rats from 
the EPM group were divided into two separate groups with one utilized for immunohistochemistry 
(n = 10; 4 controls, 3 single blast, and 3 repeat blast) and the other for western blotting (n = 14; 4 
controls, 5 single blast, and 5 repeat blast).  Twelve (12) mice were divided into three primary 
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experimental groups – anesthetized controls (n = 4), single injury with sacrifice at one week (n = 
4), and single injury with sacrifice at one month (n = 4).  All mice were utilized for western blotting 
techniques at time of sacrifice. An experimental schematic can be seen in Figure 1. 
Traumatic Brain Injury 
Briefly, all blast injuries administered to rats as part of this work were of moderate intensity 
(~50 PSI peak reflected overpressure) as determined previously and completed under isoflurane-
based anesthesia (Turner et al., 2013b; Logsdon et al., 2014; Lucke-Wold et al., 2014c).  Blast 
exposure occurred on the right side of the animal and was only administered to the head and neck 
region. The rat was outside of the blast tube and a rigid barrier protected the remainder of the 
animal.  Blast waves were of a short-duration (~2 ms) to ensure clinical relevance based on 
elucidated scaling parameters (Figure 2A). The scaling parameters are based on impulse dynamic 
measurements, which are more representative of human blast than closed models based on duration 
(Needham et al., 2015). 
Mice were utilized in a manner previously described (Petraglia et al., 2014b; Petraglia et 
al., 2014a).  Briefly, mice were placed, unanesthetized, into a rodent restraint bag/cone and 
immobilized on top of a foam bed of known spring constant.  A helmet was secured to the head 
using an elastic band, allowing for administration of a diffuse impact through force distribution.  
Impacts were delivered using a modified controlled cortical impact device that was adjusted to 
include an altered tip of vulcanized rubber (Figure 2B). 
Western Blot 
Animals were anesthetized and sacrificed by rapid decapitation.  Brains were extracted and 
immediately placed in a lysate buffer with protease and phosphatase inhibitors as described 
elsewhere (Logsdon et al., 2014).  Brains were dissected and tissue flash frozen and stored at -80 
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°C prior to blotting.  Hippocampal protein samples were dissolved in 0.5 mL of 1% sodium 
dodecyl sulfate (SDS) prior to sonication and protein assay.  Pre-cast 10% 12-well gels (Life 
Technologies, Carlsbad, CA) were loaded with 30 μg of protein per well and run with 2X Lammeli 
buffer.  Wet transfer was performed using nitrocellulose membranes (Bio-Rad, Contra Costa, CA) 
at 60 volts for 2.5 hours.  Primary antibodies against AT8 (Pierce; Rockford, IL), AT270 (Pierce; 
Rockford, IL), CP13 (kindly supplied by Dr. Peter Davies), and PHF-1 (kindly supplied by Dr. 
Peter Davies) were utilized and detected utilizing the corresponding secondary.  Membranes were 
imaged using a LI-COR fluorescent scanner (LI-COR; Lincoln, NE) and images converted to gray 
scale.  Analysis was performed using background subtraction (Odyssey Processing Software, LI-
COR) and values normalized to β–actin levels, resulting in a normalized intensity value. 
Immunohistochemistry 
For immunohistochemistry preparation, animals were anesthetized using isoflurane and 
transcardially perfused with ice-cold physiologic saline followed by 10% formalin for a total of 10 
minutes.  Brains were extracted and placed in fresh 10% formalin for a minimum of 24 hours prior 
to blocking and subsequent paraffin embedding.  Sections were prepared in 6 μm thickness using 
a Leica RM2235 microtome (Leica Microsystems, Wetzlar, Germany).  Staining was performed 
using standard protocols used within the field and previously by our laboratory, using the 
antibodies described above as well as thioflavin for detecting neurofibrillary tangles (McKee et 
al., 2010; Goldstein et al., 2012; Stern et al., 2013). 
Behavioral Assessments 
Learning and memory was assessed using the Morris water maze.  Spatial acquisition trials 
began at Day 21 after the final blast exposure (in both single and repeat injury paradigms).  The 
pool utilized was ~180 cm in diameter and filled with water at ambient temperatures (18-21 °C).  
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A platform (10 cm x 10 cm) was submerged 2.5 cm below the surface of the water.  A series of 
objects was placed in the environment around the pool to provide visual cues for the animal during 
trials.  The training paradigm (spatial acquisition) consisted of 6 days with a total of 4 trials 
occurring each day per animal.  Animals were placed into the maze from four different locations 
each day (4 trials) with a total of 2 minutes (maximum) allowed per trial.  Upon finding the 
platform, animals were allowed 15 seconds for acquisition to occur.  If unsuccessful in finding the 
platform, animals were placed on the platform at the conclusion of 2 minutes by the investigator.  
On the probe trial day (platform removed), animals were placed in the maze at a novel location 
and allowed to explore the maze for 1 minute.  Data was acquired using AnyMaze™ video tracking 
software (Stoelting Co., Wood Dale, IL) throughout all studies and allows for acquisition of 
latency, distance, and speed data to be analyzed across maze regions/quadrants. 
Impulsivity was determined, at 7 days after the final blast, as previously described using 
an elevated-plus maze and measuring exploratory behavior (Mosienko et al., 2012; Johnson et al., 
2013a; Logsdon et al., 2014).  The apparatus was placed at a height of 60 cm from the floor and 
consisted of two open and two closed arms, with open arms opposing one another and intersecting 
perpendicularly with the opposed closed arms.  Each arm was 50 cm long by 10 cm wide.  Open 
arms were surrounded by clear plastic edging ~1.5 cm high.  Closed arms were encased with black 
walls 30 cm tall, creating a 3-sided and comforting enclosure for the rodent.  At the start of each 
5-minute trial, animals were placed in the middle of the intersecting arms facing an open arm prior 
to release.  Animals were allowed to explore the apparatus for the duration of the trial.  AnyMaze™ 
software was utilized to record the animals’ position, distance traveled, and entry pattern into 
various arms throughout the trial.  An increased percentage of time spent in the open arms was 
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considered a sign of impulsive behavior (Mosienko et al., 2012; Johnson et al., 2013a; Logsdon et 
al., 2014).  
Statistical Analysis 
An observer blinded to experimental condition performed all data acquisition.  One-way 
Analysis of Variance (ANOVA) was used for statistical analysis of all tests except spatial 
acquisition trials of the Morris water maze and immunohistochemical comparisons in which a two-
way, repeated measures ANOVA and students t-test were utilized, respectively.  Bonferroni post-
hoc comparison was used to determine differences between experimental groups on two-way 
ANOVA with repeated measures for spatial acquisition.  For all other comparison’s, a Tukey’s 
post-hoc was utilized.  Analysis was completed using GraphPad Prism 5.0 (GraphPad Software, 
Inc.; La Jolla, CA).  A p <0.05 was considered statistically significant for all data analyzed. 
 
RESULTS 
Neurotrauma induces tau hyperphosphorylation in both blast and closed-head injury models 
To elucidate the effect of neurotrauma on the development of CTE-like neuropathology, 
animals were exposed to sham-injury, single-injury (either blast or modified closed-head), or 
repeat-injury (blast).  Animals were first assessed for tau phosphorylation, using AT8 and AT270 
antibodies, believed to be the initial precursor of neurofibrillary tangle development. AT8 forms a 
single band in rats and a double band in mice (Hawkins et al., 2013). Conversely, AT270 forms a 
double band in rats, but only a single band in mice (Green et al., 2007). The number of bands is 
indicative of calpain dependent phosphorylation, which is regulated uniquely between rats and 
mice (Medeiros et al., 2012). Increased phosphorylation of tau was observed after blast exposure 
and modified closed-head injury but the location of the increase was model-dependent.  
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Specifically, tau phosphorylation was observed in the contralateral hemisphere in rats exposed to 
repeat blast injury but only in the ipsilateral hemisphere, and only with the AT8 antibody, in mice 
receiving a single modified closed-head injury.   
In rats exposed to blast, no significant difference in tau phosphorylation was observed in 
the ipsilateral hippocampus after blast injury for AT8 (Fig. 3A) or AT270 (Fig. 3E).  A significant 
difference was observed in AT8 (F2,11 = 16.64, p < 0.001) and AT270 (F2,9 = 4.37, p < 0.05) levels 
in the contralateral hippocampus of rats exposed to blast injury.  At one month following a single 
blast, a significant increase in tau phosphorylation recognized by AT8 increase was measured 
compared to control (q = 3.96, p < 0.05) (Fig. 3B).  A significant increase in phosphorylation 
detected by AT8 was also observed after repeat blast (q = 8.12, p < 0.001) (Fig. 3B). 
In the modified closed-head injury model utilized on the mice, a significant difference was 
observed in tau phosphorylation AT8 (F2,9 = 4.93, p < 0.05) in the ipsilateral hippocampus.  At 
one-month following injury, AT8 expression was elevated in comparison to sham-injury (q = 4.34, 
p < 0.05) (Fig. 3C).  No significant difference was observed at 7-days post-injury on the ipsilateral 
side or between any groups or time points on the contralateral side (Fig. 3D). 
At one-month following repetitive blast exposure, a significant increase phosphorylation 
recognized by the AT270 antibody was measured in the contralateral hippocampus of rats 
compared to anesthetized control animals (q = 4.03, p < 0.05) (Fig. 3F).  No significant differences 
were observed in tau phosphorylation recognized by AT270 in either ipsilateral (Fig. 3G) or 
contralateral (Fig. 3H) hippocampus of mice receiving modified closed-head injury. 
Hyperphosphorylation of tau following neurotrauma occurs in perivascular brain regions 
Clinical case series documenting patients with CTE have demonstrated the deposition of 
neurofibrillary tangles (NFTs), an end product of tau hyperphosphorylation, in perivascular 
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regions, which is a distinct difference from other tauopathies such as Alzheimer’s disease (AD).  
Possible mechanisms leading to NFTs in perivascular regions include the disruption of the blood-
brain barrier (BBB), leading to punctate microhemorrhages, red blood cell breakdown, oxidative 
stress, and finally, persistent neuroinflammation.  We observed a significant difference in tau 
hyperphosphorylation within perivascular regions of the contralateral hippocampus in rats exposed 
to repeat blast in comparison to control when identified with both AT8 (t = 4.46,  p < 0.001) and 
AT270 (t = 11.47, p < 0.001) at 1-month post-injury (Fig. 4).  These findings were consistent with 
prior reports of CTE in humans and from our collection of post-mortem human samples with 
documented CTE. 
Neurotrauma is associated with conformational changes in tau that are recognized precursors 
of neurofibrillary tangle formation 
Following hyperphosphorylation, tau is purported to undergo conformational changes 
associated with subsequent insolubility and deposition/precipitation in the form of neurofibrillary 
tangles.  Following neurotrauma in rats and mice, we found an elevation in markers of 
conformational change of the tau molecule based on immunoblotting with PHF-1 and CP13.  After 
blast exposure, markers of tau conformational change were observed in the contralateral 
hemisphere of rats, while after the impact procedure in mice, the markers were found ipsilaterally.  
No significant differences in markers of tau conformation change were observed in the ipsilateral 
hippocampus after blast injury for neurofibrillary precursor PHF-1 (Fig. 5A) or CP13 (Fig. 5E). 
A significant difference was observed in PHF-1 (F(2,11) = 7.92, p < 0.01) and CP13 (F(2,9) = 
6.03, p < 0.05) levels in the contralateral hippocampus of rats exposed to blast injury.  At one 
month following a single blast, a significant increase in PHF expression was measured compared 
to control (q = 4.76, p < 0.05) (Fig. 5B). 
152 
 
A significant difference was observed in PHF-1 (F(2,9) = 7.18, p < 0.05) levels in the 
ipsilateral hippocampus of mice exposed to injury.  At one month following modified impact, a 
significant increase in PHF-1 expression was measured compared to control (q = 5.17, p < 
0.05)(Fig. 5C).  No significant differences were observed in PHF-1 expression in the contralateral 
hippocampus of mice exposed to cortical impact (Fig. 5D). 
At one month after repetitive blast exposure, a significant increase in CP13 expression was 
measured in the contralateral hippocampus of rats compared to control (q = 4.73, p < 0.05)(Fig. 
5F).  A significant difference was observed in CP13 (F(2,9) = 21.70, p < 0.001) levels in the 
ipsilateral hippocampus of mice exposed to  injury.  At one month following impact, a significant 
increase in CP13 expression was measured compared to control (q = 9.28, p < 0.001)(Fig. 5G).  
No significant differences were observed in CP13 expression in the contralateral hippocampus of 
mice exposed to cortical impact (Fig. 5H). 
Similar findings were seen using immunohistochemistry when comparing repeat-injured 
animals to sham-injured animals at 1 month post-injury.  Specifically, a significant difference was 
seen on PHF-1 staining (t = 6.06, p < 0.001) and CP-13 staining (t = 3.88, p < 0.01)(Fig. 6).  Again, 
the distribution of the staining was notable for being perivascular in nature, a finding shared across 
the clinical specimens diagnosed with CTE as seen in Fig. 7. We show that PHF, AT8, and a 
thioflavin stained neurofibrillary tangle are increased perivascular in human CTE specimens. CP-
13 is increased in a perivascular distribution following repeat blast in a rat.  
Neurotrauma produces cognitive impairments 
Cognitive deficits have long been associated with the neuropathological diagnosis of CTE 
in the clinical population, particularly amongst the population diagnosed with CTE at a later age 
in life.  Similarly, cognitive impairments in both learning and memory have been associated with 
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neurotrauma but have not been presented in the context of a corresponding tauopathy in both a 
single and repeat blast injury paradigm.  In cohorts of animals subjected to either sham-, single-, 
or repetitive-injury, spatial acquisition (learning) was assessed 3 weeks after the injury in single-
injury animals and the final injury in repeat-injury paradigms (Days 21-27 post-injury).  Blast 
injury exposure was associated with worsened performance in the Morris water maze as evident 
by latency to find the platform in seconds when analyzed using a two-way repeated measures 
ANOVA.  Post-hoc tests revealed significant differences between anesthetized controls and single-
injury animals during spatial acquisition on Days 22-24, and Day 26 (Day 21: t = 1.38, p > 0.05; 
Day 22: t = 3.70, p < 0.01; Day 23: t = 4.12, p < 0.001; Day 24: t = 4.38, p < 0.001; Day 25: t = 
2.17, p > 0.05; Day 26: t = 3.20, p < 0.01).  Similarly, post-hoc tests demonstrated a significant 
impairment in acquisition between anesthetized controls and repetitively injured animals on Days 
22-26 (Day 21: t = 0.66, p > 0.05; Day 22: t = 5.01, p < 0.001; Day 23: t = 4.16, p < 0.001; Day 
24: t = 4.72, p < 0.001; Day 25: t = 3.69, p < 0.01; Day 26: t = 3.76, p < 0.01).  Notably, no 
differences were seen between single- and repeat-injured animals during the course of acquisition 
trials, despite the notable difference in tau pathology at this time presented earlier (Fig. 8).  The 
differences in latency to platform between blast-injured animals and anesthetized control animals 
is apparent as well based on visualization of the track plots recorded during data acquisition (Fig. 
9).  Clearly different swimming patterns emerge with blast-injured animals exhibiting what 
appears to be more thigmotaxis (circling around the outer edge of the pool) than anesthetized 
control animals that reached statistical significance between controls and repeat-injured animals 
on Day 23 (q = 3.58, p < 0.05), although this data point did not reach significance on Days 21 and 
26 based on automated measurements generated using AnyMaze™ (Fig. 8). 
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Memory, as measured during the probe test (time spent in area surrounding the now-
removed platform) conducted on Day 27, again demonstrated deficits in animals subjected to blast-
induced neurotrauma when analyzed using a one-way ANOVA (F2,29 = 20.01, p < 0.0001).  Post-
hoc tests showed significant differences between sham and single injury animals (t = 6.44, p < 
0.05) as well as between sham and repetitively injured animals (t = 8.00, p < 0.05) but no difference 
between single injury and repeat injury paradigms (Fig. 8).  These findings were confirmed 
visually using track plots generated during data acquisition (Fig. 9).  Anesthetized control animals 
exhibit a greater preponderance of pool crossings and swimming behavior within the region near 
the platform in contrast to blast-injured animals (Fig. 9). 
Impulsivity is increased following neurotrauma 
Clinically, impulsive behavior has been described extensively in those with a history of 
repetitive neurotrauma and the context of CTE.  To make an analogous comparison between our 
animal model of blast-induced traumatic brain injury and clinically reported symptoms, the 
elevated-plus maze was utilized to measure impulsive-like behaviors based upon the percentage 
of time spent in the open-arms of the maze.  Significant differences between groups were observed 
when analyzed using a one-way ANOVA (F2,32 = 5.03, p < 0.05).  Post-hoc tests revealed a 
significant difference between sham and single injury animals (q = 3.53, p < 0.05) as well as 
between sham and repetitively injured animals (q = 4.21, p < 0.05).  No difference was seen 
between single and repeat injury paradigms with regards to percentage of time spent in the open 
arms of the apparatus (Fig. 10).  While not statistically significant, a trend towards a greater 
distance traveled in the open arms was observed with increasing levels of neurotrauma, evidence 
consistent with the percentage of time spent in the open arms (Fig. 10).  Conversely, a trend was 
also present regarding distance traveled in the closed arms with animals subjected to neurotrauma 
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traveling less distance (Fig. 10).  Post-hoc tests revealed no statistical significance when comparing 
sham to single injury groups but significance was reached when comparing sham to repetitively-
injured animals (F2,33 = 3.06 ; q = 3.47, p < 0.05). 
 
DISCUSSION 
While the clinical literature has been inundated with reports of CTE in athletes and soldiers 
alike, few experimental tools exist for investigating disease pathophysiology, establishing 
diagnostic criteria, and discovering preventative or therapeutic agents.  For these reasons, 
preclinical models of CTE are highly desirable.  In this work we demonstrate two preclinical 
models capable of generating some biochemical and behavioral hallmarks of CTE, namely 
tauopathy and impulsive-like behavior.  Furthermore, this work illustrates the utility of two distinct 
models and injury paradigms, namely blast exposure versus a more traditional modified closed-
head injury, and repeat versus single injury paradigms respectively. Likewise, the fact that this 
work was completed in two different species and builds upon prior work by both West Virginia 
University and the University of Rochester laboratories validates the use of both mice and rats in 
the preclinical modeling of neurotrauma related neurodegeneration (Logsdon et al., 2014; Petraglia 
et al., 2014b; Petraglia et al., 2014a).  The modified closed-head injury represents a helmeted 
design with controlled placement of the impact likely accounting for ipsilateral deficit. The 
tauopathy development period following modified controlled impact was not previously elucidated 
therefore warranting the 7-day time point. Petraglia and colleagues show that astrocyte activation 
and cell death occurs at 7 days post modified controlled impact (Petraglia et al., 2014a). We 
previously reported that tauopathy following blast in rats does not develop until weeks after injury 




The potential utility of these, as well as other preclinical models of neurotrauma related 
neurodegeneration, is highly promising for investigation of disease pathophysiology, particularly 
as related to biochemical endpoints associated with CTE. To fully develop a CTE model, 
transgenic rodents will be needed that include amyloid, tau, and TDP43 pathology. The quest for 
elucidating the underlying mechanisms behind CTE development is ongoing. In previous work, 
we have shown blast causes substantial blood brain barrier disruption (Lucke-Wold et al., 2014c), 
endoplasmic reticulum stress activation (Logsdon et al., 2014), and oxidative stress (Lucke-Wold 
et al., 2015a).   We show in this work the induction of hyperphosphorylated tau, conformational 
changes in tau, and more advanced precursors of NFT formation with the usage of CP13 and PHF-
1 antibodies. AT8 binds to serine 199 and 202 as well as threonine 205. AT270 binds to threonine 
181, PHF binds to serine 396 and 404, and CP13 binds to serine 202. Serine 396 and 202 are only 
exposed after tau undergoes conformational change (Lucke-Wold et al., 2014b). These changes 
are the ultimate result of tau hyperphosphorylation and protein misfolding/aggregation, and are 
likely related to dysregulation of the tau kinase/phosphatase system. Peclinical modeling of 
neurotrauma related neurodegeneration will allow for the elucidation of how and when these 
kinases and phosphatases become dysregulated, and will allow for increased understanding of the 
disease process.  Additionally, these studies will provide targets for direct or indirect therapeutic 
development.  Similarly, preclinical models may prove instrumental in identification of diagnostic 
and prognostic tests for establishing a diagnosis of CTE and tracking disease progression. There 
is a clinical need for a rapid, cheap, and reliable diagnostic test to predict severity of CTE. 
Currently neuropathological examination remains the gold standard for diagnosis with some 
studies purporting the use of PET-based imaging for diagnosis (Small et al., 2013; Gandy and 
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DeKosky, 2014; Mitsis et al., 2014).  It is possible that development and validation of these 
techniques, and others such as diffusion tensor imaging and magnetic resonance spectroscopy may 
be accelerated through the application to preclinical models. The current limitation is that 
advanced imaging is expensive, cumbersome, and requires expertise from subspecialty 
radiologists. 
Despite this work illustrating what we believe represents a clear step forward in the study 
of neurotrauma related neurodegeneration, it is clear that further study is warranted. Pre-clinical 
models must be utilized to more fully characterize behavioral, biochemical, imaging, and 
electrophysiological/functional changes associated with the development of CTE.  Future studies 
will likely address the development of behavioral/functional deficits in relation to biochemical 
changes temporally and assess the chronicity of changes based on the number, severity, and 
inter-injury interval of neurotrauma-related events. The development of better transgenic models 
is critical as the field moves forward.  Performing studies such as these will allow for the 
questions raised in our accompanying review be addressed.  Specifically, what is the role of the 
1) inter-injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5) 
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the likelihood 
















Figure 6.1. Schematic showing experimental design and behavioral experiments. Time of 




















Figure 6.2. Schematic representation of the two injury models utilized within this work.  (A) 
Experimental setup utilized at West Virginia University for the study of blast-induced 
neurotrauma.  The shock tube consists of a high-pressure driver section (nitrogen gas filled) and a 
low-pressure driven section (ambient air filled).  When the membrane dividing the chambers 
ruptures, the blast wave is formed and released, encountering the rat from the right side of the 
cranium. (B) Depiction of the model utilized at the University of Rochester in un-anesthetized 
mice.  An electromagnetic impactor used in CCI was modified with a rubber tip and a specially 





Figure 6.3. Blast and closed-head injury models both induced tau hyperphosphorylation.  (A) 
Immunoblots show no significant difference in tau phosphorylation at serine sites 199/202 and 
threonine site 205 (AT8) at one month after single and repeat blast exposures in the ipsilateral rat 
hippocampus.  (B) A significant increase in AT8 expression was measured after single (*p<0.05 
vs. CTRL) and repeat blast exposure (***p<0.001 vs. CTRL) in the contralateral rat hippocampus.  
(C) AT8 expression was significantly increased at one month after closed-head injury in the 
ipsilateral mouse hippocampus (*p<0.05 vs. CTRL).  (D) No significant differences were observed 
in AT8 expression in the contralateral mouse hippocampus.  (E) Immunoblots show no significant 
difference in tau phosphorylation at threonine site 181 (AT270) at one month after single and 
repeat blast exposure in the ipsilateral rat hippocampus.  (F) A significant increase in AT270 
expression was measured at one month after repeat blast exposure (*p<0.05 vs. CTRL) in the 
contralateral rat hippocampus.  (G) No significant differences were observed in AT270 expression 
in the ipsilateral mouse hippocampus, (H) or the contralateral mouse hippocampus after closed-
head injury.  One-way ANOVA Tukey’s post-hoc analysis (values represent mean ± s.e.m.; 






Figure 6.4. Tau hyperphosphorylation is seen in microfoci throughout the contralateral 
superficial cortex. AT8 was significantly increased at 1 month post repetitive blast (t = 4.455,  p 
< 0.001). AT270 was also significantly increased following repetitive blast (t = 11.47, p < 0.001). 
AT270 was increased in a circular distribution. Tau hyperphosphorylation is an indicator of 
progressive pathology. Values were calculated using a student’s t-test comparing the mean 








Figure 6.5. Blast and closed-head injury models both induce conformational changes in tau 
proteins.  (A) Immunoblots show no significant difference in markers of tau conformational 
change at serine site 396/404 (PHF) at one month after single and repeat blast exposure in the 
ipsilateral rat hippocampus.  (B) A significant increase in PHF expression was measured after 
single (*p<0.05 vs. CTRL) and repeat blast exposure (*p<0.05 vs. CTRL) in the contralateral rat 
hippocampus.  (C) PHF expression was significantly increased at one month after closed-head 
injury in the ipsilateral mouse hippocampus.  (D) No significant differences were observed in PHF 
expression in the contralateral mouse hippocampus.  (E) Immunoblots show no significant 
difference in markers of tau conformational change at serine site 202 (CP13) at one month after 
single and repeat blast exposure in the ipsilateral rat hippocampus.  (F) A significant increase in 
CP13 expression was measured at one month after repeat blast exposure (*p<0.05 vs. CTRL) in 
the contralateral rat hippocampus.  (G) A significant increase in CP13 expression was measured 
at one month after closed-head injury in the ipsilateral mouse hippocampus (***p<0.001 vs. 
CTRL).  (H) No significant differences were observed in CP13 expression in the contralateral 
mouse hippocampus after closed-head injury.  One-way ANOVA Tukey’s post-hoc analysis 





Figure 6.6. Tau conformational markers were increased throughout the contralateral 
superficial cortex. PHF was significantly increased at 1-month post repetitive blast (t = 6.055, p 
< 0.001). CP-13 staining was also significantly increased following repetitive blast (t = 3.883, p < 
0.01). CP-13 was increased in a perivascular distribution. Tau conformational change is required 
for the formation of neurofibrillary tangles. Values were calculated using a student’s t-test 











Figure 6.7. Tauopathy is seen in a perivascular distribution. PHF and AT8 were increased 
adjacent to longitudinal microvessels in human patients diagnosed with chronic traumatic 
encephalopathy. A neurofibrillary tangle stained with thioflavin was seen adjacent to a cut vessel 
lumen in the brain of a retired professional football player. Similarly, CP-13 was increased next to 
a cut vessel lumen in the contralateral cortex 1 month following repeat blast in the rat. Arrows 






Figure 6.8. Blast-induced brain injury produces deficits in learning and memory in rats.  (A) 
Spatial acquisition trials conducted on Days 21-26 post-injury revealed deficits in learning in 
single-injury animals on Days 22-24 and 26 in comparison to control.  Repeat-injury was 
associated with deficits on Days 22-26 in comparison to control.  No differences were seen 
between single- and repeat-injury paradigms.  (B) The probe test on Day 27 revealed a statistically 
significant difference in time spent near the prior platform location between injured animals (single 
or repeat) and control animals.  No difference was seen between single- and repetitively-injured 
rats.  (C) Animals exposed to neurotrauma exhibited a trend towards increased thigmotaxis during 





Figure 6.9. Track plots acquired across spatial acquisition and probe testing in rats.  (A-D) 
Track plots generated from anesthetized control animals on Day 21, Day 23, Day 26, and during 
the probe test.  (E-H) Track plots generated from single-injured animals on Day 21, Day 23, Day 
26, and during the probe test post-injury. (I-L) Track plots generated from repetitively-injured 
animals on Day 21, Day 23, Day 26, and during the probe test post-injury.  Injured animals appear 
to spend more time exhibiting thigmotaxis behaviors (circling edge of pool) on later days and in 
the probe trial fail to spend as much time as the anesthetized control animals within the probe 





Figure 6.10. Blast-induced brain injury in rats produces an increase in impulsive behavior 
based on the elevated-plus maze.  (A) A significant difference (p<0.05 vs. CTRL) was seen 
between anesthetized control animals and both single and repeat blasts with regards to the 
percentage of time spent in the open arm of the elevated-plus maze.  No difference was measured 
between single and repeat-injury paradigms.  (B) While not reaching statistical significance, a 
trend towards greater distance traveled in open arms was seen with neurotrauma, a finding 
consistent with the documented increase in time spent in the open arms.  (C) Animals subjected to 
neurotrauma appeared to travel less distance in the closed arms of the maze, although this finding 
did not reach statistical significance.  (D) Track plot showing little exploration of the open arm by 
control animals.  (E) Track plot showing increased exploration of the open arms of the elevated-
plus maze by single-injured animals.  (F) Track plot showing increased exploration of the open 
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Despite the extensive media coverage associated with the diagnosis of chronic traumatic 
encephalopathy (CTE), our fundamental understanding of the disease pathophysiology remains in 
its infancy.  Only recently have scientific laboratories and personnel begun to explore CTE 
pathophysiology through the use of preclinical models of neurotrauma.  Some studies have shown 
the ability to recapitulate some aspects of CTE in rodent models, through the use of various 
neuropathologic, biochemical, and/or behavioral assays. Many questions related to CTE 
development however remain unanswered.  These include the role of impact severity, the time 
interval between impacts, the age at which impacts occur, and the total number of impacts 
sustained.  Other important variables such as the location of impacts, character of impacts, and 
effect of environment/lifestyle and genetics also warrant further study.  In this work we attempt to 
address some of these questions by exploring work previously completed using single and 
repetitive injury paradigms.  Despite some models producing some deficits similar to CTE 
symptoms, it is clear that further studies are required to understand the development of 
neuropathological and neurobehavioral features consistent with CTE-like features in rodents.  

















Corsellis described the original case series of chronic traumatic encephalopathy (CTE) in 
boxers (Corsellis et al., 1973). The disease consisted of brain atrophy, dilated ventricles, a cavum 
septum pellucidum, and pallor of the substantia nigra. Chronic traumatic encephalopathy was 
reintroduced into the medical lexicon by Dr. Bennet Omalu in 2005 (Omalu et al., 2005). Omalu 
described a progressive tauopathy that was seen in the brains of deceased football players. In recent 
years, McKee, Goldstein, and Stern have defined clinical and pathologic features of the disease. 
These include behavioral disturbances such as impulsivity, depression, and lack of oversight 
(Corsellis et al., 1973; Mez et al., 2013). Pathologic criteria include neurofibrillary tangles in a 
perivascular distribution and within superficial cortical areas with occasional amyloid and TDP-
43 protein aggregations (Baugh et al., 2014). Stern recently expanded the CTE criteria further by 
describing young vs. old onset based on symptom manifestation (Stern et al., 2013). Interestingly, 
blast traumatic brain injury has been linked to CTE following a single exposure, where athletes 
develop the disease following repetitive head injury (Lucke-Wold et al., 2014b).  
CTE has been defined as a slowly progressive disease that takes years to decades to 
develop, often providing a significant latent period between when the neurotrauma occurs and 
when symptoms develop.  A few cases involve athletes/soldiers as early as late teen’s to early 
twenties (Omalu et al., 2011a; Tartaglia et al., 2014).  The reason for the discrepancies in age of 
presentation observed is currently unknown but is likely due to the age at which impacts were 
sustained and the severity of the injury.  Prior studies have shown that children with TBI have 
inadequate development of social cognition (Ryan et al., 2014) and that adolescents can develop 
post-traumatic headaches. Very rarely however do either of these groups experience symptoms of 
CTE (Dubrovsky et al., 2014).  Early behavioral symptoms of CTE usually do not appear until the 
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mid-thirties, and cognitive impairment does not begin until the early sixties (Baugh et al., 2014). 
Recent evidence suggests that neurotrauma may be linked to other neurodegenerative diseases 
such as Alzheimer’s disease (AD) as well (Johnson et al., 2010). 
CTE and AD, despite both being tauopathies, have generally been viewed as separate 
diseases. Each disease has distinct clinical presentations and unique clinical risk values.  This view 
has gradually been changing with some reports showing that CTE can develop within the context 
of AD. The relationship between these two conditions however is poorly understood.  Prior studies 
have indicated that TBI is a risk factor for development of cognitive impairment and AD 
(Guskiewicz et al., 2005), but whether the conditions are additive or synergistic remains unclear 
(Weber, 2007). Recent evidence suggests that neurotrauma may both increase the likelihood of 
disease development and accelerate the development of AD (Barnes et al., 2014).  Notably, the 
wealth of AD pathology observed in preclinical neurotrauma models supports the idea of disease 
acceleration (Tran et al., 2011).  In addition to AD, some groups have presented a possible link 
between CTE and a variant of amyotrophic lateral sclerosis that has been termed ‘chronic traumatic 
encephalomyelopathy’ (CTEM) (McKee et al., 2010).  Therefore, it is clear that neurotrauma may 
have many lasting deleterious consequences, including the potential for increased risk and 
accelerated development of neurodegenerative diseases such as AD, CTE, and CTEM.  While the 
data on these studies is preliminary in nature and not prospective, these findings demonstrate the 
need for further investigation with both preclinical models and clinical trials. 
The Quest for the Ideal Model 
The search for ideal preclinical models to study CTE remains an area of ongoing 
investigation with a relative paucity of prior studies.  Of those published previously, the majority 
of studies fail to recapitulate the extensive neuropathologic and neurobehavioral aspects of injury 
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(Goldstein et al., 2012; Ojo et al., 2015).  Post-mortem identification of neurofibrillary tangles are 
a key diagnostic marker used clinically (Baugh et al., 2012). Therefore, the development of 
hyperphosphorylated tau in animals following injury must be an important component in 
establishing a CTE model. Tau hyperphosphorylation appears to correlate with the emergence of 
neuropathologic and neuropsychiatric deficits representative of neurotrauma related 
neurodegeneration (Petraglia et al., 2014a).  By modeling CTE in rodents, we can better understand 
disease development and discover potential therapeutic avenues.  Similarly, little justification is 
given to injury severity, number of impacts, interval between impacts, and age at which the impacts 
occur.  Few studies have also evaluated secondary mechanisms of injury.  In the following sections, 
we discuss the advancements and shortcomings of prior research while highlighting areas in need 
of further investigation. 
What are the proper controls for studying CTE? 
One of the challenges in creating a preclinical model for CTE is the establishment of proper 
controls comparing sham to TBI animals (Weber, 2007).  Specifically, sham animals must undergo 
the exact same procedure each day of the injury paradigm. They must be anesthetized for the same 
duration as injured animals. The age of the animal must also be considered.  Control animals should 
be the same age as experimental animals at time of sacrifice. This is an important consideration in 
designing extended studies with behavioral assays. Biochemical time courses also require control 
animals for each time point. Numerous questions must be addressed in planning experiments while 
considering the implications of each decision in terms of experimental question addressed and 
potential complications (Figure 1).  
Utilizing Available Tools For Studying CTE 
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One of the current weaknesses of clinical investigation of CTE is that the disease remains 
a neuropathological diagnosis.  Some advancement has been made in ligand-based PET imaging. 
The imaging was used in a cohort of patients with an extensive history of neurotrauma, but the 
modality is not readily available (Small et al., 2013).  Consequently, clinical observations are 
largely retrospective in nature and it is nearly impossible to investigate disease onset and 
progression.  These clinical shortcomings can be readily addressed through the use of adequately 
designed preclinical models.  
The first step in creating a preclinical model of CTE is to choose a model that can be used 
to generate a combination of biochemical and behavioral changes post-injury consistent with the 
CTE-like phenotype. Specifically, tauopathy or a precursor of tauopathy (tau 
hyperphosphorylation), must be present. The changes in tau must be inducible in genetically 
unaltered animals and then must be verified with transgenic rodents.  Behavioral changes must be 
induced by neurotrauma. These changes should persist or worsen at chronic time points post-
injury.  Assessment of behavior should include tests capable of evaluating behavioral symptoms 
reported in clinical CTE cases. In particular, tests for cognition, depressive-like behavior, and 
impulsive-like behavior should be used.  Cognition can be measured using Morris water maze 
(MWM) whereas depressive-like behavior can be assessed with the forced swim test or tail 
suspension test.  Impulsivity can be elucidated with the elevated-plus maze (EPM). 
Once a model is established, biochemical, electrophysiological, and advanced imaging 
techniques can be employed to assess neural injury.  Biochemical mechanisms of potential interest 
include those related to cell survival/death, regulation of tau phosphorylation/dephosphorylation 
(kinases/phosphatases), bioenergetics, and propagation of tau-based changes.  
Electrophysiological studies can be performed to identify effects of injury and CTE development 
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both on individual synapses and larger tracts such as the Schaffer collaterals within the 
hippocampus. Imaging modalities such as magnetic resonance imaging (MRI), functional MRI 
(fMRI), spectroscopy (MRS), and PET studies have the unique advantage of being able to be 
performed longitudinally with multiple assessments of the same animal at different time points.  
Taken together, integration of biochemical, behavioral, electrophysiological, and imaging 
modalities may provide insight into the mechanisms and time course of CTE development.  This 
approach will also allow for more definitive evidence to be gathered. This evidence will provide a 
stepping-stone in addressing key questions about the effect of inter-injury interval, injury severity, 
and number of cumulative injuries necessary for the development of CTE.  The answers garnered 
from this potential work may then influence the design of clinical trials that dictate return-to-play 
decisions.  Baseline monitoring may become required in sports arenas and battlefields with high 
incidences of neurotrauma.  The monitoring may assist in detecting cumulative subthreshold injury 
levels and be used to decrease the overall level of concussions.  
Implications for Modeling CTE: Results from Prior CTE Modeling Studies 
Perhaps one of the most promising studies, with regards to demonstrating CTE-like disease 
in a rodent model, was performed by Luo, et al.  In this study, the authors developed a closed head 
model of neurotrauma utilizing an electromagnetic stereotaxic impact device.  The authors showed 
that enhanced force of injury or using repeat injury increased GFAP-tagged luciferase.  
Intriguingly, when this same repeat injury paradigm was applied to wild-type mice, spatial learning 
and memory deficits were observed 2 to 6 months after injury and were accompanied by increased 
hyperphosphorylated tau and astrogliosis (Luo et al., 2014). The gliosis response in human CTE 
has not been well characterized, but the findings by Luo and colleagues show that GFAP was 
increased near areas of tauopathy.  Similar findings have been seen by Petraglia and colleagues 
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who performed a rigorous investigation of the behavioral effects of both single and repetitive 
closed head injury in wild-type mice (Petraglia et al., 2014b).  The authors found that a single 
injury, in un-anesthetized animals, produced notable short-term abnormalities in behavior similar 
to a post-concussive state.  Repetitive injury (42 impacts total: 6 impacts per day over 7 days) 
produced chronic deficits, particularly with regards to depressive-like and risk-taking behaviors as 
well as spatial learning and memory (Petraglia et al., 2014b).  This same group published a recent 
follow-up study demonstrating the presence of hyperphosphorylated tau, a precursor of 
neurofibrillary tangle (NFT) development, in repetitively injured animals (Petraglia et al., 2014a).  
The model produces several of the same behavioral symptoms reported by patients suspected of 
having CTE. We recently show that endoplasmic reticulum stress contributes to tauopathy and 
CTE-like behavioral deficits following repeat blast injury (Lucke-Wold et al., 2015c).   
Other studies, conducted by Mouzon and colleagues report both behavioral and 
neuropathologic changes following repetitive neurotrauma in mice.  Specifically, 5 injuries 
administered 48 hours apart, produced durable cognitive deficits, learning disabilities, diminished 
rotarod performance, and changes in anxiety-like behavior on elevated-plus maze.  Notably, these 
behavioral changes occurred in conjunction with persistent neuroinflammatory changes and 
disruption of white matter integrity.  No changes in A and tau phosphorylation were seen at the 
chronic time points of 6 and 12 months post-neurotrauma, likely because rodents don’t naturally 
develop neurofibrillary tangles (Mouzon et al., 2014).  Rodents do however demonstrate acute tau 
changes due to phosphorylation and cleavage following injury (Huber et al., 2013). Liu and 
colleagues found that tau hyperphosphorylation was increased in rats acutely post-injury and 
triggers caspase activation in rat cortices (Liu et al., 2011). The activation of cell death can lead to 
circuit dysfunction and behavioral deficits (Abisambra and Scheff, 2014). Goldstein and 
176 
 
colleagues show that tauopathy contributes to mitochondrial dysfunction and microtubule injury 
that ultimately leads to apoptosis. In this study, they found that tau modulation is a potential avenue 
for therapeutic intervention (Kondo et al., 2015). We recently report that caspase activation was 
increased in human CTE brains near sites of neurofibrillary tangle formation (Lucke-Wold et al., 
2015a). 
Other repeat-injury studies have investigated changes in tau and amyloid post-injury with 
the goal being to more clearly elucidate the relationship between TBI and neurotrauma related 
neurodegeneration. One report showed an increase in neuronal tau immunoreactivity (Kanayama 
et al., 1996) and another showed elevated amyloid precursor protein (APP) (Dobrowolska and 
Gibson, 2005; Weber, 2007) at a variety of time points post-injury.  A final study by Zhang and 
colleagues showed that monoacylglycerol lipase can lead to behavioral deficits and tauopathy 
characteristic of a CTE-like phenotype (Zhang et al., 2015). These findings were further verified 
in other studies using transgenic models of amyloidosis and tauopathy in which repetitive injury 
paradigms produced elevated amyloid and tau levels with increased deposition.  Single injury 
however failed to produce changes above control levels (Uryu et al., 2002; Conte et al., 2004).  
Using a T44 tau Tg mouse line, Yoshiyama and colleagues sought to study dementia pugilistica 
(DP), a condition sharing many features with modern day CTE, but with several key differences.  
DP by definition occurs only in boxers and has more severe gross anatomical changes that are not 
always present in CTE.  The Yoshiyama group found that 4 impacts per day given once a week 
for 4 weeks produced only modest neuropathology with only 1 mouse demonstrating CTE or DP 
characteristics out of a total of 18 Tg mice and 24 wild-type mice (Yoshiyama et al., 2005; Weber, 
2007). The affected mouse displayed neuropathologic changes that included heightened tau 
burden, the presence of neurofibrillary tangles, and cognitive deficits (Yoshiyama et al., 2005).  
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While it remains unclear why only one mouse developed such pathology, neuropathological 
findings from this one animal demonstrated that iron deposition was increased and associated with 
blood-brain barrier disruption.  Iron deposition, associated with degradation of heme, activates 
oxidative stress-related pathways.  Importantly, this oxidative stress is then associated with 
accelerated neurofibrillary tangle formation in these perivascular locales (Yoshiyama et al., 2005).   
Notably, even single injury paradigms have been shown to produce tauopathy in a variety 
of injury models including blast (Goldstein et al., 2012), fluid percussion (Hawkins et al., 2013), 
and controlled cortical impact, findings consistent with prior clinical reports (Begum et al., 2014; 
Rubenstein et al., 2014).  Goldstein and colleagues demonstrated that tauopathy following single 
blast injury was associated with hippocampal-dependent learning and memory deficits at subacute 
and chronic time points.  These changes were also associated with electrophysiological alterations 
in long-term potentiation (Goldstein et al., 2012).  Therefore, even a single mild to moderate injury 
may induce neurodegeneration and neurological deficits leading to impaired cognition and 
disrupted synaptic transmission (Goldstein et al., 2012). Single injury has also been shown to 
contribute to blood brain barrier disruption (Glushakova et al., 2014).  This is a significant finding 
considering the numerous concussive and subconcussive injuries occurring in athletics and on the 
battlefield.  Other studies using single injury models have also demonstrated activation of 
numerous pathological processes and behavioral changes associated with neurodegeneration. 
Modeling neurotrauma related neurodegeneration is a key component in the search for a model of 
CTE (Smith et al., 1995; Logsdon et al., 2014; Lucke-Wold et al., 2014c).  While the importance 
of repeat injury in CTE modeling cannot be overstated, some single injury studies have led to 
advances in the ability to detect phospho-tau in serum at weeks to months post-injury.  These 
advances indicate the potential role of biomarkers in monitoring and understanding disease 
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pathophysiology (Rubenstein et al., 2014).  The development of animal based models that exhibit 
similar characteristics of CTE will afford researchers the opportunity to characterize the acute and 
chronic effects of injury on the phosphorylation of tau in controlled experimental conditions. In 
vitro models may even be beneficial in elucidating changes at the cellular level (Zander et al., 
2015). Evaluating imaging modalities, potential biomarkers, such as phosphorylated tau, and 
proposed therapeutics in a controlled context will promote advancement towards clinical 
applications and could be instrumental for monitoring and understanding disease pathophysiology 
in the future. 
Implications for Modeling CTE: Learning from Past Shortcomings with TBI Models 
Despite these notable advancements in CTE modeling as outlined above, the vast majority 
of repeat injury studies fail to address the role of injury severity, inter-injury interval, and the total 
number of impacts needed to reproduce a CTE-like state (Prins et al., 2010; Goddeyne et al., 2015). 
Most studies simply describe features of TBI without relating the findings to neurodegeneration 
(Loane and Kumar, 2015).  Furthermore, because CTE is a neuropathologic diagnosis, any study 
claiming to serve as a model of CTE must demonstrate the hallmark neuropathologic changes (tau 
hyperphosphorylation and neurofibrillary tangles) and show that these changes persist at delayed 
time points and coexist with behavioral deficits. Few studies have looked at amyloid, tau, or 
TDP43 accumulation following injury. 
One of the most common omissions from repetitive injury paradigms is the lack of 
consideration for inter-injury interval.  Work by Longhi and colleagues directly explored this issue, 
demonstrating that in a mouse model of closed-head injury (CHI), mice had a period of 
vulnerability estimated between 3 and 5 days where the effect of injuries was additive and 
produced deficits in cognition.  When the inter-injury interval was lengthened to 7 days, these 
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deficits were not present (Longhi et al., 2005).  While the focus of that study was elucidating 
differences in the inter-injury interval, other groups employing a repeat injury paradigm should 
consider how the inter-injury interval may relate to their findings. Inter-interval design will be an 
important consideration in developing CTE models.  Attempting to provide a clinical context for 
these decisions would be desirable, with the interval between severe concussive-type impacts 
ideally being longer than that between mild subconcussive-type impacts.  This would expand 
scientific insight for “return-to-play” guidelines that require players to be asymptomatic following 
a diagnosed concussion prior to returning to contact sports.  These types of questions have 
generally not been considered in preclinical work, with most studies using brief inter-injury 
intervals, often ranging from minutes to 24 hours with poor justification for timing (Creeley et al., 
2004; Shitaka et al., 2011; Genovese et al., 2013; Klemenhagen et al., 2013; Petraglia et al., 2014b; 
Wang et al., 2014). 
Another important limitation related to interpretation of injury severity and 
neuropathologic outcome, is the sensitivity of detecting neuropathology using current scientific 
approaches.  Shitaka and colleagues demonstrated previously that silver staining was more reliable 
for detecting axonal injury and pathology in comparison to routine histological analysis, 
assessment of neuronal cell loss, and amyloid precursor protein (APP) immunohistochemistry 
(Shitaka et al., 2011).  It may be increasingly important, particularly in studies of repetitive 
subconcussive impacts, to utilize measures of high sensitivity for injury detection.  Silver staining, 
which has been shown repeatedly to exhibit a higher degree of sensitivity in detecting axonal injury 
than many immunohistochemical techniques; electron microscopy; or other markers with these 
characteristics may prove promising (Shitaka et al., 2011). It has not yet been determined if 
neurofibrillary tangles accumulate around sites of axonal shearing.  
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Key Questions Going Forward 
Improving experimental models will enhance the quest for developing therapeutic agents that can 
be used to prevent and treat CTE.  The search for a model of CTE raises a number of questions 
that are important clinically.  These questions include issues such as length of the inter-injury 
interval, the number and severity of impacts, and the age at time of impacts, as well as the 
mechanism of impact, the gender of the patient, and what role genetic predisposition may play in 
the development of neurodegenerative disease following neurotrauma.  Another important 
question that must be addressed is does a history of neurotrauma and potential presence of CTE 
accelerate the development of Alzheimer’s disease?  Furthermore, how can the period of 
susceptibility following neurotrauma be identified most readily?  In the following sections we 
attempt to address these questions based upon available evidence. We also provide suggestions for 
handling shortcomings going forward.  Studies upon which these sections are based are referenced 
in Tables 1-6 for quick reference. 
Inter-Injury Interval 
The effect of inter-injury interval on outcome following TBI has only recently been 
investigated.  Studies have explored a variety of intervals ranging from 2 minutes apart (in vitro) 
to a few hours (in vivo) to as long as 30 days apart (in vivo).  Using a novel approach assessing 
vasoreactivity in TBI, Fujita and colleagues demonstrated that administration of seemingly mild 
injuries at brief intervals (3 hours apart) produced dramatic declines in vasoreactivity and axonal 
pathology.  When the inter-injury interval was lengthened to 5 hours, the magnitude of these 
changes was diminished substantially with complete dissolution of changes in both pathology and 
vasoreactivity at 10 hours (Fujita et al., 2012b). 
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Other studies that have investigated longer inter-injury intervals have identified periods of 
susceptibility following an initial impact at periods ranging from 24 hours to a few weeks (Meehan 
et al., 2012; Mannix et al., 2013; Bolton and Saatman, 2014; Weil et al., 2014).  Bolton and 
colleagues demonstrated with a CHI model that a single impact produced extensive gliosis 
bilaterally in the hippocampi and entorhinal cortices.  Repeat injury after 24 hours produced a 
more severe injury consisting of hemorrhage in the entorhinal cortices as well as heightened 
measures of neurodegeneration, gliosis, and neuroinflammation (Bolton and Saatman, 2014).  
When the experimental paradigm was changed such that impacts were given with a 48-hour inter-
injury interval, the histopathology resembled that of a single impact suggesting enhanced 
susceptibility when a second impact was administered within 24 hours (Bolton and Saatman, 
2014).   
Mannix and colleagues performed one of the most rigorous investigations of the effect of 
inter-injury interval on outcomes associated with TBI. These studies included measures of both 
cognition and neuropathology related to the development of neurodegenerative diseases such as 
CTE and AD.  In this study, the investigators showed that  animals who received daily or weekly 
injuries with weight-drop had persistent cognitive deficits up to 1 year post-injury (Mannix et al., 
2013).  This was in contrast to when animals were injured biweekly or monthly, which failed to 
produce deficits at such a chronic time point (Mannix et al., 2013).  Notably, the cognitive deficits 
seen in the daily- and weekly-injured animals did not correlate with elevations in tau 
phosphorylation or amyloid-β when measured by ELISA nor brain volume loss when measured 
by MRI (Mannix et al., 2013).  This finding may indicate that in addition to inter-interval time, 
injury severity must be considered. Tauopathy is essential for modeling CTE therefore an 
appropriate inter-injury interval might be best characterized in transgenic animals. Weight drop 
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produces variable injury based on the height of the drop.  A more severe TBI can produce cognitive 
deficits but may not be representative of the concussive and subconcussive injuries associated with 
CTE.  A mild TBI with a transgenic animal will likely produce the most relevant deficits. 
Meehan and colleagues performed a similar study with primarily behavioral assays.  The 
investigators subjected mice to a CHI via weight-drop for a total of 5 impacts at various intervals.  
These intervals included daily, weekly, and monthly intervals.  Mice receiving 5 impacts total at 
daily or weekly intervals were impaired in the MWM compared to sham animals (Meehan et al., 
2012).  This was not the case when injuries were delivered at monthly intervals, as these animals 
exhibited no impairment in the MWM (Meehan et al., 2012).  Interestingly, at one month post-
injury, the daily- or weekly-injured animals still exhibited deficits in the MWM and this deficit 
persisted in daily-injured animals out to 1 year (Meehan et al., 2012).  This finding may represent 
why football lineman who experience daily subconcussive injuries appear more likely to develop 
CTE based on the clinical cases reported. It is still necessary to establish if tauopathy is the driving 
mechanism behind behavior.  The findings confirm and expand upon the inter-interval studies 
completed by Longhi and colleagues (Longhi et al., 2005).  Longhi reported that shorter inter-
interval injuries produce worse outcomes, which is in agreement with the Mannix and Meehan 
findings.  These studies were consistent with findings in higher phylogenetic species as well, 
specifically piglets.  Friess and colleagues showed that a 24-hour inter-injury interval produced 
more severe deficits and higher mortality rates than when the interval was extended to 7 days 
(Friess et al., 2009).  Finally, Kanayama and colleagues demonstrated a graded response in 
locomotor activity. Both shorter inter-injury intervals as well as greater number of total injuries 
were associated with worse outcome (Kanayama et al., 1996). 
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Weil and colleagues explored the effect of altering the inter-injury interval in relation to 
recovery from TBI. They used a clear clinical-minded approach and utilization of metabolic 
imaging (PET).  This group showed that injuries separated by only 3 days were associated with 
worse neuropathology and an inability to mount the typical hypermetabolic response with regards 
to glucose utilization following TBI.  This worse outcome was not seen following either a single 
injury or repeat injuries with an extended inter-injury interval of 20 days (Weil et al., 2014).  
Similarly, a brief inter-injury interval of 3 days was associated with elevated IL-1β and TNFα gene 
expression when compared with other experimental groups (Weil et al., 2014). 
The longest interval between injuries used in preclinical studies, to the best knowledge of 
the authors, was 30 days.  The additional injury had no additive effect on anxiety (EPM), 
depression (FST), and cognitive function (MWM) when compared to animals receiving only one 
injury (Mychasiuk et al., 2014).  These findings indicate that either the window of vulnerability 
following the first injury was avoided or that the response to the first injury may protect the animal 
from subsequent injuries, a concept known as preconditioning (Mychasiuk et al., 2014). The 
progression towards tauopathy was not well characterized in this work. 
In vitro studies have shown similar findings to the in vivo studies described above. Shorter 
inter-injury intervals between mechanical stretching resulted in an elevation in S-100β protein 
release and increased cellular permeability identified with propidium iodide staining (Weber, 
2007).  Similarly, a ‘subthreshold’ level of stretch did not produce any overt cellular damage or 
death when repeated at 1-hour intervals but did cause neuronal loss and neuron-specific enolase 
(NSE) release when performed at incredibly short intervals (every 2 minutes) (Slemmer and 
Weber, 2005; Weber, 2007).  Remarkably, this rapid and repetitive ‘subthreshold’ stretch that 
produced changes in neurons, failed to produce an increase in S-100β protein release,indicating a 
184 
 
differential response between neurons and glia to neurotrauma severity and interval (Slemmer and 
Weber, 2005; Weber, 2007). 
In contrast to the above studies, one group showed that repeat injury, when administered 
in different anatomical locations within the brain, failed to result in heightened damage when an 
inter-injury interval was 3 days. It did however increase tissue vulnerability with a 7-day interval 
as evident by increased hemorrhage (Donovan et al., 2012; Donovan et al., 2014).  The authors of 
the study therefore argue that the period of susceptibility likely depends on not only the time 
interval between injuries, but also the anatomic location of injury (Donovan et al., 2012; Donovan 
et al., 2014).  Importantly, this study utilized an open injury model (controlled cortical impact), a 
scenario that is only seen in a subset of clinical neurotraumas. 
In summary, these studies demonstrate a period of vulnerability following initial injury in 
which sustaining a second brain injury may result in an additive effect.  Additive injury is not 
clearly apparent when the brain is allowed a more extensive recovery period.  Interestingly, this 
vulnerability may not solely be due to initial axonal pathology but may also be the result of 
cerebrovascular reactivity and the inability to utilize glucose effectively (Fujita et al., 2012b; Weil 
et al., 2014).  This concept of a varied cellular response to TBI is consistent with findings from in 
vitro studies that demonstrate a varied response amongst glia and neurons (Slemmer et al., 2004; 
Slemmer and Weber, 2005; Weber, 2007). 
Number of Impacts 
The prevailing theory for ‘mild’ neurotrauma is that repetitive injuries are associated with 
more short- and long-term detrimental effects than a single injury alone (Laurer et al., 2001; 
Mouzon et al., 2012; Bolton and Saatman, 2014).  This concept has been applied regardless of 
injury severity (concussive versus subconcussive) with emerging evidence indicating that even 
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subthreshold impacts are cumulatively detrimental (Fujita et al., 2012b; Bailes et al., 2013).  In 
this section we explore the effect of repeat injury through analysis of studies employing both repeat 
and single injury paradigms. 
One of these studies, conducted by Mouzon and colleagues, showed that when rodents are 
exposed to 5 total injuries with an interval of 48 hours, these animals exhibit both impaired learning 
and memory at extended time points (Mouzon et al., 2014).  These findings are in contrast to single 
injured animals that display only learning deficits but no retention impairment at the same time 
points (Mouzon et al., 2014).  This study closely parallels the clinical findings documented by 
Guskiewicz and colleagues in which former athletes with a history of repetitive concussions 
experience memory-related issues at a rate 5 times higher than those without a history of 
concussion (Guskiewicz et al., 2005; Mouzon et al., 2014).   
Other work that investigated various iterations of impacts (0, 1, 3, 5, and 10) demonstrated 
that while a single injury does not produce deficits in MWM performance in comparison to sham-
injured animals, repetitive injury does in fact produce deficits and these deficits may exhibit a 
dose-dependent relationship.  When mice were given 10 concussive weight-drop injuries, those in 
which the weight was dropped from a height of 42 inches performed worse than those injured from 
a height of 38 inches.  Therefore, this work demonstrates the potential for both injury number and 
injury severity in contributing to neurological dysfunction (Meehan et al., 2012).  Luo and 
colleagues utilized a GFAP-driven luciferase mouse line and a repetitive closed head injury model 
to investigate cumulative decline.  The investigators showed that there appeared to be a linear 
increase in GFAP luminescence from 1 to 3 injuries but that this response appeared to reach a 
plateau by 5 injuries (Luo et al., 2014).  In addition to the increase in GFAP fluorescence with 
repetitive injuries, mice receiving three injuries demonstrated less freezing time than sham animals 
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in both cued and contextual fear conditioning (Luo et al., 2014).  This was in contrast to single 
injury animals that did not differ from sham-injured animals in cued or contextual memory (Luo 
et al., 2014).  Consequently, this data demonstrates that an increase in injury number is associated 
with an increasing severity of injury markers (based on protein expression of GFAP) as well as 
functional deficits (fear conditioning).  Others employing both single and repeat injury paradigms 
have shown that while single injury may not induce pathological findings, repeat injury, of the 
same severity, does.  This was particularly notable in work by Uryu and colleagues in which 
repetitive injury produced an increase in Aβ deposition in Tg2576 animals, whereas no increase 
was observed in single injury paradigms in these same animals (Uryu et al., 2002).  Likewise, 
Kanayama and colleagues demonstrated that repeat injury paradigms induced tau 
hyperphosphorylation, a precursor to NFT formation, in conditions such as CTE and AD 
(Kanayama et al., 1996).  
The observed findings in closed-head, repeat injury models, were also consistent with those 
found in open-head injury using a craniectomy and controlled cortical impact.  In work by 
Donovan and colleagues, the investigators showed that repeat injury induces progressive and 
evolving changes that are not observed in single injury paradigms (Donovan et al., 2014). The 
basis of many of the memory and cognitive changes following repeat TBI, may be explained by 
electrophysiological alterations in synaptic transmission.  In work by Aungst and colleagues, 
repetitive TBI was found to prevent the induction of long-term potentiation (LTP) 28-days post-
injury due to alterations in the NMDA receptor.  This is in stark contrast to single injury paradigms 
that revealed the ability to induce LTP in both hemispheres, with the contralateral hemisphere 
exhibiting less LTP than the ipsilateral hemisphere. The impairments in excitatory 
neurotransmission following repeat injury were accompanied by extensive neuroinflammation and 
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neurodegeneration as well as behavioral/functional impairments (Aungst et al., 2014).  
Specifically, repeat injury produced deficits more severe than single injury when measured at one-
week intervals out to a month.  Importantly, even single injury produced deficits at chronic time 
points post-injury when compared to sham animals, indicating long-term effects of TBI (Aungst 
et al., 2014). 
Povlishock and colleagues expanded the concept of subthreshold injury.  In these studies, 
the investigators showed that administering a single weight-drop injury from 1.0 m resulted in 
neither axonal nor microvascular change.  With repeat injury of short inter-injury intervals (hours), 
significant axonal and microvascular pathology was observed (Fujita et al., 2012b).  This work 
was the first to assess microvascular reactivity to acetylcholine (ACh) following repetitive 
subthreshold brain injury.  This work demonstrates the clear danger of subthreshold impacts when 
sustained in a repeated and rapid fashion.  It also illustrates the role of the microvasculature in 
neuronal injury, showing that the neurovascular unit is essential for neuronal homeostasis. 
Importantly, work regarding the number of impacts has been extended higher up the 
phylogenetic tree to rabbits and piglets (Olsson et al., 1971; Raghupathi et al., 2004).  In rabbits, 
repeated loading with loads of up to 1.5 atm failed to produce an additive concussive response 
over a single load.  A multi-loading paradigm at higher loads however caused respiratory arrest 
(Olsson et al., 1971).  In piglets, multiple less severe injuries induced neuropathological findings 
similar to a severe load based on the density of injured axons as well as number and distribution 
of foci (Raghupathi et al., 2004). 
In vitro studies have reported similar findings to the in vivo studies.  Weber and colleagues 
applied a mild stretch to hippocampal neuronal cultures that produced low-grade injury when 
applied at a single time.  When this injury was repeated, the cells exhibited cumulative damage 
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with two injuries inducing an increase in neuron-specific enolase (NSE) (Slemmer et al., 2004; 
Slemmer and Weber, 2005; Weber, 2007). 
Notably, the group led by Mychasiuk and colleagues provides evidence contrary to the 
widely held belief that an increased number of impacts are associated with detrimental findings on 
behavioral or histological measures.  With a 30-day inter-injury interval, rodents receiving 
multiple injuries performed similar to single-injury animals on measures of anxiety, depression, 
and cognitive ability.  Therefore, they propose that receiving head injury at an early age may prime 
the brain to be less susceptible to the effects of a later neurotrauma, a theory known as ‘pre-
conditioning’ (Mychasiuk et al., 2014).  DeRoss, et al also showed that while one concussive 
impact resulted in diminished performance in 85% of animals, less deviation was seen with 
subsequent impacts. The number of impacts has an inverse relationship with animal performance 
in the water maze (DeRoss et al., 2002).  Again, the mechanism behind these findings is not 
entirely clear as those animals sustaining multiple injuries also received additional exposure to the 
water maze, allowing for enhanced training/learning of the maze (DeRoss et al., 2002).  Therefore, 
while repetitively injured animals did better than single-injured animals in the maze, this is likely 
a product of increased training rather than a protective response but this cannot be said with 
absolute certainty. 
Severity of Impacts 
The effect of injury severity on likelihood of neurodegenerative disease development is not 
entirely clear, although some clinical reports indicate that more severe injury results in a greater 
predisposition for AD development (Plassman et al., 2000; Uryu et al., 2002).  What is known 
from preclinical studies using an array of animal models is that there is a dose-dependent increase 
in neural injury markers and cognitive deficits with more severe injury (DeFord et al., 2002; 
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Manley et al., 2006; Long et al., 2009; Budde et al., 2013; Turner et al., 2013b; Luo et al., 2014).  
Similarly, repetitive ‘mild’ injuries may produce a phenotype more consistent with a single more 
severe injury (DeFord et al., 2002).  
How ‘mild’ TBI contributes to the likelihood of developing CTE remains unclear.  
Emerging evidence from preclinical studies raises concern about lasting effects of subthreshold 
injuries when sustained in a rapid and repetitive fashion.  These repetitive injuries contribute to 
vascular reactivity and subsequent axonal degeneration in vivo (Fujita et al., 2012b).  Some studies 
suggest that severity of injury may dictate the rest period required to minimize cumulative 
cognitive deficits, although further studies are required to validate these findings (Meehan et al., 
2012). 
Similarly, preclinical studies, even those in which only a mild force is imparted to a thinned 
cranium, indicate that a substantive inflammatory response is produced quickly after injury (Roth 
et al., 2014).  This response is associated with heightened vascular permeability, also seen 
clinically, as well as microglial response (Roth et al., 2014).  It is these mechanisms, both primary 
and secondary, that may contribute to neurodegenerative disease post-neurotrauma. 
In vitro studies may be of further use in addressing the role of injury severity, particularly 
in subconcussive/subthreshold-type studies, as levels of injury and subsequent cellular responses 
can be monitored rapidly and performed over a greater number of iterations at a lower cost in 
comparison to in vivo studies.  In fact, a number of injury paradigms and mechanisms have been 
investigated successfully in this manner including fluid pulse-induced shear stress, repetitive 
stretching, and other mechanical deformation procedures, both in vitro and ex vivo (LaPlaca and 
Thibault, 1998; Mukhin et al., 1998; Sieg et al., 1999; Slemmer et al., 2004; Slemmer and Weber, 
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2005; Morrison et al., 2006).  The in vitro shearing studies found a significant amount of axonal 
beading and glial death (LaPlaca et al., 2005). 
Age at Time of Impacts 
Age is the biggest risk factor for the development of neurodegenerative disease and has 
been associated with poor outcomes following TBI in a variety of clinical and preclinical reports 
(Hamm et al., 1991; Maughan et al., 2000; Hoane et al., 2004; Anderson et al., 2009; Wali et al., 
2011; Mehan and Strauss, 2012; Timaru-Kast et al., 2012; Turner et al., 2012d; Turner et al., 2014).  
Similarly, neurotrauma has been associated with an increased risk of neurodegenerative disease 
development with regards to AD (Plassman et al., 2000; Van Den Heuvel et al., 2007; Magnoni 
and Brody, 2010; Sivanandam and Thakur, 2012), PD (Bower et al., 2003), and CTE (Omalu et 
al., 2005; Omalu et al., 2006; McKee et al., 2010; Omalu et al., 2010b; Omalu et al., 2010a; Omalu 
et al., 2010c; Gavett et al., 2011; Omalu et al., 2011a; Omalu et al., 2011b; Goldstein et al., 2012; 
Stern et al., 2013; Montenigro et al., 2014; Omalu, 2014).  One of the primary questions currently 
in the field is how the age at which the patient sustains the neurotrauma pertains to the 
development, or lack thereof, of CTE. 
Similar findings have been observed in preclinical studies.  Mychasiuk and colleagues 
showed that TBI during brain development leads to worse outcomes than TBI affecting the mature 
brain (Mychasiuk et al., 2015).  Preclinical work has also shown that young animals experience 
less edema than middle-aged animals following TBI (Kasturi and Stein, 2009).  The increased 
edema is associated with an increase in lesion size in aged rodents experiencing TBI (Kumar et 
al., 2013).  TBI in aged rodents is also more likely to increase sensorimotor and cognitive decline 
(Hoane et al., 2004).  TBI in youth may ultimately be more detrimental for social development, 
whereas severe injury in the elderly results in rapid cognitive decline due to increased edema and 
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therefore, lesion size.  In regards to human TBI, it is unclear if the elderly would have a more 
progressive form of the disease similar to rodent studies or if the disease would develop in the 
normal manner.  It is also important to consider that males <35 years old are the most likely to 
have repetitive TBIs, a group associated with heavy participation in sports and now the military 
(Theadom et al., 2014).  Future preclinical studies should therefore continue to investigate TBI 
secondary mechanisms in both young and aged animals with particular attention paid to addressing 
repetitive injury paradigms and the development of CTE-like features, both behaviorally and 
biochemically. 
Mechanism of Impact 
CTE has been diagnosed in athletes sustaining direct impacts as a result of participation in 
warfare, football, wrestling, and soccer (Omalu et al., 2005; Omalu et al., 2006; McKee et al., 
2010; Omalu et al., 2010b; Omalu et al., 2010a; Omalu et al., 2010c; Gavett et al., 2011; Omalu et 
al., 2011a; Omalu et al., 2011b; Goldstein et al., 2012; Stern et al., 2013; Montenigro et al., 2014; 
Omalu, 2014).  The mechanism of injury is different between blast and athletic concussions, but 
how these mechanisms relate to injury progression remains to be elucidated. For blast, primary to 
quaternary injury must be considered (Kobeissy et al., 2013). Other important questions include 
what is the influence of linear versus rotational impacts?  What is the effect of direct impacts such 
as a football tackle versus indirect impacts such as primary blast exposure?  Furthermore, how can 
comparisons most accurately be made across these various impacts?  Are accelerometers and 
recording systems (such as the HITS system) the best method for understanding and comparing 
these impacts?  What role does high-speed videography and subsequent kinematic analysis play?  
Each of these questions remains to be answered and may provide further insight into understanding 




Interestingly, glymphatic clearance has recently been shown to play a role in injury 
progression. Iliff and colleagues showed increased tauopathy accumulation in aquaporin knock-
out mice following traumatic brain injury due to disrupted glymphatic clearance (Iliff et al., 2014). 
It has yet to be determined how the primary injury mechanism causes the disruption to glymphatic 
channels. Cernak proposed an interesting theory about low-frequency stress waves transmitting 
kinetic energy through tissue (Cernak, 2015). This mechanism may account for the dysfunction of 
the aquaporin channels. The energy transfer may also injure other cellular components such as 
axons or vessels. Chodobski and colleagues have shown that kinetic transfer of energy can account 
for blood brain barrier disruption (Chodobski et al., 2011). Blood brain barrier disruption post-
injury can trigger increased neuroinflammation. Agoston and colleagues showed that blast 
traumatic brain injury, in particular, causes persistent neuroinflammation, which leads to 
behavioral deficits (Kovesdi et al., 2012). The neuroinflammation can also contribute to post-
traumatic epilepsy and tauopathy (Salazar and Grafman, 2015). Investigating how tauopathy 
spreads is a topic warranting further investigation (Koliatsos and Xu, 2015). Furthermore, 
Kobeissy and colleagues highlight in their recent review that underlying neuronal damage can 
cause lasting neuropsychiatric deficits such as post-concussion syndrome and post-traumatic stress 
disorder (Kobeissy et al., 2013). 
Role of Genetics 
Genetics and lifestyle choices may play a role in likelihood of sustaining a TBI and also 
the outcome following a TBI.  Little to no evidence currently exists regarding lifestyle choices 
associated with TBI and only recently has genetic contribution to CTE been addressed.  
Specifically, it is well known in the human literature that the APO4 allele is associated with worse 
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outcome following TBI (Ponsford et al., 2011).  APO4 and APO3 have also been implicated in 
the development of both CTE and AD (Weber, 2007; Saulle and Greenwald, 2012).  The 
mechanism by which APO4 worsens outcome following TBI is poorly defined (Mannix et al., 
2013), but targeted replacement of the allele in mice has allowed focused research into cholesterol 
metabolism and may lead to insights in the field of traumatic brain injury and subsequent 
neurodegeneration (Laskowitz and Dawson, 2014).  Notably, a study by Maroon and colleagues 
recently demonstrated that there was no significant difference between ApoE4 carriers in a 
population of patients afflicted with CTE when compared to the general population, suggesting 
that perhaps ApoE may not represent a significant risk factor for CTE development, even in 
individuals exposed to neurotrauma (Maroon et al., 2015).   
Other genetic influences have also been observed but are currently limited to preclinical 
evidence. Rare genetic alterations such as mutation of the CACNA1A calcium subunit gene have 
also been shown to lead to poor TBI outcomes in human patients (Kors et al., 2001).  Recent pre-
clinical studies have shed light on other potential genetic factors that may influence TBI outcomes.  
Decreases in micro RNA 23a and 27a increase apoptosis following TBI in rodents (Sabirzhanov 
et al., 2014).  Deficient caveolin expression can exacerbate neuroinflammation post-TBI (Niesman 
et al., 2014).  The knock-in mouse APP696swe has accelerated deposition of A following TBI 
(Yoshiyama et al., 2005).  Emerging evidence also suggests dysfunctional mitochondrial genes 
following TBI such as Fas, Apaf1, and Chp.  Interestingly, these genes become more dysfunctional 
and mutated with time after mild TBI (Sharma et al., 2012). TBI can also induce DNA 
fragmentation leading to an upregulation of p53, a critical regulator of cell cycle (Lu et al., 2000).  
On the other hand, upregulation of insulin growth factor expression prior to TBI is associated with 
neuroprotection (Carlson et al., 2014).  Similarly, genetic regulation of aquaporin 4 channels can 
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reduce edema formation following TBI in rodent models (Ke et al., 2001).  Surprisingly, disruption 
or the PARP1 gene offers protection against TBI hypoxia (Hagberg et al., 2004).  Studying genetic 
risk factors for TBI is an area of growing importance and requires further investigation.  
Understanding factors that lead to increased or decreased TBI severity may also allow the 
development of novel pharmaceutics for the prevention of neurodegenerative disease.  
An emerging area is the role of epigenetic modulation following TBI. Epigenetic markers 
are now being used preliminarily to predict recovery following injury (Lipsky and Lin, 2015). 
VandeVord and colleagues show enhanced methylation of DNA in the rat hippocampus following 
blast traumatic brain injury (Bailey et al., 2015b). These epigenetic changes are mediated by 
HDACs and DNMTs (Bailey et al., 2015a). Interestingly, the methylation changes are cumulative 
with repetitive injury (Haghighi et al., 2015). HDAC has been shown to contribute to GSK3 
activation, which is a known tau kinase. When HDAC is inhibited white matter damage is reduced 
(Wang et al., 2015). Epigenetic regulation has been tied to the development of post-traumatic stress 
disorder clinically (Almli et al., 2015). Targeting epigenetic regulation may therefore be a viable 
target in preventing tauopathy and behavioral deficits following traumatic brain injury. 
Influence of Gender 
The influence of gender on outcome after TBI remains controversial, particularly in light 
of the few cases of CTE diagnosed in women.  Some studies claim that females have better 
outcomes following neural injury (Bramlett and Dietrich, 2001) while others report no change 
(Kadyan et al., 2004; Bruce-Keller et al., 2007), or worse outcome (Farace and Alves, 2000b).  
Estrogen treatment has shown improved outcomes in rodent models of neural injury (Simpkins et 
al., 1997; Suzuki et al., 2007; Jia et al., 2009; Li et al., 2011), including TBI (Gatson et al., 2012; 
Day et al., 2013).  Female rodents exhibit better outcomes after neural injury as evidenced by 
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increased neurotrophin production (Gatson et al., 2012), decreased neuroinflammation (Brown et 
al., 2009), and better performance on motor tasks (Wagner et al., 2004b).  Clinical evidence shows 
that female patients exhibit lower oxidative damage after TBI (Wagner et al., 2004a), which could 
be the result of a higher estrogen circulation following injury.  Gender differences should be 
considered when conducting clinical trials for TBI therapy.  
Interestingly, Dixon and colleagues found that TBI in female humans reduces estradiol in 
the CSF (Garringer et al., 2013). The reduction of estradiol may have unique long-term effects 
because it is not yet known if this is transient or permanent. The limited amount of data about 
women with TBI has restricted the comparisons of injury between genders (Bell and Pepping, 
2001). The majority of traumatic brain injuries in women are subdural hematomas from falls. 
Elderly women with subdural hematomas tend to fair worse than the general TBI population as a 
whole (Farace and Alves, 2000a). Menopause may therefore dampen the neuroprotective 
physiologic properties mediated by estrogen post-injury. TBI in elderly women is also linked with 
earlier onset Alzheimer’s disease (Nemetz et al., 1999). Hormonal changes may also be a 
contributing factor to CTE, but this has yet to be verified. It is clear based on the limited pre-
clinical and clinical data that further investigation into the gender differences surrounding TBI 
outcome is warranted. 
Effect of Environment 
Another area of investigation required for elucidation of factors influencing the likelihood 
and/or severity of CTE development following neurotrauma includes the effect of environment.  





Good social support has been shown to decrease the likelihood of developing a 
postconcussional disorder following acute head injury (McCauley et al., 2001). Strong family 
support is linked to better outcomes (Khan et al., 2003). Another important feature of environment 
is diet. While the effect of diet is well understood with regards to general health, there are limited 
studies relating diet and mental health, particularly in the context of traumatic brain injury.  A 
preclinical study conducted by Mychasiuk and colleagues showed that high-fat diet in conjunction 
with TBI resulted in cumulative deficits on assessments of motor function, short-term working 
memory, and produced depressive-like effects compared to animals with normal diet and TBI 
(Mychasiuk et al., 2014).  Similarly, administration of dietary supplements such as Vitamin E and 
DHA have been shown to improve outcomes from TBI in numerous studies (Conte et al., 2004; 
Wu et al., 2004; Mills et al., 2011b; Mills et al., 2011a; Bailes and Patel, 2014).  The suggestion 
has been made previously, based on evidence that some cases of diagnosed CTE occurred in former 
athletes with a history of anabolic steroid use, that anabolic steroid use may predispose these 
athletes to CTE development.  While this question has not been completely resolved in terms of 
studying markers of CTE, preliminary studies found no difference in amyloid precursor protein 
(APP) expression post-TBI regardless of when anabolic steroids were used (Mills et al., 2012). 
Preconditioning 
Any neural injury model has the potential to be complicated by the concept of 
preconditioning.  Preconditioning at the most basic levels refers to neuroprotection for a given 
injury induced by a prior stimulus/injury.  The concept of preconditioning has been well 
documented in a variety of neural injury models ranging from ischemic stroke to TBI (Weber, 
2007).  Initial stimuli that serve a protective effect in a subsequent injury include but are not 
limited to brief periods of ischemia, chronic exposure to moderate heat or heat acclimation, and 
197 
 
subthreshold or mild injury (Weber, 2007). The proposed mechanism is that neuronal antioxidant 
machinery is upregulated with subthreshold injury thereby increasing the cells ability to respond 
to free radical production during subsequent injuries (Hu et al., 2008) Whether preconditioning 
serves a protective phenomenon in the development of CTE is unclear, but the general clinical 
consensus is that any brain injury no matter how small may be detrimental long-term, 
minimizing any potential benefit of the preconditioning phenomenon (Bailes et al., 2013; 
Talavage et al., 2014).  This is in contrast to preclinical literature demonstrating that sustaining 
repetitive mild injury prior to a single severe injury protects the animal from the most deleterious 
effects of the severe injury (Allen et al., 2000).  In other words, animals receiving repetitive mild 
injury prior to a severe injury do better than animals receiving a single severe injury (Allen et al., 
2000).  Similar findings have been observed in vitro in which subthreshold stretch prevented 
more deleterious injury when a threshold stimulus was given (Slemmer and Weber, 2005).  The 
concept of preconditioning versus additive injury is captured pictorially in Figure 2. 
Summary 
In conclusion, understanding CTE as a disease remains in its infancy and current studies 
remain largely speculative in nature without prospective clinical investigation.  The required 
clinical studies to advance the field mandate extensive financial resources and time.  Preclinical 
studies represent the most promising mechanism for studying many of the basic biologic questions 
about CTE, as discussed above.  While these studies are continuing to evolve, numerous groups 
have reported exciting findings.  Better modeling has allowed more extensive biochemical and 
behavioral characteristics to be defined.  Now that our laboratory and others have established CTE 
models, options for translational investigation of CTE pathophysiology abound.  In this work we 
discussed numerous avenues for addressing translational questions, namely the role of 1) inter-
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injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5) mechanism 
of impact, 6) genetics, 7) gender, and 8) effect of environment on the development of CTE.  We 
also highlighted some of the challenges of CTE modeling and specific requirements for successful 
models.  By improving our understanding about CTE mechanisms, we believe that significant 
strides can be made not only in understanding CTE but also potentially developing prevention and 
therapeutic-related approaches.  A companion manuscript describes our collective experience in 















Figure 7.1. Schematic representation of factors influencing injury outcomes, particularly in 
repetitive injury paradigms.  Initial evidence indicates that longer inter-injury intervals, less 
severe initial injury, a younger age, and female gender may serve as protective effects in repeat 
paradigms.  In contrast, shorter intervals, increased severity, older age, and male gender may be 


















Figure 7.2. Methodological challenges associated with repeat injury in comparison to single 
injury paradigms include balancing equal age at time of exposure versus age at sacrifice.  

































































































































































































































































































A tremendous need for traumatic brain injury (TBI) therapy is driving the focus of research. 
With over 250,000 TBI hospitalizations per year, the neuropsychiatric symptoms and cognitive 
deficits that develop after neurotrauma are detrimental to patients and even those around them. 
An estimated 60 billion dollars in annual healthcare costs are spent to treat the behavioral 
sequelae of TBI. This staggering cost warrants a desperate need for an effective treatment for 
TBI. Much like Stroke, pre-clinical therapeutic success has not translated into the clinic. Over 
the past few decades, the lack of clinical relevance in pre-clinical TBI models has prevented 
effective treatment options from enduring the rigor of clinical trials.  
Historically, our lab has focused on making neural injury models more clinically-
relevant. For instance, our aged model of embolic stroke was better recapitulating clinical 
ischemic stroke in a more relevant pre-clinical sub-population. We wanted to do the same for the 
sub-population of patients who sustain non-penetrating head trauma. As such, we developed a 
clinically-relevant model of blast-induced TBI for young Sprague-dawley rats. To develop our 
model we needed to understand the physical characteristics behind a blast wave and how to scale 
human exposure to rodent exposure. We scaled our model for rat exposure based on lung 
leathality curves and could gauge blast exposure from mild to severe. We could produce gross 
macroscopic hemorrage and mortality with the severe blast exposure, and microscopic neural 
injury and no mortality using the mild blast exposure. Because 75% of all TBI hospitalizations 
are mild in nature, and because mild TBI is often undiagnosed, we used the mild blast exposure 
for the rest of our experiments in order to encompass a larger clinical population and to explore 
underlying mechanism of symptom onset.  
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A relatively new disease has been classified in patients in particular who have sustained 
head injuries and has been called Chronic Traumatic Encephalopathy (CTE). CTE is commonly 
reported in soldiers and athletes due to their susceptibility to multiple head injuries during their 
careers. Impulsivity and memory loss are two symptoms common amongst patients diagnosed 
with CTE. The cause of the disease is largely unknown and warrants further examination. New 
advanced imaging modalities have allowed clinicians to gain a better understanding of disease 
progression, but the pathophysiology of CTE is still in its infancy.  
After model validation, we sought to characterize the temporal and regional profile of the 
blast injury. In addition, we wanted to evaluate rodent behaviors associated with the symptoms 
observed in patients with CTE. Furthermore, we investigated the neurophysiological response in 
brain slice recordings at various time points after TBI. Once we could determine where, when 
and to what extent, neural injury occurred, then we could correlate our biochemical and 
physiological findings to the behavioral changes associated with CTE. After blast injury, we 
discovered microscopic pathology which suggested damage to the neurovascular unit (NVU) in 
the hippocampus and cortex. We also revealed a sustained increase in biochemical markers of 
cell death such as DNA fragmentation and apoptosis after blast. A subtle deficit in short term 
plasticity was also observed at more chronic time points after TBI, and suggested a decreased 
probability of neurotransmitter release. Spatial memory deficits were also oberved using the 
Morris water maze at chronic time points after blast injury. Interestingly, we also observed an 
increase in the phosphorylation of Tau protein, which has been heavily linked to CTE. These 
results were merely a characterization, and more concrete follow-up studies were necessary to 




Tau is a microtubule stabilizing protein found in axons. When neural injury occurs, tau 
can become dissociated from axonal microtubules and become insoluble. Insoluble tau exposes 
multiple phosphorylation sites that are targets of many tau kinases. When tau becomes 
hyperphosphorylated, it changes its conformation and can bind to and aggregate with additional 
tau proteins to form an oligomer. Oligomeric tau is toxic to neurons and is thought to contribute 
to neurodegenerative diseases such as CTE. Therefore, we wanted to first determine the extent of 
tauopathy occurring in rodents exposed to our TBI model.  
CTE is a progressive neurodegenerative disease and has been labeled as a tauopathy due 
to the extent of tau protein aggregation observed in post-mortem samples of those with the 
disease. Tau phosphorylation and aggregation are considered hallmarks of CTE development. 
We observed an increase in marker of tau phosphorylation and conformational change in rats 
exposed to single and repetitive blast. We also revealed that rats subject to repetitive blast injury 
displayed behavioral deficits associated with the neuropsychiatric symptoms observed in patients 
with CTE. Interestingly, Tau changes and cell death markers were discovered in brain regions 
that correlated to the observed behavioral deficits.  
CTE, like many other neurodegenerative diseases have some vascular component to their 
pathophysiology. CTE shows a perivascular tau distribution in clinical samples, so we wanted to 
evaluate damage to the NVU in rodents. We observed an acute increase in Evan’s blue 
extravasation in the frontal cortex and the hippocampus. We also observed astrocyte and 
microglia activation in the same regions, which suggested damage to the NVU. The link between 
damage to the NVU and neurobehavioral dysfunction following TBI is poorly understood. 
Interestingly, we also observed tau changes in brain regions where the damage to the NVU was 
revealed. We believe the primary effects of blast injury can result from damage to the NVU can 
212 
 
trigger secondary injury cascades, which if go untreated, can eventually lead to neuronal cell 
death. 
The overarching goal of this study was to elucidate a link between damage to the NVU 
and the development of tauopathies and cell death. This link would provide us with novel targets 
for pharmaceutical intervention to ameliorate the behavioral sequelae of CTE. Recently 
secondary injury cascades, such as endoplasmic reticulum (ER) stress and neuroinflammation, 
have been hypothesized to be early indicators for the development of tauopathy. We revealed a 
robust increase in markers of ER stress and neuroinflammation within the frontal cortex after 
TBI. Interestingly, we observed impulsive-like behavior in rats after TBI, which is indicative of 
damage to the frontal cortex. These findings support the literature and provides a new 
perspective to the link between vascular injury and neurodegeneration.  
After characterization of secondary injury cascades, we investigated the role of ER stress 
modulation in mediating neuroinflammation, cell death and neurobehavioral dysfunction 
following TBI. ER stress modulation attenuated markers of neuroinflammation and neuronal cell 
death. Moreover, ER stress modulation ameliorated impulsive-like behavior and improved 
working memory in rats after TBI. These results suggest that the ER stress response may be the 
missing link between primary injury and tauopathy development. Elucidation of these 
mechanisms will provide new therapeutic options to reduce neuronal cell death after injury and 
hopefully reduce the symptoms of neurodegenerative diseases, such as CTE. 
 
FUTURE DIRECTIONS 
Because we can’t predict, or prevent a TBI from occurring, and because it is difficult to 
treat neurodegenerative disease once they have been diagnosed, our only option to this point is to 
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target and treat secondary injury cascades. Future studies should aim to causally link secondary 
injury cascades to tauopathy in order to elucidate new drug targets for improving TBI outcome. 
In order to implement an effective treatment strategy we need to intervene early after injury to 
avoid neurodegeneration and inevitable cell death. Therapeutic strategy could be biphasic in 
nature and contain an early intervention of ER stress modulation, followed by a prolonged 
suppression of neuroinflammation for optimal results. Developing effective treatment for TBI 
may be more than just finding novel targets, but also determining the rights times to intervene. 
Better modeling has allowed for more extensive biochemical and behavioral 
characteristics to be defined. Now that our laboratory has established a potential CTE model, 
options for translational investigation of CTE pathophysiology become available. We have 
revealed damage to the NVU, tau pathology, and neurobehavioral dysfunction in rats exposed to 
our TBI model. Bridging the gap between these effects remains the key to therapeutic success. 
Therefore, we investigated secondary injury cascades, such as ER stress and neuroinflammation, 
as potential CTE mechanisms for novel therapeutic intervention. By improving our 
understanding about CTE mechanisms, significant strides can be made to develop novel 
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